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Abstract 
The area surrounding the central canal of the spinal cord is a highly plastic region 
containing a range of poorly defined cell types, including ependymal cells and 
cerebrospinal fluid-contacting cells (CSFcCs). This study aims to characterise 
ependymal cells and CSFcCs, determining whether they are capable of responding 
to neurotransmitters. To test the hypothesis, whole cell patch clamp 
electrophysiology and intracellular dye-loading in in-vitro Wistar rat and C57/bl6 
mouse spinal cord slices were combined with immunohistochemistry.  
CSFcCs could be categorised into three subtypes based on their voltage responses 
to positive current pulses. CSFcCs did not show an immediate electrophysiological 
response to 5HT or substance P but could respond to GABA with a GABAA receptor 
mediated depolarisation or hyperpolarisation. Ependymal cells were defined by their 
passive response properties and high degree of gap junction coupling and could 
depolarise in response to GABA; this could only be partially antagonised by the 
GABAA antagonist, bicuculline. CSFcCs and ependymal cells were both 
depolarised by ACh, with the size of the cholinergic response increasing from 
ependymal cells and subtype 1 CSFcCs to subtype 3 CSFcCs. Evidence indicated 
that the response was direct and mediated by nicotinic ACh receptors (nAChRs). 
Antagonism by the non α7*nAChR antagonist dihydro-β-erythroidinne or 
potentiation by the α7*nAChR modulator PNU-120596 revealed that non 
α7*nAChRs predominantly mediate the cholinergic responses but there is also a 
contribution from α7*nAChRs. These contributions varied between ependymal cells 
and the different CSFcC subtypes, reflecting variation in the functional responses of 
these cells.  
GABA and ACh modulate neurogenesis and plasticity in other neurogenic niches 
and these results demonstrate that they are also capable of modulating cells within 
the neurogenic niche of the postnatal spinal cord. Manipulation of these 
neurotransmitter systems could influence ependymal cell proliferation and 
differentiation resulting in beneficial implications for the treatment of spinal cord 
pathologies. 
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1.1 The spinal cord 
The spinal cord has been predominantly regarded as a relay centre within the CNS 
for many years. It is essential for the relaying of sensory information from the 
periphery to the brain, the subsequent relay of motor information from the brain to 
the periphery and the co-ordination of sensorimotor reflexes. However, it is 
becoming increasingly evident that the spinal cord is far more than a simple relay 
centre. The complex and diverse network of spinal cord neurones can modulate 
both the sensory input, and the autonomic and motor outputs, thus influencing the 
brain’s perception of the sensory information and the magnitude of the autonomic or 
motor responses. Furthermore, certain groups of neurones within the spinal cord 
are capable of generating their own pattern of firing, such as the central pattern 
generators that are involved in controlling the muscle activity that underlies 
locomotion (for review see Kiehn (2006)). 
Structurally, the spinal cord is divided into white matter, consisting of fibre tracts, 
and grey matter, containing neuronal cell bodies and their associated processes. 
The grey matter is further divided into laminae based on the cytoarchitecture of the 
specific areas (Rexed, 1952). The dorsal horn, which receives sensory input, can 
be divided into laminae I-VI. The ventral horn, where the somatic motor neurones 
and their associated interneurones reside, can be divided into laminae VIII and IX. 
The intermediate zone is found between the dorsal and ventral horn and 
incorporates the lateral horn, which contains the intermediolateral column (IML) and 
is associated with autonomic output; the intermediate zone can be divided into 
laminae VII and X.  Lamina X was originally known as the substantia grisea 
centralis as it is the area of the grey matter at the centre of the spinal cord 
surrounding the central canal (CC), and it is this area that the following research 
focuses on.  
 
1.2 Lamina X 
Lamina X forms its dorsal border with the white substance of the dorsal funiculus 
and its ventral border with the commissura alba ventralis. The lateral borders of 
lamina X are formed with lamina VII; these borders are indistinct but are roughly 
where the central grey matter starts to widen towards the dorsal and ventral 
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columns. Lamina X itself can be further sub-divided into the commissural dorsalis 
grisae (the dorsal gray commissure), the commissural ventralis grisea (the ventral 
gray commissure) and the substantia gelatinosa centralis.  
The substantia gelatinosa centralis is the ring of grey matter directly surrounding 
the CC and was considered by Rexed to consist almost wholly of glial cells and 
unmyelinated neuronal processes whilst being poor in neurones. It is this specific 
area that my research focuses on; therefore, the current knowledge about the cell 
types within this area will be most thoroughly examined. In addition, there are many 
other cell types within lamina X that must be considered, as they are likely to impact 
on the cells within the substantia gelatinosa centralis. Finally, the neuronal inputs to 
lamina X and the possible receptors that could mediate the responses to these 
inputs will be discussed.  
 
1.3 Cell types of lamina X 
The cells of lamina X can be divided into four categories: sympathetic preganglionic 
neurones (SPNs), interneurones, cerebrospinal fluid-contacting cells (CSFcCs) and 
ependymal cells.  
1.3.1 Sympathetic preganglionic neurones 
SPNs are peripherally projecting neurones whose axons exit the spinal cord by the 
ventral horn and synapse with the sympathetic postganglionic neurones, which in 
turn synapse with target organs. This sympathetic system is essential for the 
correct functioning of numerous vital organs, including the heart, vascular smooth 
muscle and kidneys. Using various techniques including the retrograde axonal 
transport of horseradish peroxidase (Chung et al., 1975), pseudorabies virus 
(Strack et al., 1989) and fluorogold (Strack et al., 1988) from different autonomic 
ganglia, including the adrenal medulla, SPNs have been identified in three areas of 
the spinal cord. Studeis in both the cat and rat have demonstrated that the majority 
of SPNs reside in the IML in the lateral horn of the spinal cord; others are located in 
the intercalated nucleus (IC), located between the IML and CC and in the central 
autonomic area (CAA) which is found dorsal to the CC in lamina X (Chung et al., 
1975; Strack et al., 1988). SPNs are restricted to the thoracic and upper lumbar 
regions, from segments C8 to L3 (Strack et al., 1988). SPNs can also be identified 
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by their expression of choline acetyl transferase (ChAT), the enzyme necessary to 
produce ACh which thus identifies cholinergic cells (Houser et al., 1983; Barber et 
al., 1984). In the rat these cells are, however, intermingled with numerous other 
ChAT positive interneurones within the CAA. SPNs cannot definitively be 
distinguished by their morphology from these interneurones at autonomic levels, 
although they do commonly have larger cell bodies (Barber et al., 1984). They can 
be distinguished following the intraperitoneal injection of fluorogold, which labels 
only those neurones which have axons terminating in the periphery (Ambalavanar 
and Morris, 1989). SPNs of the IML can also be identified from neighbouring 
interneurones by their electrophysiological properties, for example, in the rat spinal 
cord SPNs have a longer action potential duration than interneurones due to a 
slower repolarisation phase (Deuchars et al., 2001). Although, the action potential 
duration of SPNs in the CAA of the rat was much shorter (3 ms) than that observed 
in SPNs of the IML (9 ms; Bordey et al., (1996a)). The SPNs of the CAA have 
dendrites orientated in numerous directions including laterally projecting dendrites 
that form large ChAT positive transverse dendritic bundles and dendrites that form 
longitudinal dendritic bundles (Barber et al., 1984). Through these dendrites and 
their cell bodies, SPNs receive inputs from supraspinal neurones and local 
interneurones. In the rat, SPNs respond to stimulation of glutamatergic and γ-
aminobutyric acid (GABA)-ergic neurones of the rostral ventrolateral medulla 
(Deuchars et al., 1995; Deuchars et al., 1997) and GABAergic interneurones of the 
CAA (Deuchars et al., 2005). SPNs also respond to substance P (Dun and Mo, 
1988), vasopressin, oxytocin (Backman and Henry, 1984; Hosoya et al., 1995), 
noradrenaline, adrenaline, dopamine (DA) (Lewis and Coote, 1990; Llewellyn-Smith 
et al., 2006), and 5HT (Ma and Dun, 1986; Bacon and Smith, 1988; Pickering et al., 
1994). Many of the functional studies were observing SPNs of the IML, thus it is yet 
to be confirmed whether SPNs in the CAA respond in the same way to all of these 
stimuli. It has been confirmed that SPNs of the CAA respond to 5HT (Pickering et 
al., 1994) and ACh (Bordey et al., 1996a; Bradaia and Trouslard, 2002b; Bradaia et 
al., 2005) and produce glycinergic (Bradaia and Trouslard, 2002a) and GABAergic 
(Seddik et al., 2006) mediated miniature inhibitory postsynaptic potentials 
(mIPSPs). 
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1.3.2 Interneurones 
There are numerous spinal interneurones within lamina X and although some of 
these neurones have been sub-typed using neurochemistry, there is little 
understanding of their function. To date subtypes of GABAergic, cholinergic and 
glutamatergic interneurones have been identified, with the possibility of 5HTergic 
interneurones also being present. 
 
1.3.2.1 GABAergic interneurones 
GABAergic interneurones are distributed throughout many areas of the CNS, 
including the spinal cord. These interneurones are most commonly identified 
through their expression of glutamic acid decarboxylase (GAD), the enzyme which 
synthesises GABA from glutamate. There are two isoforms of this enzyme, GAD65 
and GAD67, and antibodies detecting these enzymes have been used to detect 
GABAergic neurones. More recently, transgenic mice have been generated that 
express green fluorescent protein (GFP) under the control of promoters for GAD65 
and GAD67 (Tamamaki et al., 2003; Lopez-Bendito et al., 2004). This means that 
any neurones that usually express GAD should now express GFP, enabling 
GABAergic neurones to be visualised by fluorescence.  In both the GAD65-GFP 
mice and GAD67-GFP mice, numerous GABAergic neurones can be observed in 
lamina X (Conte, 2009). This distribution is similar to that seen when using GAD 
antibodies or detecting GAD mRNA in rats (Barber et al., 1982; Feldblum et al., 
1995). In the rat, GAD positive soma have a mean area of 153 µm2 and appear to 
be organised into two longitudinal columns either side of the CC, one dorsolaterally 
and one ventrolaterally to the CC (Barber et al., 1982). Although there are GAD 
positive processes in numerous orientations from these neurones, there are more 
processes in a dorsoventral orientation from the dorsolaterally located cells, and 
more longitudinal processes from the ventrolaterally located cells (Barber et al., 
1982). In the rat, a group of presympathetic GABAergic interneurones have been 
identified in the CAA by transneuronal labelling (Deuchars et al., 2005). These 
neurones provide ongoing monosynaptic inhibition to SPNs, which can be 
abolished by the GABAA receptor antagonist bicuculline. Other functions of these 
GABAergic interneurones are, to date, unknown.  
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1.3.2.2 Cholinergic interneurones 
There are two types of cholinergic interneurone located in lamina X throughout the 
entire length of the spinal cord, namely partition neurones and CC cluster cells. The 
partition neurones are such named since they divide the dorsal and ventral aspects 
of the spinal cord as they extend across the intermediate grey matter from the CC 
to the lateral edges of the grey matter (Barber et al., 1984; Phelps et al., 1984). The 
partition neurones can be further divided into lateral, intermediate and medial 
depending on their position within the spinal cord, with the medial partition 
neurones being located in lamina X. Immunohistochemistry for ChAT established 
that these neurones possess complex dendritic arborisations and ventrolaterally 
projecting axons. Combining the immunohistochemistry with retrograde tracing 
using True blue in the rat demonstrated that they can project rostrocaudally up to 
six spinal cord segments from the segment in which the cell body is located 
(Sherriff and Henderson, 1994).  As a result of this projection system they have 
been suggested to play a role in activities that require the co-ordination of 
numerous spinal segments (Sherriff and Henderson, 1994). Following fictive 
locomotion, which initiates the circuitry controlling movement without movement 
actually occurring, some partition neurones in the cat spinal cord express the 
activity dependent c-fos transcription factor, demonstrating that they are part of the 
circuitry involved in locomotion (Huang et al., 2000).  A subpopulation of the ChAT 
positive medial partition neurones in the postnatal mouse spinal cord can be 
defined by their expression of the promoter for developing brain homeobox protein 
1, Dbx1, and the expression of paired-like homeodomain transcription factor, Pitx2, 
during their development, and their lack of expression of nitric oxide synthase 
(Miles et al., 2007; Zagoraiou et al., 2009). The axons from this subpopulation of 
partition neurones form c-bouton synapses with motor neurones enabling them to 
regulate motor neurone excitability (Miles et al., 2007; Stepien et al., 2010). Genetic 
inactivation of ChAT in these specific neurones impairs the locomotor task-
dependent modulation of hindlimb muscle activity (Zagoraiou et al., 2009; Stepien 
et al., 2010).  
The CC cluster cells are a group of small neurones found in the grey matter 
surrounding the CC. ChAT positive processes from these cells contribute to small, 
longitudinal fascicles located near the ependymal layer in the rat spinal cord. These 
fascicles are most commonly observed ventral to the CC (Barber et al., 1984). 
These cells, like the partition neurones, have been observed to send projections up 
to six spinal cord segments away (Sherriff and Henderson, 1994). Although little is 
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known about these CC cluster cells it appears that at least a subpopulation are 
involved in locomotion, as evidenced by the fact that in the cat spinal cord they too 
express the activity dependent marker, c-fos, following fictive locomotion (Huang et 
al., 2000). 
Due to the intersegmental projections of these cholinergic interneurones and their 
location in lamina X, it has been suggested that they provide a relay between 
dorsal, intermediate and ventral grey matter, providing integration between sensory, 
motor and autonomic functions (Borges and Iversen, 1986; Deuchars, 2007). 
 
1.3.2.3 Glutamatergic interneurones 
A population of small interneurones expressing the homeodomain transcription 
factor, Hb9, were identified predominantly in medial lamina VIII but also in ventral 
lamina X in mice (Hinckley et al., 2005; Wilson et al., 2005). These interneurones 
express vesicular glutamate transporter 2 (VGlut2) mRNA and are immunoreactive 
for the VGlut2 protein, therefore they are glutamatergic. They also receive 
glutamatergic inputs from both peripheral sources, identified by the expression of 
vesicular glutamate transporter 1 (VGluT1), and central sources, identified by the 
expression of VGlut2, as well as receiving input from 5HT-containing terminals 
(Wilson et al., 2005). These cells exhibit numerous characteristics expected of 
interneurones participating in locomotor rhythm generation. For example, there are 
pronounced membrane potential oscillations in these cells following the application 
of chemical stimuli that induce locomotor activity (Wilson et al., 2005), the activity 
dependent marker c-fos is expressed in these neurones following walking (Wilson 
et al., 2005) and the activity of these interneurones is synchronised to rhythmic 
ventral root output (Hinckley et al., 2005; Hinckley et al., 2010).  
 
1.3.2.4 5HTergic interneurones  
There is much debate over the presence of intraspinal 5HT interneurones. A few 
studies have shown 5HT positive interneurones within lamina X of the spinal cord in 
monkeys and rats (Lamotte et al., 1982; Newton et al., 1986; Takeoka et al., 2009). 
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These interneurones were located in levels associated with autonomic function, 
including T4-L2 and L6-S1, with the greatest numbers in T7-T10 (Newton et al., 
1986). In the rat, these interneurones were always observed either dorsal or lateral 
to the CC and never ventral to the CC (Newton et al., 1986), however, in the 
monkey these interneurones were predominantly observed ventral to the CC 
(Lamotte et al., 1982). To support the presence of these interneurones, following a 
spinal cord transection at T9, 5HT immunoreactive fibres were observed in lamina 
X at T12, L3 and S1  in the rat (Takeoka et al., 2009). Despite these positive 
identifications of 5HT immunoreactive interneurones in the spinal cord many 
groups, including the Deuchars’s lab, have been unable to detect any intraspinal 
5HT interneurones; this could be due to a difference in antibodies used, the fact 
that these neurones have a small profile in transverse sections or due to their 
sparse numbers (Takeoka et al., 2009).  
 
1.3.3 Cerebrospinal fluid-contacting cells 
CSFcCs are an unusual cell type found within the substantia gelatinosa centralis. 
The cell bodies of CSFcCs are found predominantly in the subependymal layer 
surrounding the CC, but are also found within the ependymal layer itself (Figure 
1.1). These cell bodies are roughly 92 µm2, much smaller than nearby 
interneurones in rats (Barber et al., 1982). The defining feature of all CSFcCs is the 
process that extends from the cell body and through the ependymal layer to contact 
the cerebrospinal fluid (CSF) in the CC; this is commonly referred to as the CSF-
contacting process (Vigh et al., 1977). The CSF-contacting process terminates in 
an enlarged bulb, 4-5 µm wide, which possesses stereocilia (Vigh et al., 1977). 
Although CSFcCs appear to be remarkably well conserved throughout evolution, 
this feature of CSFcCs varies between mammalian and non-mammalian 
vertebrates. The terminal bulbs of CSFcCs of non-mammalian vertebrates have 
numerous stereocilia and a larger kinocilium; in contrast mammalian CSFcCs 
possess fewer stereocilia and no kinocilium (Vigh et al., 1983). The CSFcCs also 
have axons that extend from the cell bodies to terminate on the ventral and 
ventrolateral surfaces of the cord in numerous species (Vigh et al., 1977; 
Shimosegawa et al., 1986; Lamotte, 1987; Stoeckel et al., 2003). These axons 
contain synaptic vesicles and express synaptic machinery such as synaptotagmin 
and synaptophysin, however in the rat, electron microscopy revealed that the 
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Figure 1.1: Morphology of CSFcCs. 
A) Electron microscope image of a CSFcC with a round nucleus (N) and the CC-
contacting process extending between two ependymal cells (E) to contact the 
lumen of the CC, arrowheads indicate P2X2 labelling (Stoeckel et al., 2003). B and 
C) Immunohistochemistry for doublecortin (Dcx) and polysialylated-neural cell 
adhesion molecule (PSA-NCAM), highlighting the distribution of CSFcCs around 
the CC, arrows indicate CSFcC cell bodies and arrowheads indicate CSF-
contacting processes (Marichal et al., 2009).
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distribution of these proteins was throughout the axonal tracts but not in synaptic 
endings (Stoeckel et al., 2003). Using immunohistochemistry and electron 
microscopy in rats, unmyelinated axons believed to belong to CSFcCs were 
observed in close apposition to the basal bodies of ependymal cells; these axons 
were immunoreactive for GAD, GABA, P2X2, synaptotagmin and growth associated 
protein (GAP)-43 (Stoeckel et al., 2003). The lack of synaptic endings observed in 
these axons combined with the expression of GAP 43, a protein which is expressed 
at high levels throughout axon genesis and is believed to play a role in 
synaptogenesis (Benowitz and Routtenberg, 1997), suggests that these axons are 
immature in nature or are involved in axonal remodelling.  
CSFcCs have previously been classified into subtypes based on their morphology, 
including the shape of the cell body or on the relationship between the CSF-
contacting and axonal processes. The cell bodies can be either oval, polygonal or 
elongated (Shimosegawa et al., 1986). The axonal processes extend from (1) the 
basal surface of the cell body, directly opposite the CSF-contacting process; (2) the 
lateral surface of the cell body; (3) the same origin as the CSF-contacting process; 
and (4) regions further along the CSF-contacting process (Shimosegawa et al., 
1986). This demonstrates the variations in morphology that are present within the 
CSFcC population, although it is unknown whether these morphologically different 
CSFcCs perform specific functions.  
 
1.3.3.1 Possible functions of CSFcCs 
Most of the hypotheses regarding the function of CSFcCs have been based on their 
expression of different enzymes, neurotransmitters, neuromodulators and receptors 
that has been determined through immunohistochemical studies. The expression of 
such molecules is different between non-mammalian and mammalian vertebrates, 
however, the variation may appear greater than it is due to a lack of investigation of 
all molecules in all species. To outline the actual variation, as opposed to lack of 
data, Table 1 states those species that were positively immunoreactive for a 
molecule and those that were found to be negatively immunoreactive for the same 
molecule. Although mammalian CSFcCs are the focus of this research, it is 
important to look at non-mammalian vertebrate CSFcCs to compare the 
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Table 1.1: Immunoreactivity of CSFcCs to several neurotransmitters, enzymes 
and receptors in numerous species.  
[1] (Nagatsu et al., 1988); [2] (Jaeger et al., 1983); [3] (Roberts et al., 1995); [4] 
Deuchars’s Lab; [5] (Barber et al., 1982); [6] (Fernandez et al., 2002); [7] (Margeta-
Mitrovic et al., 1999); [8] (Lamotte, 1987); [9] (Fuji et al., 1983); [10] (Gibson et al., 
1981); [11] (Shimosegawa et al., 1986); [12] (Stoeckel et al., 2003); [13] (Huang et al., 
2006). 
Enzyme, Neurotransmitter or 
Receptor  
Species with CSFcCs 
immunoreactive for 
 
Species with CSFcCs 
not immunoreactive for 
 L-aromatic acid 
decarboxylase (AADC) 
Mouse [1], Rat [2]  
Tyrosine Hydroxylase (TH) Eel, Trout [3] Mouse, Rat [1,2] 
Dopamine-β-hydroxylase 
(DβH) 
 Mouse, Rat [1] 
DA Eel, Trout [3] Mouse, Rat [1] 
Phenylethanolamine N-
methyltransferase (PNMT) 
 Mouse, Rat [1,2] 
5HT  Mouse, Rat [2] 
GAD Mouse [4], Rat [5], Eel, 
Trout [3], Turtle [6] 
 
GABAB Receptors Rat [7]  
Vasoactive intestinal 
polypeptide (VIP) 
Cat, Monkey [8], Rat [9], 
Guinea Pig [10] 
 
Methionine-enkephalin-Arg6-
Gly7-Leu8 
Rat [11]  
ACh  Eel, Trout [3], Mouse, 
Rat [4] 
P2X2 Mouse [4], Rat [12]  
Polycystic kidney disease-2-
like 1 (PKD2L1) 
Mouse [13], Rat [4]   
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differences. Whether these differences could have impacted on the loss of 
regenerative capacity of mammalian spinal cords is of great importance.One of the 
greatest differences observed between mammalian and non-mammalian CSFcCs is 
their expression of monoamines. Non-mammalian CSFcCs, such as those of the 
eel and trout, express tyrosine hydroxylase (TH), the enzyme that is needed for the 
production of DA, and express DA itself (Roberts et al., 1995). On the other hand 
mammalian CSFcCs are devoid of DA, TH, 5HT and dopamine-β-hydroxylase 
(DβH) and phenylethanolamine N-methyltransferase (PNMT), the enzymes 
required for the conversion of DA to noradrenaline and noradrenaline to adrenaline, 
respectively (Jaeger et al., 1983; Nagatsu et al., 1988). It is interesting to note, 
however, that despite the lack of expression of all these monoamines and the 
enzymes required for their synthesis, the CSFcCs of both mice and rats express L-
aromatic acid decarboxylase (AADC), the enzyme that converts L-3,4-
dihydroxyphenylalanine (L-DOPA) to DA and 5-Hydroxytryptophan to 5HT (Jaeger 
et al., 1983; Nagatsu et al., 1988). Another cell type, known as monoenzymatic-
AADC neurones have been discovered throughout the brain, including in the 
suprachiasmatic nucleus (Ishida et al., 2002; Ugrumov, 2009). Also within the 
suprachiasmatic nucleus, in-situ hybridisation, has found mRNA for a membrane 
transporter of large neutral amino acids that can capture L-DOPA from the 
extracellular fluid (Fernandez et al., 2005). Loading the extracellular fluid of the 
suprachiasmatic nucleus with L-DOPA resulted in the appearance of DAergic 
neurones whose distribution correlated with that of AADC neurones (Ishida et al., 
2002), implying that these AADC-neurones can take up L-DOPA from the 
extracellular fluid and subsequently convert it to DA. As CSFcCs are in contact with 
the CSF, it is possible that they could be performing a similar function. The 
expression of DA within CSFcCs could have been missed as L-DOPA may only be 
available at certain times of day or following certain perturbations. Alternatively the 
expression of AADC could be an evolutionary remnant that is no longer functional. 
The one consistency between all species investigated to date is their expression of 
the enzyme GAD, the enzyme required to produce the neurotransmitter GABA 
(Barber et al., 1982; Roberts et al., 1995; Fernandez et al., 2002). This 
conservation throughout evolution suggests that the expression of GABA within 
CSFcCs is one of functional significance. In mammals GABAergic CSFcCs are 
found surrounding the CC in dorsal, ventral and lateral locations (Barber et al., 
1982). In non-mammalian vertebrates, such as the eel and trout, there is a location 
specific expression of GABAergic CSFcCs as they are predominantly found lateral 
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to the CC, with DAergic CSFcCs located surrounding the ventral pole of the CC  
(Roberts et al., 1995). It would appear that throughout evolution the expression of 
monoamines such as DA has been lost, however, that of GABA has been 
maintained and these GABAergic CSFcCs could be compensating for the loss of 
the monoaminergic CSFcCs.  
It is possible that it is not only the cell bodies of CSFcCs that are GABAergic, 
electron microscopy studies in the rat demonstrate that CSFcCs possess small, 
clear synaptic vesicles in the CSF-contacting terminal bulbs (Unpublished 
observation Deuchars’s Lab). Given the lack of monoamine and ACh expression in 
mammalian CSFcCs it would be logical to suggest that the small, clear synaptic 
vesicles are either GABA- or glutamate-containing. In support of the presence of 
GABA within these vesicles, immunohistochemistry has revealed the presence of 
the vesicular GABA transporter (VGAT), which is necessary to load synaptic 
vesicles with GABA, within the CSF-contacting terminal bulbs in rats (Conte, 2009). 
In addition, large, dense granules were observed within the terminal bulb using 
electron microscopy in rats. As immunohistochemistry has revealed the presence of 
the endogenous opioid peptide, methionine-enkephalin-Arg6-Gly7-Leu8, in the rat 
(Shimosegawa et al., 1986) and vasoactive intestinal polypeptide  (VIP) in the 
monkey within CSFcCs it could be proposed that one of these peptides is present in 
the large, dense granules, although neither have been confirmed by electron 
microscopy (Fuji et al., 1983; Gibson et al., 1984; Lamotte, 1987). In addition to 
these vesicles, this lab has identified that the terminal bulb contains certain 
molecules involved in the exocytosis of synaptic vesicles, including synaptic vesicle 
protein 2 (SV2) and synaptophysin (Edelmann et al., 1995; Chang and Sudhof, 
2009) . This indicates that mammalian CSFcCs could be capable of releasing 
GABA or peptide transmitters into the CSF of the CC, suggesting that the CSF-
contacting process has a secretory function. 
The CSF-contacting process could also perform a sensory function.  The presence 
of cilia suggests that CSFcCs have a mechanosensory function, possibly 
monitoring the flow of CSF (Vigh et al., 1977), although this has never been 
supported by any functional studies. In addition, as mammalian CSFcCs possess 
fewer and less developed cilia than non-mammalian CSFcCs (Vigh et al., 1983) it 
suggests that mechanosensation would be limited and that it is not the primary 
function of mammalian CSFcCs. 
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CSFcCs also express receptors and channels capable of sensing the environment 
suggesting that CSFcCs could perform a different type of sensory function. These 
sensory ion channels are expressed on both the cell bodies and CSF-contacting 
processes of CSFcCs of mice and rats. One of these channels is the purinergic 
receptor, P2X2 (Figure 1.1), a non-selective cation channel whose natural ligand is 
ATP (North and Surprenant, 2000; Stoeckel et al., 2003). Despite the ligand being 
ATP, the function of this receptor is also modulated by pH (King et al., 1997; Stoop 
et al., 1997). P2X2 receptors expressed by CSFcCs do appear to be functional as 
the application of ATP elicited a depolarisation, with the channel properties 
resembling those of P2X2 receptors (Marichal et al., 2009). Another channel 
observed in CSFcCs is the transient receptor potential polycystin 3 channel, also 
known as polycystic kidney disease-2-like 1(PKD2L1) channel (Stoeckel et al., 
2003; Huang et al., 2006). PKD2L1 is a relatively newly discovered channel 
therefore its properties are poorly understood. However, when in a complex with 
polycystic kidney disease-1-like 3 it has been observed to respond to the 
application of acid with a large inward current (Ishimaru et al., 2006). PKD2L1 is 
believed to be found within the cytosol, thus it reacts to intracellular acidification as 
opposed to extracellular acidification (Huang et al., 2008), although intracellular 
acidification can occur as a consequence of extracellular acidification; on activation 
PKD2L1 appears to mediate intracellular calcium release (Huang et al., 2008). 
CSFcCs increase their rate of action potential firing in response to a decrease in pH 
from 7.4 to 6.9 (Huang et al., 2006), and to produce a large inward current in 
response to a 100 ms pressure application of pH 6 solution (Marichal et al., 2009), 
although the channel through which this response was mediated was not 
determined in either experiment. The CSFcCs considered so far have been spinal 
CSFcCs, however, there are also CSFcCs present in the dorsal vagal complex of 
the mouse brainstem that express PKD2L1 (Orts Del'immagine et al., 2012). In 
these brainstem CSFcCs, spontaneous single channel activity with properties 
strongly resembling those of PKD2L1 channels have been reported (Orts 
Del'immagine et al., 2012). 
The ability of CSFcCs to respond to changes in pH and ATP implies that they could 
be sensing the CSF or the extracellular solution in the area surrounding the CC. 
Alternatively or indeed additionally, the CSFcCs could be receiving synaptic inputs 
from ATP-releasing terminals on to post-synaptic densities containing P2X2 
receptors. Electron microscope studies in the rat and mouse have shown that 
CSFcCs are contacted by synaptic boutons (Stoeckel et al., 2003; Alfaro-Cervello 
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et al., 2012) providing evidence that CSFcCs are to some extent integrated into the 
circuitry of the spinal cord; however, what neurotransmitters are present in these 
synaptic boutons is yet to be observed at the ultrastructural level. 
Immunohistochemistry in rats has revealed GABAergic terminals in close apposition 
to CSFcCs (Mclaughlin et al., 1975) and functional studies, also in rats, suggest 
that these terminals form synapses onto CSFcCs as whole cell patch clamp 
recordings reveal that CSFcCs can respond to the pressure application of GABA, 
although whether this effect was direct was not investigated  (Marichal et al., 2009).  
The GABAergic response in this investigation was mediated by GABAA receptors 
as it was fully antagonised by the GABAA receptor antagonist gabazine (Marichal et 
al., 2009); however, as this experiment was not performed in a low Ca2+ solution or 
in the presence of compounds that prevent synaptic transmission, unequivocal 
evidence for the expression of GABAA receptors by spinal CSFcCs has not been 
provided. At a membrane potential of -80 mV spontaneous inward current activity 
that is antagonised by gabazine has been observed in mouse brainstem CSFcCs, 
indicating the presence of functional GABAergic synapses onto brainstem CSFcCs 
(Orts Del'immagine et al., 2012). Immunohistochemistry has provided evidence 
indicating that CSFcCs express GABAB receptors in the rat (Margeta-Mitrovic et al., 
1999), although as yet there is no functional evidence for the presence of GABAB 
receptors in CSFcCs. Nevertheless, the combined evidence suggests that CSFcCs 
could release GABA and respond to GABA, implying that the CSFcCs could 
communicate with each other and could regulate their own excitability with a 
negative feedback mechanism.  
Finally, with regards to function, it has been proposed that CSFcCs could connect 
the internal CSF, found within the CC, with the external CSF, found surrounding the 
entire spinal cord (Vigh et al., 2004). The CSFcCs could become excited through 
either mechanosensation of the CSF flow within the CC or via changes in pH or 
neurotransmitter content of the CSF within the CC, and as a result release 
neurotransmitters into the external CSF. However, although this may be their 
function in lower vertebrates, the lack of synapse formation observed in the axons 
of mammalian CSFcCs (Stoeckel et al., 2003) suggests that they are not involved in 
secreting neurotransmitter or neuropeptides into the external CSF. It appears more 
likely that their primary role is to sense the environment in their immediate vicinity 
due to the functional evidence showing their ability to respond to changes in ATP 
concentrations and pH, and possibly use this information to regulate the local 
environment surrounding the CC.   
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1.3.3.2 Phenotype of CSFcCs 
One big question regarding CSFcCs is whether they are mature neurones, 
immature neurones, glial or a mixed population of cells. There are two main 
methods used to study cell types, immunohistochemistry and electrophysiology. 
Immunohistochemistry has revealed that CSFcCs in the mouse do not express glial 
fibrillary acidic protein (GFAP; Hamilton et al., (2009); Sabourin et al., (2009)) a glial 
marker, indicating that they are not glial cells. However, in the rat they do not 
express neuronal nuclei (NeuN), a widely used marker of mature neurones, either 
(Mullen et al., 1992; Marichal et al., 2009). There are a few types of mature 
neurones that do not express NeuN, including cerebellar purkinje cells (Mullen et 
al., 1992); therefore a lack of NeuN is not a definitive method for determining 
whether CSFcCs are neurones. In fact, immunohistochemistry in the rat and mouse 
has revealed that CSFcCs express doublecortin (Dcx), polysialylated-neural cell 
adhesion molecule (PSA-NCAM), neuronal specific class III β-tubulin (Tuj1), the 
neurone specific RNA binding protein (HuC/D) and GAP 43 (Figure 1.1; Stoeckel et 
al., (2003); Hamilton et al., (2009); Marichal et al., (2009); Conte (2009)). These are 
proteins predominantly expressed during states of maturation, at times when the 
neurone is considered immature; however, they can also be expressed by mature 
neurones undergoing plastic changes (Lee et al., 1990; Theodosis et al., 1991; 
Benowitz and Routtenberg, 1997; Okano and Darnell, 1997; Brown et al., 2003). 
Using PSA-NCAM as an example, many areas in the adult CNS contain neurones 
that regularly undergo morphological alterations, such as dendritic remodelling 
which leads to alterations in the existing synapses; in these areas there is a high 
expression of PSA-NCAM, for example in the adult hypothalamo-neurohypophysial 
system of the rat (Theodosis et al., 1994). It is possible that the area surrounding 
the CC is one such area whose neurones are regularly undergoing morphological 
and thus synaptic remodelling. 
To better determine whether CSFcCs are mature neurones that undergo plastic 
changes, immature neurones or a mixture of both, functional studies using whole 
cell patch clamp electrophysiology were employed. In rats, this has revealed that 
CSFcCs are a heterogenous population. They have characteristics of immature 
neurones that are at varying degrees of maturity. Based on the electrophysiological 
properties of mammalian CSFcCs from the rat they have previously been divided 
into three different subtypes (Marichal et al., 2009). The first subtype had high input 
resistances and responded to depolarising current pulses with slow Ca2+-mediated 
depolarisations that were abolished in the presence of Mn2+. The second subtype 
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had smaller input resistances and produced what the authors termed as a spike in 
response to the injection of a positive current pulse. The use of the term spike 
rather than action potential implies that although this was a significant, fast event 
with a depolarising and repolarising phase, it did not meet the normal definition of 
an action potential in that the size was smaller and the half-amplitude duration 
slower than would be expected; this term spike will be used throughout this work in 
the same context. The single spikes observed in this subtype had an average 
amplitude of 38 mV, an average half amplitude duration of 6 ms and were abolished 
in the presence of TTX, thus indicating that they were mediated by voltage-gated 
Na+ channels. The third subtype was able to respond to the positive current pulse 
with multiple spikes. On average these spikes had a larger amplitude of 56 mV and 
a shorter half-amplitude duration of 4 ms, than those in the second subtype. Within 
this subtype there can be further differentiation; some CSFcCs responded with 
robust repetitive firing, whereas others could not sustain the firing throughout or the 
half-amplitude duration of the spikes increased throughout the pulse.  
CSFcCs also varied in their responses to GABA; from their resting membrane 
potential some CSFcCs depolarised whilst others hyperpolarised, with reversal 
potentials ranging from -43 mV to -80 mV (Marichal et al., 2009). The varying 
reversal potentials were due to differences in intracellular Cl- concentration, which 
are determined by the variable expression of the Na+-K+-2Cl- cotransporter 
(NKCC1) and the K+-Cl- cotransporter (KCC2). Immature neurones express high 
levels of NKCC1 (Clayton et al., 1998) which drives Cl- into the cell in exchange for 
the extrusion of Na+ and K+, thus maintaining a high intracellular Cl- concentration. 
On activation of GABA receptors the Cl- ions exit the cell due to the concentration 
gradient, causing a depolarisation. As neurones mature they express less NKCC1, 
thus the KCC2 transporter has a greater influence over the intracellular Cl- 
concentration (Rivera et al., 1999); KCC2 drives Cl- out of the cell in exchange for 
K+ moving into the cell thus the intracellular Cl- concentration is lower as neurones 
mature. Thus the lower intracellular Cl- concentration means that when GABA 
receptors are activated the Cl- moves into the cell, causing a hyperpolarisation. 
Therefore the variable responses of CSFcCs to positive current pulses and GABA 
appear to support the belief that CSFcCs are immature neurones at varying levels 
of maturity. 
Another question to ask concerning CSFcCs is whether they are born postnatally? 
To investigate this question, a number of studies have used 5-bromo-2’-
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deoxyuridine (BrdU), a marker that can be incorporated into newly synthesised 
DNA during the S phase of the cell cycle, highlighting newly developed cells 
(Wojtowicz and Kee, 2006). Under physiological conditions in the rat, CSFcCs were 
only observed when the BrdU injections were given during the embryonic period, 
E7-E17, not when the injections were given during the postnatal period, P0-P5, 
providing evidence that CSFcCs are born in the embryo and not postnatally 
(Marichal et al., 2009). Furthermore, other studies have been unable to observe co-
localisation of BrdU with the mature neuronal marker, NeuN, or the immature 
marker, Dcx, either under physiological conditions or following perturbations 
(Johansson et al., 1999; Horner et al., 2000; Martens et al., 2002; Mothe and Tator, 
2005). A small number of studies have observed newborn neurones in the adult 
spinal cord and these will be discussed later, however, those newborn neurones 
observed do not have the morphology of CSFcCs (see section 1.5.4.2; Danilov et 
al., (2006); Shechter et al., (2007); Vessal et al., (2007); Shechter et al., (2011)). 
 
1.3.4 Ependymal Cells 
Other than the CSFcCs, the most well defined cell type within the substantia 
gelatinosa centralis is the ependymal cell. This is the cell type that directly 
surrounds the CC forming the barrier between the CSF and the rest of the grey 
matter. It is becoming increasingly clear that there are different subtypes of 
ependymal cells as well as other poorly defined cell types within the ependymal 
layer.  
Ependymal cells in the postnatal spinal cord of the mouse are derived from Nkx6.1 
homeodomain progenitor gene-expressing ventral neuroepithelial cells (Fu et al., 
2003). In the rat, they line the CC with a single layer in most areas of the CC; 
however, in certain regions there can be up to four layers of ependymal cells (Bruni 
and Reddy, 1987).  The thickness of the ependymal layer is generally dependent on 
the spinal region, with the thoracic region having the thinnest ependymal layer, 
followed by the cervical region, then the lumbar region and finally the sacral region 
generally has the thickest ependymal layer  in the rat (Bruni and Reddy, 1987).  
The ependymal cells themselves are a pseudostratified cuboidal to columnar shape 
with a round nucleus located in the mid to basal aspect of the cell (Bruni and 
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Reddy, 1987). Microvilli cover the apical cell surface, with a cluster of long cilia in 
the centre projecting into the CC. Neighbouring ependymal cells have closely 
apposed lateral margins that are joined by zonula adherins junctions near the apical 
surface (Del Bigio, 2010).  In the rat, the basal surface of the ependymal cells is 
separated from the underlying grey matter by a basement membrane that consists 
of collagens and fibronectin (Azzi et al., 1989). Ependymal cells are also connected 
to each other by gap junctions, allowing intercellular communication and aiding in 
ion homeostasis and volume regulation. Both connexin 43 (Belliveau and Naus, 
1995; Ochalski et al., 1997; Marichal et al., 2012) and connexin 45 (Chapman et al., 
2012) are present in ependymal cells of the rat spinal cord. Connexin 30 is 
expressed in ependymal cells lining the ventricles (Kunzelmann et al., 1999); 
however, it is not known whether it is expressed in those lining the CC. 
Immunohistochemistry in the mouse has revealed that ependymal cells express 
both the intermediate filament protein, vimentin, and the calcium binding protein, 
S100β (Hamilton et al., 2009). Sox2, another marker of undifferentiated stem and 
progenitor cells in the forebrain subventricular zone (SVZ)  is expressed by all 
ependymal cells surrounding the CC in the mouse (Hamilton et al., 2009). 
Ependymal cells in the rat express the transporter NKCC1 (Kanaka et al., 2001), 
suggesting that they accumulate intracellular Cl-, as described previously for 
immature neurones.   
Few electrophysiological studies of ependymal cells have been made; however, a 
recent study by Marichal et al., (2012) has provided the first electrophysiological 
characterisation of ependymal cells at the lateral aspects of the CC of the 
mammalian spinal cord in P0-P5 rats. The cells recorded had a low input resistance 
of 124 ± 24 MΩ, a hyperpolarised resting membrane potential of -84 ± 2 mV and 
passive responses to depolarising current pulses, with a linear voltage-current 
relationship. The study demonstrated gap junction coupling between ependymal 
cells, through dye-coupling observed by Alexa 488 which was present in the 
intracellular solution of the patch pipette. The functional presence of gap junctions 
was demonstrated by an increase in input resistance observed following the 
application of the gap junction blocker, carbenoxelone. This study did not 
investigate whether the ependymal cells could respond to neurotransmitters.  
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1.3.4.1 Ependymal cell subpopulations 
Studies have analysed the ultrastructure of cells in the ependymal layer using 
electron microscopy and as a result have identified a plethora of subpopulations of 
ependymal cells in the murine spinal cord (Meletis et al., 2008; Alfaro-Cervello et 
al., 2012). The classical cuboidal ependymal cell was identified using the marker 
FoxJ1, which specifically identifies cells with motile cilia (Meletis et al., 2008). 
Studying the ciliary structure of these ependymal cells revealed that the most 
common ependymal cell type had two long motile (9+2 microtubule axoneme 
structure) cilia; this was named as a biciliated ependymal cell (Alfaro-Cervello et al., 
2012). There were also ependymal cells with one, three and four cilia; the cells with 
four cilia were binucleated, containing two distinct nuclei (Alfaro-Cervello et al., 
2012). All of these cells expressed the intermediate filament protein, vimentin, 
which is typically used to identify ependymal cells (Alfaro-Cervello et al., 2012). A 
subpopulation of these cells express the cannabinoid receptor, CB1, in the mouse 
(Garcia-Ovejero et al., 2012). 
In addition to the cuboidal ependymal cells described above, a number of studies in 
the murine spinal cord have determined cells that have varied structural or 
molecular properties from the cuboidal ependymal cell (Meletis et al., 2008; 
Hamilton et al., 2009; Sabourin et al., 2009; Alfaro-Cervello et al., 2012; Marichal et 
al., 2012). Unfortunately, there is currently no consensus as to what these cell types 
should be called, with each study using different names; the following paragraphs, 
figure 2 and table 2 aim to clarify this issue by uniting the findings.  
Using scanning and transmission electron microscopy a population of CC-
contacting astrocytes (Acc) were observed within the ependymal layer in cervical, 
thoracic and lumbar regions surrounding of the spinal cord; these cells contacted 
the CC through a thin process, had a primary cilium and were defined as astrocytes 
due to their expression of GFAP (Alfaro-Cervello et al., 2012). These Accs were 
distributed in the lateral and ventral regions around the CC and also expressed 
vimentin and nestin.  
All of the other subpopulations of ependymal cells had a preferential expression at 
either the dorsal or ventral poles (Meletis et al., 2008; Hamilton et al., 2009; 
Sabourin et al., 2009). The FoxJ1 marker identified a cell type whose cell body was 
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Cell type Markers Location surrounding CC 
Vimentin GFAP Nestin BLBP Dcx 
Cubiodal ependymal cell 
  
 + - - - - All regions 
Acc [1]  + + + - - Lateral, ventral 
Radial ependymal cell [4] Nestin-expressing [2] + ? + ? - Dorsal, ventral, few lateral 
GFAP-expressing [2] + + ? ? - Dorsal, ventral 
BLBP-expressing [3] - + ? + - Dorsal 
Radial glia [5]  - - + ? - Dorsal, ventral 
CSFcC [6]  - - - - + All regions 
Table 1.2: Summary of the cell types in the ependymal layer of the spinal cord of postnatal mice.  
[1] (Alfaro-Cervello et al., 2012), [2] (Hamilton et al., 2009), [3] (Sabourin et al., 2009), [4] (Meletis et al., 2008), [5] (Marichal et al., 2012), [6] 
(Marichal et al., 2009). 
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similar to that of cuboidal ependymal cells but had a long basal process that 
extended from the cell bodies found at the dorsal and ventral poles of the CC along 
the dorsoventral axis; these cells were termed radial ependymal cells (Meletis et al., 
2008). Using immunohistochemistry, three markers were identified predominantly at 
the dorsal pole but also at the ventral pole of the CC in the mouse and rat: GFAP, 
nestin and brain lipid binding protein (BLBP; Hamilton et al., (2009); Sabourin et al., 
(2009); Alfar-Cervello et al., (2012); Marichal et al., (2012)). All of these markers 
identified the cell bodies plus the radially projecting fibres. The GFAP-expressing 
cells located at the dorsal and ventral poles appear to differ from those of Accs as 
some studies observed that they did not co-localise with vimentin (Alfaro-Cervello et 
al., 2012), although other studies have observed a co-localisation of the two 
proteins (Hamilton et al., 2009); this could be due to the use of different antibodies. 
GFAP-expressing cells at the dorsal pole only co-localise with the less frequently 
observed BLBP-expressing cells (Sabourin et al., 2009; Alfaro-Cervello et al., 
2012). Nestin-expressing cells are also observed at the dorsal pole, with fewer seen 
at the ventral pole and a very small amount found in lateral regions of the CC in the 
rat (Hamilton et al., 2009). The nestin expressing cells co-localise with vimentin but 
it is unclear whether they co-localise with either GFAP or BLBP (Hamilton et al., 
2009). The cells defined as radial ependymal cells by Meletis et al., (2008) could 
encompass all of the cells types observed at the dorsal and ventral poles with 
different protein expressions, therefore, until further clarification is made these cells 
will be referred to as radial ependymal cells.    
In the turtle, a lower vertebrate, neural progenitor cells known as radial glia are 
expressed in high numbers around the CC throughout adulthood (Russo et al., 
2008). These radial glia express BLBP and have a long process that extends away 
from the CC; on this classification the BLBP expressing radial ependymal cells 
observed in rats and mice could be radial glia (Meletis et al., 2008; Russo et al., 
2008; Hamilton et al., 2009; Sabourin et al., 2009). Interestingly, some of the nestin 
expressing processes extending along the dorsal and ventral midline in the rat 
spinal cord have been found to originate from cell bodies further away from the CC, 
it has also been proposed that these cells could be the equivalent mammalian 
radial glia (Marichal et al., 2012). Unlike the cuboidal ependymal cells found at the 
lateral aspects of the CC, these nestin-expressing cells that have been proposed as 
radial glia were found to have a higher input resistance (361 ± 56 MΩ), a lack of 
dye-coupling, outward currents with the properties of delayed rectifier K+ currents 
and A-type K+ currents and inward currents with properties of low voltage-activated 
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Ca2+ currents (Marichal et al., 2012). The radial glia in the turtle depolarise in 
response to GABA, a response which is mediated via the GABA transporter (GAT)-
3 and through GABAA receptors and induces an increase in intracellular Ca2+ (Reali 
et al., 2011). It remains to be seen whether radial ependymal cells or radial glia in 
mammals are capable of a similar response. 
 
 
Figure 1.2: Cell subtypes surrounding the CC of the postnatal spinal cord in 
mammals. 
 
1.3.4.2 Neurogenic potential of ependymal cells 
As stated some subpopulations of ependymal cells within the mammalian postnatal 
spinal cord express nestin and GFAP; these are both expressed by neural 
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progenitor cells and neural stem cells in other postnatal neurogenic niches, 
although GFAP is also used widely as a marker of astrocytes. Ki67, which is 
expressed by actively proliferating cells at all stages of their cell cycle (Gerdes et 
al., 1984), and BrdU, a marker of newborn cells, are also expressed by ependymal 
cells. The following section will examine these points further, discussing the 
neurogenic potential of ependymal cells and using other postnatal neurogenic 
niches for comparison.  
The SVZ is a well established and characterised mammalian postnatal neurogenic 
niche located near the walls of the lateral ventricles in the brain (Ihrie and Alvarez-
Buylla, 2011). It consists of a quiescent population of ependymal cells that line the 
lateral ventricles and a heterogeneous subependymal cell population that consists 
of astrocytes, transit amplifying progenitors, neuroblasts, tanycytes, microglia and 
blood vessels (Doetsch et al., 1997; Tavazoie et al., 2008). The neural stem cells 
are believed to be the subependymal astrocytes, which express GFAP, retain an 
apical contact with the lateral ventricle and produce the transit amplifying progenitor 
cells that in turn produce the neuroblasts which mature and migrate to become 
olfactory bulb neurones (Lois and Alvarezbuylla, 1994; Doetsch et al., 1999; 
Mirzadeh et al., 2008). There are parallels that can be drawn between the SVZ and 
the CC region, namely the presence of cells expressing GFAP and the neural stem 
and precursor marker, nestin (Doetsch et al., 1997; Hamilton et al., 2009). To 
distinguish whether GFAP- and nestin- expressing cells are capable of proliferation 
in the CC region as well as the SVZ, immunohistochemistry for Ki67 was combined 
with immunohistochemistry for GFAP or nestin in the rat (Hamilton et al., 2009). 
Ki67 immunohistochemistry in the rat and mouse revealed that there was 
proliferation in the ependymal layer and that it was predominantly found at the 
dorsal pole of the CC (Hamilton et al., 2009; Sabourin et al., 2009). Ki67 was 
commonly found co-labelled with nestin at the dorsal pole, indicating that the 
population of nestin expressing cells within the CC are important in proliferation 
(Hamilton et al., 2009). In contrast to the involvement of nestin expressing cells in 
proliferation in the CC region and the role of GFAP expressing astrocytes in the 
SVZ, Ki67 was never seen to co-localised with GFAP (Hamilton et al., 2009), 
suggesting that GFAP expressing cells of the ependymal layer are not involved in 
proliferation.  It is possible, however, that proliferating GFAP expressing cells could 
have been missed for two reasons. Firstly, the GFAP expressing ependymal cells 
are fewer in number than the nestin expressing ependymal cells. Secondly, the 
GFAP expressing astrocytes in the SVZ are a slowly proliferating cell type unlike 
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some of the nestin expressing cells in the SVZ (Doetsch et al., 1997), therefore if 
the same is true for the CC region, the slower proliferation rate could have been 
missed by the Ki67 immunohistochemistry. 
In addition to the use of Ki67 immunohistochemistry, BrdU (Wojtowicz and Kee, 
2006) has been used to investigate the proliferation of cells surrounding the CC 
(Johansson et al., 1999; Hamilton et al., 2009). These methods showed that, in-vivo 
under physiological conditions in rodents, ependymal cells proliferate but that this 
appears to be in the form of symmetrical ependymal division, with the purpose to 
maintain ependymal cell numbers, and not to produce any non-ependymal progeny 
(Johansson et al., 1999; Hamilton et al., 2009). However, grey matter from cervical, 
thoracic, lumbar and sacral adult mouse spinal cord tissue can be cultured in-vitro 
to form spheres of undifferentiated cells, known as neurospheres, which can be 
separated into individual cells that self renew (Weiss et al., 1996). These cells can 
also be stimulated by epidermal growth factor and basic fibroblast growth factor to 
differentiate into neurones, astrocytes and oligodendrocytes (Weiss et al., 1996), 
providing evidence that the cells are multipotent. The ability of cells to self renew 
and produce cells of multiple lineages are the two key criteria required for a cell to 
be classed as a neural stem cell, thus neural stem cells are present in the spinal 
cord. Importantly, if the CC region is not present within the cultured mouse tissue 
there is a distinct lack of neurosphere formation even when both epidermal growth 
factor  and basic fibroblast growth factor are present within the culture media 
(Martens et al., 2002); this implies that cells within the area surrounding the CC are 
neural stem cells. Injection of the dye, 1,1’-dioctadecyl-6,6’-di(4sulphopentyl)-
3,3,3’,3’tetramethylindocarbocyanin (DiI), into the ventricles of rats labelled cells 
lining the CC, allowed tracking of these cells and their progeny and demonstrated 
that following spinal cord injury cells lining the CC differentiated into astrocytes 
(Mothe and Tator, 2005). To confirm that it is ependymal cells specifically that are 
the neural stem cells, a genetically modified FoxJ1 mouse was made that had an 
inducible, permanent and heritable reporter gene, β-galactosidase (Meletis et al., 
2008). FoxJ1 is restricted to cells with motile cilia, for example ependymal cells, 
thus in FoxJ1 mice, any new born cells produced from ependymal cells will be 
identified by their β-galactosidase expression. In these mice, all of the ependymal 
cell division was symmetrical under physiological conditions, however, following 
spinal cord injury ependymal cells differentiated into both astrocytes, which 
subsequently migrated towards the site of injury and oligodendrocytes (Meletis et 
al., 2008; Barnabe-Heider et al., 2010). Therefore, it appears that ependymal cells 
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need specific environmental conditions and cues to differentiate as opposed to 
merely proliferate.  
One example of a factor that could be influencing the neural stem cell potential of 
ependymal cells is the oxygen levels, for example hypoxia prevents neural stem cell 
differentiation and promotes proliferation (Gustafsson et al., 2005). The notch 
pathway has been shown to be essential to allow this hypoxia driven control of 
neural stem cell proliferation and differentiation (Gustafsson et al., 2005). In fact, 
notch signalling has been shown to heavily influence neurogenesis in the adult 
zebrafish, with inhibition of the notch pathway increasing the generation of new 
motor neurones following a spinal cord injury (Dias et al., 2012). Furthermore, the 
ability of ependymal cells to differentiate into different populations of interneurones 
is being studied in the zebrafish spinal cord (Kuscha et al., 2012). The ability of this 
organism to generate new neurones in the spinal cord is in contrast to the restricted 
generation of new neurones in the mammalian system, as will be subsequently 
discussed, and means that zebrafish are a great model to study spinal cord 
regeneration. 
There are currently only a few studies that have observed the formation of new 
neurones in the adult mammalian spinal cord (Danilov et al., 2006; Shechter et al., 
2007; Vessal et al., 2007; Shechter et al., 2011), and of these studies only one 
could define the cells surrounding the CC as the source of this neurogenesis 
(Danilov et al., 2006). The first case was in a model of multiple sclerosis, known as 
experimental autoimmune encephalomyelitis, in rats (Danilov et al., 2006).  This 
study used the same technique as Mothe & Tator (2005), injecting DiI into the 
ventricles to label cells surrounding the CC. These cells proliferated and in 10/15 
animals they differentiated into cells which expressed the neuronal markers NeuN 
and Tuj1, and the newborn cell marker, BrdU. These newborn neurones could 
produce action potentials in response to the injection of a positive current pulse, 
indicating that they are also functional. The second case observed newborn 
neurones expressing both the marker of immature neurones, Dcx, and BrdU 
predominantly in the dorsal horn under physiological conditions in the mouse 
(Shechter et al., 2007). It is not clear why this study would observe such a 
phenomenon when others using the same technique have failed to make such 
findings, however, it could be due to the administration of a higher dose of BrdU 
compared to studies which failed to find newborn neurones, or a difference in the 
antibodies used to detect the neuronal nature of the newborn cells. The third case 
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related to the second and revealed that an increased number of newborn neurones 
were produced two-four weeks following the repeated exposure to novel tactile 
stimuli; this study also used a higher dose of BrdU and the same neuronal marker 
(Shechter et al., 2011).  Finally, the fourth case observed newborn neurones in the 
dorsal horn in both primates and rats following a dorsal root lesion but not following 
a dorsal column transection (Vessal et al., 2007). The cells were identified as 
newborn using BrdU and identified as neuronal using the neurone markers, NeuN, 
Dcx and GAD67. In addition to these studies, when neural stem cells originating in 
the rat spinal cord are implanted into the hippocampus they can differentiate into 
neurones (Shihabuddin et al., 2000). These studies, with the exception of Shechter 
et al., (2007) indicate that newborn neurones can be produced in the adult spinal 
cord but under specific conditions. They also indicate that ependymal cells are one 
of the sources of newborn neurones (Danilov et al., 2006) but there could be other 
sources, for example a neural progenitor population in the dorsal horn (Vessal et 
al., 2007; Shechter et al., 2011).   
 
1.3.4.3 Other proposed functions of ependymal cells 
For many years ependymal cells had been considered to perform little more than a 
barrier function between the CSF in the ventricles and CC and the grey matter of 
the brain and spinal cord. In addition to the role they appear to have in 
neurogenesis, it is becoming clear that they are a multifunctional cell type that 
perform a wide range of tasks. To date, most of the studies investigating ependymal 
cells are relevant to those lining the ventricles of the brain, with few studies 
investigating ependymal cells lining the CC; therefore unless stated the following 
applies to ependymal cells of the ventricles but it is likely that some properties will 
be conserved in ependymal cells of the CC. It must be noted that many of the 
following studies consider ependymal cells as a single cell type and thus do not 
consider any variation between cuboidal and radial ependymal cells.  
The barrier function assigned to ependymal cells is an important one, as they 
produce proteins that are capable of preventing harmful metabolites in the CSF 
from re-entering into the grey matter (Del Bigio, 2010). For example, ependymal 
cells in rats and humans express catechol-O-methyltransferase, an enzyme 
involved in the inactivation of catecholamines (Matsumoto et al., 2003) and mice 
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express monoamine oxidase B, an enzyme involved in the inactivation of biogenic 
amines (Vitalis et al., 2002). These enzymes could protect the grey matter from 
trace amines that are found in the CSF (Vitalis et al., 2002). In line with this, 
ependymal cells can also regulate the amount of energy substrates present in the 
CSF; evidence for this come from the rat and mouse and includes their possession 
of facilitative glucose transporters (Yu et al., 1995; Kobayashi et al., 1996; Silva-
Alvarez et al., 2005), which can remove glucose from the CSF, glucokinase, which 
can act as a glucose sensor, and monocarboxylase transporters, which are 
involved in the uptake and release of lactate, pyruvate and ketone bodies (Pierre et 
al., 2000). This ability could ensure that energy substrates within the CSF are 
maintained at the necessary levels.  
Ependymal cells can also release substances, including growth factors and thus 
perform a trophic function both in the developing and adult CNS (Del Bigio, 2010). 
These growth factors include fibroblast growth factor 2 (Cuevas and Gimenez-
Gallego, 2000), which is important for brain development but is also expressed in 
the adult rat, vascular endothelial growth factor, which is expressed embryonically 
in humans (Arai et al., 1998) and appears to be important for the stability of 
ependymal cells themselves (Maharaj et al., 2008), and S100β, which is a Ca2+ 
binding protein that is expressed embryonically and throughout adulthood and has 
both neurotrophic and gliotrophic properties, amongst many other growth factors 
(Del Bigio, 2010). 
The function of ependymal cell cilia has been a source of much debate. Recently, 
the (9+2) cilia of mammalian ependymal cells surrounding the CC have been 
observed to move back-and-forth, in a motion consistent with that seen for other 
(9+2) cilia (Alfaro-Cervello et al., 2012); this is in contrast to the rotary motion 
observed by the (9+0) cilia that are present on the ependymal cells surrounding the 
zebrafish CC (Kramer-Zucker et al., 2005).  Cilia on ependymal cells can beat in a 
coordinated way (Roth et al., 1985); this beating can be increased by the 
application of 5HT and adenosine, with the effect of ATP being variable as both 
increases and decreases in ciliary beating have been observed following its 
application in rats and mice (Nguyen et al., 2001; Genzen et al., 2009b). The 
receptor mediating the 5HT regulation is unknown and it can only be postulated that 
the P2X7 receptor mediates the ATP response, due to the presence of P2X7 
mRNA in rat ependymal cells throughout the ventricular system and CC (Yu et al., 
2008; Genzen et al., 2009a). Selective A2B receptor antagonists confirmed that it is 
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this receptor mediating the adenosine induced ciliary beating in rats (Genzen et al., 
2009b). The variation in ciliary beat frequency along the ventricular system of 
hamsters suggests that ciliary beating does not contribute to the bulk flow of CSF, 
however, it could still aid in the movement of cellular debris along with the bulk flow, 
ensuring that the CC, which is a narrow cavity, remains unobstructed (Roth et al., 
1985). It has also been postulated that this ciliary beating could stir the local CSF to 
facilitate diffusion of its contents, optimising the dispersal of neuronal messengers 
(Roth et al., 1985; Nguyen et al., 2001). Indeed it has been suggested that these 
cilia could aid in the formation of concentration gradients of guidance molecules in 
the CSF that direct the migration of neuroblasts from the SVZ to the olfactory bulb 
(Sawamoto et al., 2006).  
As demonstrated, ependymal cells are a multifunctional cell type, performing a 
protective barrier from harmful CSF metabolites, facilitating diffusion of messengers 
within the CSF and acting as neural stem/progenitor cells. It is only recently that the 
importance of ependymal cells has been recognised and there is still a lot to 
discover about this cell type. 
 
1.4 Cerebrospinal fluid 
Given the close proximity of cells within the substantia gelatinosa centralis to the 
CSF it is important to understand a little about CSF, including its flow, composition 
and proposed functions. 
1.4.1 Flow of CSF 
The adult human CNS has a constant volume of roughly 140 mls of CSF, with 
approximately 30 mls within the ventricles and CC, and 110 mls in the 
subarachnoid spaces found on the outside of the brain and spinal cord (see review 
Veening and Barendregt (2010)). CSF is produced by areas of specialised epithelial 
cells called the choroid plexus; these are located in parts of the lateral, third and 
fourth ventricles. The bulk flow of CSF is in a caudal direction, from the lateral 
ventricles, through the third ventricle to the fourth ventricle. At the base of the fourth 
ventricle, CSF can either flow into the subarachnoid space to bathe the outside of 
the brain or it can flow down into the CC where it will eventually reach the filum 
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terminale and access the subarachnoid space. CSF in the subarachnoid space 
eventually passes through membrane structures called arachnoid granulations to 
drain into the venous blood. CSF has been observed to flow at a rate of 1 ml/minute 
within the CC of the rat. This bulk flow throughout the ventricular system and CC 
appears to be driven by the arterio-venous pressure gradient and CSF secretion in 
the choroid plexus. In addition to the bulk flow, there is also laminar flow of CSF; 
this type of flow occurs close to the ependyma and appears to be driven by the 
ciliary beating of ependymal cells, as a result the flow is not necessarily in a caudal 
direction and it achieves mixing of the constituents of CSF (see reviews Johanson 
et al., (2008); Skipor and Thiery (2008); Veening and Barendregt (2010)). 
 
1.4.2 Composition of CSF 
CSF is a clear fluid as it is 99 % water. It also contains numerous ions, Na+, K+, 
Ca2+, Mg2+, Cl- and HCO3-, and micronutrients such as vitamin C, folates, 
deoxyribonucleic acids, vitamin B6 and glucose (Spector and Johanson, 1989). The 
concentration of K+, Ca2+, HCO3- and glucose are all lower in CSF than in plasma 
and the pH, usually 7.33, is slightly more acidic. Although the amount of proteins 
found in CSF is only 0.5 % of that found in blood plasma (Spector and Johanson, 
1989), there is still a wide range of proteins found within the CSF. Detailed 
proteonomic analysis of human embryonic CSF revealed the presence of numerous 
peptides, with 27.8 % being involved in protein metabolism and modification, 25 % 
being involved in signal transduction, 16.1 % being involved in developmental 
processes and 4.4 % being involved in cell proliferation and differentiation 
(Zappaterra et al., 2007). Finally, there are a host of supra- and sub-ependymal 
structures containing different neuroactive substances that are differentially 
distributed over specific regions (see review Veening and Barendregt (2010)). For 
example, in rats and monkeys terminals originating in the raphe nuclei and 
containing 5HT have been located along the walls of the ventricular system but 
were particularly dense along the third ventricle where they are well placed to 
release 5HT into the CSF (Chan-Palay, 1976). Other neuroactive substances 
observed in terminals in the CSF include luteinising hormone releasing hormone, 
corticotrophin releasing factor, adreno-corticotropic hormone, melatonin, 
neuropeptide tyrosine and oxytocin (see reviews Skipor and Thiery (2008) ; 
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Veening and Barendregt (2010)). These terminals could release these substances 
into the CSF and enable their widespread and long distance distribution.  
 
1.4.3 Function of CSF 
One of the first noted functions of the CSF was that it provides buoyancy to the 
brain, which aids in protecting the brain from any damage that would otherwise 
result from any sudden movements of the head (Spector and Johanson, 1989). 
Another function is to remove waste products; these products diffuse into the CSF 
from interstitial fluid and are carried in the bulk flow to be removed into the venous 
circulation. More recently it has become apparent that the CSF contains many 
molecules that are important in cellular signalling and can influence cellular 
proliferation. Combined with the fact that the apical surfaces of neural stem cells 
border with the CSF, this has led to the hypothesis that CSF can influence 
neurogenesis (see review Lehtinen and Walsh (2010)). In support of this, cultures 
of neurospheres formed from human neural stem cells can be maintained when 
CSF alone is used as the culture medium (Lehtinen et al., 2011). Molecules 
including insulin-like growth factor 2, Slit1/2 and sonic hedgehog are found within 
the CSF and studies where their expression has been altered demonstrates their 
ability to influence neurogenesis (Sawamoto et al., 2006; Huang et al., 2010; 
Lehtinen et al., 2011). Thus, CSF is a complex fluid that works in unison with 
ependymal cells to ensure the health of the grey matter. 
 
1.5 Inputs to lamina X 
As well as the possible neuroactive substances found in the CSF, lamina X 
receives many neuronal inputs from the periphery, from supraspinal nuclei and from 
local interneurones found with the spinal cord itself. These inputs vary in the 
neurotransmitters that they release and the functional relevance of such inputs is 
predominantly unknown.  
Terminals expressing VGluT1 have been observed in lamina X of the rat; terminals 
expressing VGluT1 are generally considered to arise from neurones in the 
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periphery, supporting the presence of inputs from the periphery to lamina X 
(Kaneko et al., 2002). The inputs from the periphery have been identified as 
nociceptive primary afferents in the cat and monkey (Light and Perl, 1979). 
Terminals expressing endogenous opioid met-enkephalin (Hokfelt et al., 1977; 
Gibson et al., 1981) and substance P (Hokfelt et al., 1975; Gibson et al., 1981) 
have been identified in lamina X of the rat. In addition to the widespread distribution 
of substance P expressing terminals within lamina X, immunohistochemistry 
revealed a dense plexus of substance P fibres ventral to the CC in the rat (Barber 
et al., 1979). Although whether these substance P fibres are from the periphery, 
supraspinal regions or substance P-immunoreactive interneurones that have been 
identified in the dorsal horn of the cat (Arvidsson et al., 1990) is unknown.  
Known supraspinal inputs include noradrenergic terminals, revealed by DβH, which 
are found in close apposition to both partition neurones and CC cluster cells inn the 
rat (Takeoka et al., 2010). There are also inputs from the hypothalamus, with 
orexin-, vasopressin- and oxytocin- expressing terminals observed within lamina X 
of a number of different mammals, predominantly within the CAA where the SPNs 
reside (Swanson and Mckellar, 1979; Sawchenko and Swanson, 1982; van den 
Pol, 1999). There are many 5HT-immunoreactive terminals in lamina X with 
5HTergic axon varicosities observed close to the CC, in close apposition to ChAT 
positive SPNs, partition cells and CC cluster cells in the rat (Takeoka et al., 2009). 
Anterograde and retrograde tracing in the rat have revealed that the majority of 
these terminals originate from supraspinal sources, particularly the raphe nuclei in 
the brainstem (Bowker et al., 1981; Bacon et al., 1990). Some axons, however, 
have been identified from thoracic (T10) to sacral (S1) spinal cord that is caudal to 
a spinal cord transection at T9, indicating that at least some of the axons arise from 
rarely observed 5HT interneurones in the rat (Takeoka et al., 2009).  
As well as the VGluT1-immunoreactive terminals observed in lamina X, VGluT2-
immunoreactive terminals have been observed in the rat (Kaneko et al., 2002), 
indicating the presence of glutamatergic inputs from within the CNS. These VGlut2-
containing terminals could originate from the glutamatergic interneurons, observed 
in the mouse, in lamina X and lamina VII that influence the motor output from the 
spinal cord (Wilson et al., 2005; Hinckley et al., 2005). There are many ChAT 
positive fibres in lamina X with some terminal-like structures observed in close 
apposition to ChAT negative cells in the ependymal layer of rats (Barber et al., 
1984; Phelps et al., 1984). It is likely that these cholinergic terminals originate from 
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cholinergic interneurones, including the partition neurones and the CC-cluster cells. 
There are also many GABAergic terminals observed within lamina X of the rat 
(Mclaughlin et al., 1975) with electron microscopy revealing that some of these 
GABAergic terminals form synapses with ependymal cells (Magoul et al., 1987). 
The source of these GABAergic terminals could be the local GABAergic 
interneurones that are found lateral to the CC in the rat (Barber et al., 1982). 
Given the variety of inputs to lamina X, it is important to consider the receptors that 
are present within lamina X that could be mediating the postsynaptic responses to 
the release of neurotransmitters or neuromodulators from these inputs. The 
following sections 1.6-1.9 will focus on the receptors that are present within lamina 
X that could be mediating responses to cholinergic inputs (section 1.6), GABAergic 
inputs (section 1.7), 5HTergic inputs (section 1.8) and substance P inputs (section 
1.9). These chapters will consider the structure, composition, distribution and 
function of the relevant receptors as well as the role that these receptors are known 
to play in postnatal neurogenesis. The focus is on these four neurotransmitter 
systems as there are a large amount of ACh-, GABA-, 5HT- and substance P-
containing terminals within lamina X, in particular in the area directly surrounding 
the CC, suggesting that all of these neurotransmitters/neuromodulators are well 
placed to influence CSFcCs and ependymal cells. In addition, there is evidence that 
each of these neurotransmitters can influence neurogenesis which is pertinent 
given the neurogenic potential of this area. More specifically, the GABAergic 
system is considered due to previous reports of GABAergic responses in CSFcCs 
and the influence of GABA on neurogenesis in other areas. The 5HTergic and 
substance P systems are considered as they can be assigned more specific roles 
than GABA and thus give an indication of the function of CSFcCs if they were to 
respond to these neurotransmitters. Finally, the cholinergic system is considered 
due to the great influence that is has on the other postnatal neurogenic niches, the 
DG and the SVZ.  
 
1.6 Cholinergic receptors 
There are a vast array of cholinergic receptors located throughout the body whose 
properties and functions are highly varied. Cholinergic receptors can be divided into 
two subtypes: muscarinic ACh receptors (mAChRs) which are metabotropic 
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receptors that are coupled to heterotrimeric guanine nucleotide-binding proteins (G-
proteins) and nicotinic ACh receptors (nAChRs) which are ligand-gated ion 
channels.  
1.6.1 Structure, distribution and function of mAChRs 
mAChRs are class I, seven transmembrane, G-protein coupled receptors; they are 
encoded by five mammalian genes (M1-M5), and are also known as receptor 
subtypes M1-M5 (Caulfield and Birdsall, 1998). mAChR subtypes are coupled to 
different G-proteins (see reviews Caulfield (1993); Caulfield and Birdsall (1998)). 
M1, M3 and M5 receptors preferentially couple to the Pertussis toxin-insensitive 
Gαq/11 family of G-proteins (Caulfield, 1993). ACh binding to these receptors results 
in the inhibition of K+ channels which causes a depolarisation at the postsynaptic 
density. M2 and M4 are preferentially coupled to the Pertussis toxin-sensitive Gαi 
family of G-proteins (Caulfield, 1993). ACh binding to postsynaptic M2 receptors 
results in Gαi activation which subsequently activates inwardly rectifying K+ 
channels causing a hyperpolarisation at the postsynaptic membrane. ACh binding 
to presynaptic M2 and M4 receptors results in Gαi activation which subsequently 
inhibits voltage-gated Ca2+ channels, causing a hyperpolarisation at the presynaptic 
membrane which decreases the likelihood of neurotransmitter release (Caulfield, 
1993).  
The mAChR subtypes have different distribution patterns within the CNS. M1 
mAChRs have an abundant expression in all major forebrain areas, for example, in 
the hippocampus, the cerebral cortex and the striatum, but do not appear to be 
expressed in the spinal cord of mice (Oki et al., 2005). Autoradiography using the 
non-selective muscarinic ligand, 3[H]-N-methylscopolamine (3[H]NMS) in wild-type 
and M2 mAChR knock out mice, revealed that M2 mAChRs have a widespread 
distribution and are the predominant subtype of mAChR found in the thalamus, 
hypothalamus, midbrain, medulla, pons, cerebellum, and spinal cord (Oki et al., 
2005). Pre-incubating sections from the thoracic spinal cord with pirenzepine, to 
occlude M1, M3 and M4 mAChRs, followed by autoradiography using the ligand 
3[H]NMS revealed the presence of M2 mAChRs in most areas of the spinal cord 
including lamina X in the rat (Hoglund and Baghdoyan, 1997). Mice lacking 
functional M2 mAChRs show a markedly reduced analgesic response to a centrally 
administered muscarinic agonist (Gomeza et al., 1999); this effect is likely mediated 
by M2 mAChRs located in both the spinal cord and at the supraspinal level. 
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Autoradiography using the ligand 3[H]NMS in wild-type and M3 mAChR knock out 
mice, revealed that M3 mAChRs have a wide distribution and are expressed in the 
hippocampus, hypothalamus, midbrain, pons, medulla and spinal cord (Oki et al., 
2005). More in depth investigation of the spinal cord using 3[H]NMS following the 
occlusion of M1, M2 and M4 mAChRs revealed expression of M3 mAChRs in 
laminae I and II of superficial dorsal horn but not in lamina X of the rat (Hoglund and 
Baghdoyan, 1997). M4 mAChRs are expressed in the cerebral cortex, striatum, 
thalamus and spinal cord of mice (Oki et al., 2005), however, the distribution of M4 
mAChRs within the laminae of spinal cord is unknown. The distribution and function 
of M5 mAChRs are not as well understood as the other mAChR subtypes and have 
not been observed in the spinal cord (see review Eglen (2006)). In summary, only 
M2 mAChRs have been positively identified in lamina X, however, M4 mAChRs 
may also be present. Both of these receptors cause hyperpolarisations (Caulfield, 
1993), therefore, any muscarinic mediated ACh effects in lamina X would be 
expected to be inhibitory. 
 
1.6.2 Structure and composition of nAChRs   
nAChRs are part of the cys-loop family of ligand-gated ion channels that contains 
GABAA receptors,  GABAC receptors, glycine receptors and 5HT3 receptors, 
amongst others (see review Sine and Engel (2006)). The receptors are 
transmembrane oligomeric proteins composed of five subunits (Figure 1.3; Karlin et 
al., (1983)). Each subunit has four transmembrane segments, with the ion channel 
itself being lined by the second transmembrane segment (Unwin, 1993, 2005). The 
ACh binding site is found on the relatively hydrophilic extracellular amino acid 
segment of the subunit (Karlin et al., 1983; Chiara et al., 1999; Brejc et al., 2001). 
The conformational change from the closed, resting state to the open state occurs 
on agonist binding (Watanabe et al., 1998), allowing the movement of Na+ and Ca2+ 
into the cell and K+ out of the cell (Mulle and Changeux, 1990); this is subsequently 
halted as the channel closes to enter a desensitised state.  
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Figure 1.3: Structure of ligand gated ion channels of the cys-loop family. 
A) Schematic representation of a single subunit with four transmembrane 
segments. B) Schematic representation of the pentameric structure of cys-loop 
family ion channels. Examples of nAChRs with either heteromeric or homomeric 
structures are shown (Modified from Collingridge et al., (2009)).  
 
There are five different types of subunits that contribute to muscle nAChRs, α, β, γ, 
δ and ε (Raftery et al., 1980; Takai et al., 1985), however, there are only two 
subunit groups in neuronal nAChRs, α2-α10 and β2-β4 (for identification of different 
subtypes in different species see review Sargent (1993)). The receptors are 
predominantly heteromeric, consisting of α and β subunits; these include the 
subunits α2-α6 and β2-β4, and are defined pharmacologically by their ability to bind 
to nicotine and other related agonists with nano molar affinity (Romano and 
Goldstein, 1980; Clarke et al., 1985). Conversely, α7, α8 and α9 subunits can form 
homomeric receptors, independent of β subunits; these are defined 
pharmacologically by their nano molar affinity for α-Bungarotoxin (α-BgT), with only 
a micro molar affinity for nicotine (Clarke et al., 1985; Couturier et al., 1990). There 
are a large number of possible subunit combinations that are present in nAChRs, 
therefore it is common to use the term ‘containing’ when referring to specific 
nAChRs, where containing is denoted by an asterix (*). For example α7-containing 
nAChRs are referred to as α7*nAChRs.  The homomeric α7*nAChRs have quite 
different properties to the other nAChRs; they have a higher Ca2+ permeability and 
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a higher rate of desensitisation than any other nAChR currently known (Bertrand et 
al., 1993; Wooltorton et al., 2003). Their pharmacological profile is also quite 
unique: choline, the breakdown product of ACh, is a weak yet selective α7*nAChR 
agonist (Papke et al., 1996), methyllycaconitine (MLA) is a specific α7*nAChR 
antagonist at concentrations ≤ 20 nM (Alkondon et al., 1992; Wonnacott, 1993), and 
finally many synthetic compounds are being produced to act as α7*nAChR-
selective agonists and modulators, for example 1-(5-chloro-2,4-dimethoxy-phenyl)-
3-(5-methyl-isoxazol-3-yl)-urea, known as PNU-120596, selectively potentiates 
cholinergic responses mediated by α7*nAChRs  (Hurst et al., 2005).  
 
1.6.3 Distribution and function of nAChRs  
The function of nAChRs in the mammalian CNS is not straightforward as they are 
found at numerous subcellular locations, including presynaptic terminals, 
postsynaptic terminals, extrasynaptic sites, dendrites, soma and axons (Dani and 
Bertrand, 2007). A high proportion of nAChRs are found on presynaptic terminals 
modulating neurotransmitter release (see review Wonnacott (1997)). nAChRs 
modulate neurotransmitter release by two methods: firstly, in a TTX-sensitive 
manner, preterminal nAChRs facilitate propagation of the action potential (Lena et 
al., 1993) and secondly in a TTX-insensitive manner, terminal presynaptic nAChRs 
cause a local depolarisation that activates voltage-sensitive Ca2+ channels, 
resulting in an increase in local Ca2+ concentration and the stimulation of synaptic 
vesicle release (McMahon et al., 1994; Tredway et al., 1999). 
Some nAChRs are found in postsynaptic somatodendritic regions, although this is 
relatively rare (Alkondon et al., 1998; Frazier et al., 1998). There are also nAChRs 
found at perisynaptic and extrasynaptic regions, where they are believed to 
modulate neuronal activity in response to the volume transmission of ACh, which is 
also referred to as non-synaptic or paracrine transmission (Umbriaco et al., 1994; 
Descarries et al., 1997). Finally, nAChRs are also expressed on many non-neuronal 
cells, including astrocytes, macrophages, endothelial cells of the vascular system 
and epithelial cells that line the respiratory airways (see review Wessler and 
Kirkpatrick (2008)). 
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nAChRs are distributed widely throughout the CNS, however, this study will only 
consider their distribution throughout the spinal cord. In-situ hybridisation in the rat 
revealed the presence of low levels of α4 and β2 subunits throughout the spinal 
cord, and low levels of α2 and α3 in more specific regions, including lamina X 
(Wada et al., 1989). A stronger signal was observed for the α7 subunit in the 
superficial dorsal horn, the ventral horn and lamina X, following in-situ hybridisation 
in the rat (Seguela et al., 1993). Looking at lamina X in more detail, studies using 
whole cell patch clamp electrophysiology in the rat have determined the functional 
expression of nAChRs in specific neuronal cell populations. At numerous levels of 
the spinal cord, in the ventral half of the dorsal commissure, interneurones are 
capable of responding to ACh; the responses were not affected by the α7*nAChR 
specific antagonists, MLA and α-BgT, thus this provides evidence of functional non 
α7*nAChRs in the CAA (Bordey et al., 1996b). In response to the application of the 
nicotinic agonist, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), SPNs in the 
CAA were found to have two separate responses (Bradaia and Trouslard, 2002b). 
The first response was a fast decaying α-BgT-sensitive current that indicated the 
presence of α7*nAChRs (Bradaia and Trouslard, 2002b), evoked excitatory 
postsynaptic potentials (EPSP) could also be antagonised by α-BgT, demonstrating 
that the α7*nAChRs are located at postsynaptic densities on SPNs (Bradaia et al., 
2005). The second response was a non-desensitising, α-BgT-insensitive current 
that indicated the presence of non α7*nAChRs; these receptors were suggested to 
be located at extrasynaptic locations due to the non-desensitising nature of the 
response over the 20 second agonist application (Bradaia and Trouslard, 2002b). It 
was suggested that the non α7*nAChR could contain α4 and β2 subunits; this is 
because β2*nAChRs are less sensitive to cytosine compared to DMPP and ACh, 
and α4β2*nAChRs are very sensitive to ACh compared to DMPP, correlating with 
the agonist potencies observed in this study (Luetje and Patrick, 1991; Bradaia and 
Trouslard, 2002b).  
nAChRs have also been found on presynaptic terminals within lamina X (Bradaia 
and Trouslard, 2002a; Seddik et al., 2006).  Glycinergic mediated mIPSPs were 
recorded in SPNs of the CAA; an increase in mIPSP frequency but not in mIPSP 
amplitude was observed following the application of DMPP. This suggests an 
increase in the number of vesicles released rather than an increased post-synaptic 
response indicating the presence of presynaptic nAChRs on glycinergic terminals 
(Bradaia and Trouslard, 2002a). Other nAChR agonists could mimic the DMPP 
effect on glycinergic mIPSPs, however, ACh was the most potent whereas cytosine 
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was the least potent; this suggests the involvement of α4β2*nAChRs (Luetje and 
Patrick, 1991; Bradaia and Trouslard, 2002a). In addition, the DMPP effect on 
glycinergic mIPSPs could be partially antagonised by MLA, indicating the 
involvement of α7*nAChRs. GABAergic mIPSPs can also be recorded from SPNs 
in the CAA; the frequency but not the amplitude of these mIPSPs can be increased 
by ACh indicating the presence of nAChRs on the presynaptic terminals of 
GABAergic interneurones (Seddik et al., 2006). Choline, the preferential α7*nAChR 
agonist (Papke et al., 1996), could not mimic the ACh-induced effect on GABAergic 
IPSPs suggesting that non α7*nAChRs are mediating this response. This was 
confirmed as DHβE, a non α7*nAChR antagonist at the concentration of 1 µM, that 
was used by Seddik et al., (2006), antagonised the ACh-induced GABAergic 
mIPSPs in SPNs (Seddik et al., 2006). This receptor is suggested to be an 
α4β2*nAChR because DHβE is a preferential antagonist at β2*nAChRs, compared 
to β4*nAChRs (Harvey and Luetje, 1996), and at α4*nAChRs, compared to 
α3*nAChRs (Harvey et al., 1996). Thus there are a number of nAChRs expressed 
at different subcellular locations on different neuronal populations within lamina X, 
however, their presence and function within the area directly surrounding the CC 
has not been investigated.  
 
1.6.4 Role of ACh in postnatal neurogenesis 
In the developing CNS and in established areas of postnatal neurogenesis, 
neurotransmitters are important in regulating neuronal maturation. In cell lines such 
as the small cell lung carcinoma cell line, in which α7*nAChRs are expressed, 
nicotine can induce cellular proliferation (Quik et al., 1994). In cultures of spinal 
neurones, growth cones turn and neurites extend towards ACh; this turning is 
abolished in the presence of a nicotinic antagonist, D-turbocararine, and in Ca2+ free 
extracellular solutions (Zheng et al., 1994). ACh does not, however, have any direct 
influence over the neurogenic niche in the SVZ. Nevertheless, ablating cholinergic 
neurones of the basal forebrain by injecting 192IgG-saporin into the lateral 
ventricles, reduces cholinergic inputs to the olfactory bulb and decreases the 
number of newly born neurones in rats (Cooper-Kuhn et al., 2004). In addition, 
enhancing cholinergic signalling by the intraperitoneal administration of the 
acetylcholinesterase inhibitor, donezepil, increased the survival of BrdU-labelled 
newborn neurones in the olfactory bulb and the dentate gyrus (DG) of the mouse 
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hippocampus (Kaneko et al., 2006). In the DG of rats and mice, newborn neurones 
receive cholinergic inputs, as evidenced by the presence of vesicular ACh 
transporter (VAChT) or ChAT in close apposition to BrdU- or PSA-NCAM-
expressing cells, respectively (Kaneko et al., 2006; Kotani et al., 2006). PSA-NCAM 
expressing immature neurones of the mouse DG express α7*nAChRs, β2*nAChRs, 
M1 mAChRs and M4 mAChRs, indicating that both nicotinic and muscarinic ACh 
receptors could influence these immature neurones (Kaneko et al., 2006). For both 
the nicotinic receptors, there is functional evidence that they influence postnatal 
neurogenesis. There is a decrease in the number of BrdU-expressing newborn cells 
in the DG in β2*nAChR knockout mice (Harrist et al., 2004). In postnatal wild-type 
mice, ACh promotes the switch from excitatory GABAergic signalling to inhibitory 
GABAergic signalling in DG neurones, however, in α7*nAChR knockout mice the 
switch is delayed and the DG neurones show abnormally high levels of NKCC1 (Liu 
et al., 2006b; Liu et al., 2007). Furthermore, the normal survival, maturation and 
integration of adult-born neurones is reliant on the presence of functional 
α7*nAChRs (Campbell et al., 2010). For example, in one to three month old mice, 
less BrdU-expressing newborn neurones are found in α7*nAChR knockout mice 
four weeks but not two weeks post-BrdU injection compared to in wild type mice; 
this indicates that more newborn neurones die in the two to four week period after 
being produced in α7*nAChR knockout mice (Campbell et al., 2010).  Labelling 
newborn cells with a GFP-tagged virus revealed that the dendritic arbours are less 
complex and truncated as evidenced by the fewer branch points and the shorter 
dendritic length, in α7*nAChR knockout mice compared to wild-type mice  
(Campbell et al., 2010). These studies demonstrate the importance of nAChRs in 
postnatal neurogenesis; however, they have yet to be studied in the neurogenic 
niche of the spinal cord.  
 
1.7 GABAergic receptors 
There are two categories of GABAergic receptors: ionotropic receptors, which 
include GABAA receptors and GABAC receptors, and metabotropic receptors, which 
include GABAB receptors. GABAC has now officially been subsumed into the GABAA 
receptor class and will be considered as such in this study (Olsen and Sieghart, 
2008).  
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1.7.1 Structure, composition and function of GABAA receptors 
GABAA receptors are part of the cys-loop family of ligand-gated ion channels that 
also includes nAChRs, and thus the receptors are made up of five subunits, each of 
which contains four transmembrane domains, with the second transmembrane 
domain forming the ion channel lining, as described for nAChRs (see chapter 1.6.2; 
see review Sine and Engel (2006)). There are 19 different GABAA receptor subunits 
that have been identified in humans, including α1-6, β1-3, γ1-3, ρ1-3, δ, ε, π and θ 
(Simon et al., 2004). Despite this wide variety of subtypes the majority of 
GABAergic receptors within the mammalian CNS consist of α-, β- and γ-subunits, 
with the most common receptor subtype consisting of α1, β2 and γ2 isoforms (see 
review Barnard et al., (1998)). It is believed that this subtype comprises of two α1- 
and two β2-subunits with one γ2-subunit, although there is little evidence for this yet 
in-situ (see review Olsen and Sieghart (2008)).   
On ligand binding GABAA receptors undergo a conformational change that allows 
the movement of Cl- ions and to a lesser extent bicarbonate ions (HCO3-; Bormann 
et al., (1987)) through the pore. In mature neurones, the intracellular Cl- 
concentration is low in comparison to the extracellular Cl- concentration, thus when 
the GABAA receptors open the Cl- ions move into the cell along the electrochemical 
gradient making the cell more negative i.e. hyperpolarising the cell. In immature 
neurones, the intracellular Cl- concentration is higher than in mature neurones, so 
even though it is not a greater concentration than the extracellular Cl- concentration, 
the negative membrane potential of the cell leads to the movement of Cl- ions out of 
the cell, making the cell more positive i.e. depolarising the cell. The difference in 
intracellular Cl- concentration is predominantly due to the differential expression of 
the two cation exchangers: NKCC1 and KCC2 (as discussed in section 1.3.3.2; 
Clayton et al., (1998); Rivera et al., (1999)). 
There are two types of transmission mediated by GABAA receptors, these are 
synaptic, which can also be known as phasic transmission, and extrasynaptic, 
which can also be known as tonic or paracrine transmission (see review Farrant 
and Nusser (2005)). Phasic transmission is the more classically known action of 
GABA, which results in rapid and direct transmission of signals from one neurone to 
another, with GABA-containing vesicles released from the pre-synaptic terminal to 
bind to GABA receptors at the post-synaptic density of the post-synaptic terminal 
(see reviews Edwards et al., (1990); Mody et al., (1994)). Phasic transmission can 
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also include the activation of perisynaptic receptors that are activated by synaptic 
spillover of GABA (Telgkamp et al., 2004); this mode of transmission could be 
considered a mix of phasic and tonic GABAergic transmission. Tonic transmission 
is a more recent concept (see review Brickley and Mody (2012)); it has more long-
term, modulatory effects on neurones. GABA transporters can release GABA from 
neurones or astrocytes in a way that does not correlate with the activity of the cell 
from which it is released, this GABA can activate extrasynaptic GABAA receptors 
(Kaneda et al., 1995; Brickley et al., 1996). The two types of transmission are 
mediated by GABAA receptors composed of different subunits, for example, the 
most abundant GABAA receptor composition α1(2)β2(2)γ2 is located at the post-
synaptic density, as are most γ2-subunit containing GABAA receptors (Essrich et 
al., 1998; Schweizer et al., 2003). The exception to this rule is the α5βγ2-containing 
GABAA receptor, with immunohistochemistry revealing that α5-containing GABAA 
receptors in pyramidal-like cells in the hippocampus are located extrasynaptically 
and electrophysiological studies in the IML of the spinal cord revealing that α5-
containing GABAA receptors mediate a tonic conductance (Brunig et al., 2002; 
Wang et al., 2008). Finally, the δ-subunit, which often replaces the γ2-subunit, is 
present in extrasynaptic GABAA receptors which mediate a tonic conductance 
(Nusser et al., 1998). For example, tonic conductances have been observed in 
cerebellar granule cells, mediated by GABAA receptors containing α6βδ subunits 
(Brickley et al., 2001) and in hippocampal dentate granule cells, mediated by 
GABAA receptors containing α4βδ subunits (Stell et al., 2003). 
 
1.7.2 Distribution of GABAA receptors 
GABAA receptors are distributed widely throughout the CNS, therefore, only their 
expression within the spinal cord will be considered. In the superficial layers of the 
dorsal horn, laminae I-III, expression of α2, α3, β2/β3 and γ2 subunits has been 
observed following immunohistochemistry in a number of different mammals, 
whereas α1 and α5 subunits were expressed in only lamina III of the superficial 
dorsal horn (Alvarez et al., 1996; Bohlhalter et al., 1996). Throughout laminae IV-
VIII an abundant expression of α1, α2, α3, α5, β2/β3 and γ2 subunits has been 
observed by immunohistochemistry, although these subunits were expressed by 
distinct areas and populations of neurones (Bohlhalter et al., 1996). For example, in 
the rat reverse transcription-PCR (RT-PCR) within the IML found expression of the 
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α5 subunit (Wang et al., 2008). Immunohistochemistry also demonstrated that 
motorneurones of lamina IX showed a high expression of α2 and γ2 subunits, a low 
expression of the α5 subunit and no expression of α1, α3 and β2/β3 subunits 
(Bohlhalter et al., 1996). In lamina X,  immunohistochemistry found that α1, α3, 
β2/β3 and γ2 subunits are highly expressed, although there is also some 
expression of α2 and α5 subunits (Bohlhalter et al., 1996). Both α6 and δ subunits 
could not be detected by immunohistochemistry, in-situ hybridisation or RT-PCR in 
the spinal cord (Wisden et al., 1991; Bohlhalter et al., 1996; Wang et al., 2008). 
Immunohistochemistry for the ρ1 and ρ2 subunits, previously defined as GABAC 
receptor subunits, revealed that they were distributed throughout the adult rat spinal 
cord, including lamina X (Rozzo et al., 2002). Strong evidence suggests the 
presence of functional GABAA receptors on CSFcCs (see section 1.3.3.1), however, 
the evidence is not unequivocal and the receptor composition has not been 
investigated.  
 
1.7.3 GABAB receptors 
GABAB receptors belong to the same class as metabotropic glutamate receptors, 
and form a functional heterodimer consisting of two subunits, GABAB1 and GABAB2, 
both of which contain seven transmembrane domains (Kaupmann et al., 1997; 
Kaupmann et al., 1998). GABAB receptors are coupled to Pertussis toxin sensitive 
G-proteins (Andrade et al., 1986). Through these G-proteins, the activation of 
GABAB receptors can mediate the inhibition of voltage-activated presynaptic Ca2+ 
channels which decreases transmitter release (Holz et al., 1986; Dolphin and Scott, 
1987), and activates a postsynaptic inwardly rectifying K+ current which 
hyperpolarises the postsynaptic cell (Newberry and Nicoll, 1984; Gahwiler and 
Brown, 1985; Inoue et al., 1985; Andrade et al., 1986). Work defining the function 
and distribution of GABAB receptors has been greatly advanced by the specific 
agonist, baclofen (Bowery et al., 1980).  
Autoradiography revealed the presence of GABAB receptors throughout the spinal 
cord, with the greatest amount of binding sites present in lamina II (Price et al., 
1987). In the mammalian spinal cord, binding sites were observed in the dorsal 
region of lamina X and appeared to associate with the distribution of SPNs (Price et 
al., 1987); this correlates with electrophysiological recordings from SPNs of the IML 
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where baclofen induced a hyperpolarisation (Wang et al., 2010). 
Immunohistochemistry in the rat has revealed that CSFcCs express GABAB 
receptors (Margeta-Mitrovic et al., 1999), although there is no functional evidence of 
such expression to date. In-situ hybridisation and immunohistochemistry in the rat 
revealed that GABAB1 receptors were differentially distributed throughout the cord, 
predominantly in laminae II and IX, whereas GABAB2 receptors were evenly 
distributed throughout the spinal cord, including lamina X (Towers et al., 2000).  
To summarise, functional GABAA receptors are present on CSFcCs in rats 
(Marichal et al., 2009), however, subunit distribution data show that α1, α2, α3, α5, 
β2/β3, γ2, ρ1 and ρ2 GABAA receptor subunits are all expressed in lamina X, 
therefore the composition of the GABAA receptor on CSFcCs is unknown. GABAB 
receptors have also been observed on CSFcCs; however, there is no functional 
confirmation of such expression.  
 
1.7.4 Role of GABA receptors in postnatal neurogenesis 
There is a great deal of evidence proving that GABA plays an important role in 
mammalian postnatal neurogenesis; this evidence is greatest for the SVZ (Carleton 
et al., 2003) and the DG (Tozuka et al., 2005). In the rodent SVZ, neuronal 
precursor and stem cells express GABAA receptors and can respond to GABA with 
an increase in intracellular Ca2+; resulting in the inhibition of progression through 
the cell cycle (Nguyen et al., 2003; Wang et al., 2003; Liu et al., 2005). RT-PCR 
demonstrated that the precursor cells themselves could be producing GABA as 
they expressed the enzymes GAD65 and GAD67 that are required to synthesise 
GABA (Nguyen et al., 2003). Furthermore, the addition of GABAA antagonists to 
cultured spheres of precursor cells increased the number of BrdU-expressing 
newborn cells, indicating that GABA is acting as an autocrine modulator, being 
tonically released from the spheres to regulate their own rate of proliferation 
(Nguyen et al., 2003). Electrical stimulation of neuroblasts in the SVZ also induced 
depolarisation in neuronal precursor cells that could be antagonised by GABAA 
antagonists and enhanced by GAT blockers (Liu et al., 2005). The release of GABA 
could act as a feedback mechanism from newborn neurones to neural 
precursor/stem cells in the SVZ. A decrease in the speed of migration of newborn 
neurones from the SVZ to the olfactory bulb was observed in the presence of GABA 
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as viewed by time-lapse video microscopy from acute brain slices in rodents, 
indicating that newborn neurones also express GABA receptors (Bolteus and 
Bordey, 2004). Addition of the GABAA receptor antagonist, bicuculline, increased 
the rate of migration of these neurones suggesting the presence of endogenous 
GABA acting in a tonic manner, reducing migration (Bolteus and Bordey, 2004). 
Although the ambient GABA reduces migration, observing the neurones using time-
lapse microscopy both in culture and in acute brain slices from rodents revealed 
that GABA is necessary for the proper initiation, elongation and stabilisation of 
dendrites (Gascon et al., 2006); thus the levels of ambient GABA must be finely 
tuned to allow dendritic formation without inhibiting migration.  
In the mouse DG, spontaneous, transient, TTX-sensitive currents were observed in 
neural progenitor cells; these transients could be inhibited by bicuculline indicating 
that neural progenitor cells of the DG, like those of the SVZ, express GABAA 
receptors (Wang et al., 2005). Application of GABA elicits a depolarisation of the 
neural progenitor cells which initiates an increase in intracellular Ca2+ and the 
expression of NeuroD, a positive regulator of neuronal differentiation (Tozuka et al., 
2005), implying that GABA induced depolarisations can promote neuronal 
differentiation in the mouse. As with newborn neurones in the SVZ, those in the DG 
can also respond to GABA, in fact there is a sequence in ability to respond to 
neurotransmitters which newborn neurones progress through that was determined 
in the mouse by retroviral labelling of proliferating cells and their progeny with GFP 
to follow their maturation (Ge et al., 2006). Firstly, three days following birth of the 
newborn neurones, a tonic GABAergic current was revealed in the presence of 
bicuculline, then at seven days a bicuculline-sensitive post-synaptic current was 
observed and finally at 14 days a glutamate antagonist-sensitive current was seen 
(Ge et al., 2006). Knock down of NKCC1 expression in newborn DG neurones 
resulted in tonic hyperpolarisations by GABA, delayed the time point at which 
postsynaptic GABAergic and glutamatergic currents were observed and drastically 
reduced the number of spontaneous synaptic currents (Ge et al., 2006). This 
suggests that tonic GABA-mediated depolarisations are essential for the correct 
formation of the GABAergic and glutamatergic synapses. 
In the CC region of the adult turtle, a lower vertebrate with a substantial 
regenerative capacity (Dervan and Roberts, 2003), there are numerous modes of 
GABAergic signalling (Reali et al., 2011). Neural progenitors are depolarised by 
GABA; this response is mediated through both GAT3 and GABAA receptors, 
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although whether this depolarisation mediates neurogenesis is yet to be 
investigated (Reali et al., 2011).  
This section has demonstrated how essential GABAergic signalling is for the 
appropriate proliferation and differentiation of neural progenitor cells and for the 
correct migration and synapse formation of newborn neurones in the postnatal 
neurogenic niches of the mammalian brain. GABAergic signalling has already been 
shown in the neurogenic niche of the postnatal turtle CC and in CSFcCs of the 
mammalian spinal cord; however, there is no evidence to date about how GABA 
affects the neurogenic capability of the mammalian CC. 
 
1.8 5HT receptors 
There are seven subfamilies of 5HT receptors, 5HT1-5HT7 with 14 receptor 
subtypes including 5HT1A, 5HT1B, 5HT1D, 5HT1E, 5HT1F, 5HT2A, 5HT2B, 5HT2C, 5HT3, 
5HT4, 5HT5A, 5HT5B, 5HT6, 5HT7 (Hoyer et al., 1994; Barnes and Sharp, 1999). All 
of the receptors, with the exception of the 5HT3 receptor, are G-protein coupled 
receptors. 
1.8.1 Structure and function of 5HT receptors 
The metabotropic 5HT receptors vary in functional properties due in part to the 
different G-proteins that they are coupled to and the subsequent downstream 
effects that occur (See review Raymond et al., (2001)). For example, 5HT1A 
receptors couple negatively to adenylate cyclase via G-proteins to mediate 
downstream signalling (Schoeffter and Hoyer, 1988; Bertin et al., 1992) and also 
induce a neuronal hyperpolarisation through the opening of K+ channels that are 
directly coupled to G-proteins (Andrade et al., 1986). On the other hand, 5HT2 
receptors couple positively to phospholipase C via G-proteins and induce 
intracellular Ca2+ release (Conn and Sanders-Bush, 1986). 5HT3 receptors are 
unique to the 5HT receptor subfamilies in that they are ligand-gated ion channels 
that do not mediate their effects through G-proteins (Derkach et al., 1989). The 
activation of 5HT3 receptors results in a rapid cellular depolarisation as it is a cation 
selective ion channel (Derkach et al., 1989; Malone et al., 1991). The great variety 
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of 5HT receptors and the downstream effects that they mediate are vast and will be 
covered no further in this study.  
 
1.8.2 Distribution of 5HT receptors 
Autoradiography revealed the presence of both 5HT1A receptors and/or 5HT7 
receptors, as identified by 8-OH-[3H]DPAT, in the dorsal region of lamina X in the 
thoracic and lumbar spinal cord of the rat (Marlier et al., 1991). The same study 
identified 5HT1B receptors in lamina X, surrounding the CC, using 
[125I]iodocyanopindolol; the density of these receptors increased along the rostro-
caudal gradient, with the most 5HT1B receptors identified in the sacral spinal cord 
(Marlier et al., 1991). Autoradiography using [3H]ketanserin revealed 5HT2 
receptors in the area surrounding the CC, these were predominant at the thoracic 
level of the spinal cord (Marlier et al., 1991). In-situ hybridisation in the rat 
determined that it is the 5HT2C receptor subtype, and not the 5HT2A receptor, that is 
expressed around the CC; with a higher density dorsal and lateral to the CC, 
compared with ventral to the CC (Fonseca et al., 2001). The 5HT3 receptor mRNA 
has also been identified at low levels in lamina X at all spinal cord levels (Fonseca 
et al., 2001). Immunohistochemistry in the rat revealed the presence of the 5HT5A 
receptor subtype dorsal to the CC in the CAA (Doly et al., 2004). The gene 
expression nervous system atlas (GENSAT) that generates bacterial artificial 
chromosome (BAC) reporter mice demonstrates that cells directly surrounding the 
CC express 5HT5B and 5HT6 receptors. These cells have a morphology resembling 
CSFcCs; however, it is not conclusive that they are CSFcCs. The presence of such 
a wide variety of 5HT receptors along with the high density of 5HT-immunoreactive 
terminals in lamina X (Takeoka et al., 2009), suggests that the 5HTergic system is 
important in regulating cells within lamina X and is capable of mediating a diverse 
range of responses within these cells. Given the presence of both 5HTergic 
interneurones in lamina X (Takeoka et al., 2009) and supraspinal inputs from the 
raphe nuclei of the brainstem (Bowker et al., 1981) the 5HTergic system appears to 
be an essential part of the circuitry that connects lamina X to the rest of the CNS.  
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1.8.3 Role of 5HT receptors in postnatal neurogenesis 
5HT has been demonstrated to influence neurogenesis in the postnatal mammalian 
CNS, in both the DG and the SVZ (see review Young et al., (2011)). For example, 
the number of adult mouse SVZ derived primary neurospheres cultured in-vitro was 
increased following the direct application of 5HT and following the infusion of 5HT 
into the lateral ventricles prior to culturing (Hitoshi et al., 2007). In the rat DG, the 
number of BrdU expressing cells was decreased following a lesion to the raphe 
nuclei, where most 5HTergic neurones reside; this decrease can be reversed 
following a foetal raphe graft (Brezun and Daszuta, 2000). In addition, chronic 
treatment with antidepressant drugs such as fluoxetine, which is a 5HT selective 
reuptake inhibitor (Wong et al., 1975), increased the number of BrdU-expressing 
cells within the rat DG (Malberg et al., 2000), indicating that 5HT influences 
neurogenesis in the rodent DG. 
5HT appears to exert this influence over postnatal neurogenesis through a number 
of 5HT receptors (see review Young et al., (2011)). To investigate the role of 5HT 
receptors in cell proliferation, neurogenesis and newborn cell survival three different 
BrdU protocols were used in the rat. For cell proliferation, animals were terminated 
immediately following the injection of BrdU which was given at the end of specific 
5HT receptor agonist or antagonist treatments (Banasr et al., 2004; Soumier et al., 
2009). For neurogenesis, animals were terminated four weeks following the 
injection of BrdU which was given at the end of specific 5HT receptor agonist or 
antagonist treatments and newborn neurones were identified by performing dual 
immunohistochemistry for BrdU and NeuN in fixed tissue (Banasr et al., 2004; 
Soumier et al., 2009; Soumier et al., 2010). Finally, newborn cell survival was 
investigated by injecting BrdU on the first experimental day, then applying the 
specific 5HT receptor agonists or antagonists before terminating the animals 
(Soumier et al., 2009; Soumier et al., 2010). Using these protocols it was 
determined that in the DG, activation of 5HT1A receptors by (±)-8-Hydroxy-2-
dipropylaminotetralin (8-OH-DPAT) increases the number of proliferating cells, the 
number of BrdU-expressing newborn neurones and the survival of these BrdU-
expressing newborn neurones (Banasr et al., 2004; Soumier et al., 2010). In the 
SVZ, activation of 5HT1A receptors by 8-OH-DPAT increases the number of 
proliferating cells and the number of BrdU-expressing newborn neurones; however, 
it does not increase the survival of these newborn neurones in the olfactory bulb 
(Banasr et al., 2004; Soumier et al., 2010). It has been suggested that the chronic 
activation of 5HT1A receptors could reduce the migration of newborn neurones from 
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the SVZ to the olfactory bulb (Soumier et al., 2010). In the DG, antagonism of 
5HT2A receptors decreases cell proliferation (Banasr et al., 2004) whereas 
antagonism of 5HT2C receptors by agomelatine increases cell proliferation (Soumier 
et al., 2009). The 5HT2C receptor agonist, RO600,175 has no effect on the number 
or survival of newborn neurones (Soumier et al., 2010). In contrast, activation of 
5HT2C receptors in the SVZ increases the number of proliferating cells and the 
number of newborn neurones in the olfactory bulb (Banasr et al., 2004; Soumier et 
al., 2010). 5HT2C receptors are not expressed on proliferating cells within the SVZ 
but are expressed by ependymal cells of the choroid plexus (Palacios et al., 1990), 
therefore the effect of the 5HT2C agonist on SVZ proliferation appears to be indirect. 
The differential effects of 5HT2C agonists and antagonists within various regions 
serves to highlight how difficult it is to determine the role of 5HT receptors in adult 
neurogenesis, considering how the role of receptors varies from one neurogenic 
niche to another and from one aspect of neurogenesis to another, such as cell 
proliferation to migration of newborn neurones. 
 
1.9 Substance P receptors 
Substance P is a peptide neuromodulator that is a member of the tachykinin family, 
which was previously known as the neurokinin family (Chang et al., 1971). The 
other members of this family include neurokinin A, neurokinin B, and the more 
recently discovered neuropeptide K, neuropeptide γ and hemokinin-1(Kangawa et 
al., 1983; Kage et al., 1988; Carter and Krause, 1990; Burcher et al., 1991; Zhang 
et al., 2000; Pennefather et al., 2004). Three tachykinin receptors have been 
discovered, NK1, NK2 and NK3. These are G-protein coupled receptors with seven 
transmembrane spanning domains (see review Nakanishi (1991)). Substance P can 
activate all three receptors; however, it has a far greater potency at NK1 receptors 
(Regoli et al., 1994), therefore these receptors will receive the main focus.  
1.9.1 Structure of substance P receptors 
Evidence from pharmacology studies had suggested that NK1 receptors were G-
protein coupled receptors (Macdonald and Boyd, 1989); this was confirmed by the 
cloning of this receptor which determined the seven transmembrane domain 
structure of the NK1 receptor (Masu et al., 1987; Yokota et al., 1989). The activation 
of NK1 receptors by substance P results in the initiation of a number of downstream 
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pathways through the interaction with Gαq/11, Gαs and Gαi proteins, and thus has 
numerous outcomes (see review Quartara and Maggi (1997)). Coupling to Gαq/11 
protein results in the accumulation of inositol phosphate, the release of intracellular 
Ca2+ and mediates an inward current (Nakajima et al., 1992; Kwatra et al., 1993; 
Mochizuki-Oda et al., 1994). Coupling to Gαs protein results in an increase in cAMP 
and an inhibition of K+ channels (Nakajima et al., 1988; Mitsuhashi et al., 1992; 
Nakajima et al., 1992; Takeda et al., 1992). Coupling to the Gαi protein results in the 
opening of large conductance Cl- channels (Sun et al., 1993).  
 
1.9.2 Distribution of substance P receptors 
In-situ hydridisation in the rat revealed the presence of cells expressing NK1 
receptor mRNA in the dorsal horn, the IML and the area surrounding the CC (Elde 
et al., 1990). Immunohistochemistry in the rat revealed that the most intense 
labelling of NK1 receptors within the spinal cord was at thoracic levels in the IML, 
followed by lamina I, part of the substantia gelatinosa (Nakaya et al., 1994). 
Moderate levels of NK1 receptor expression have been observed in laminae III, IV 
and X with immunohistochemistry (Nakaya et al., 1994). The subcellular expression 
of the NK1 receptor has varied in studies, with some in the rat observing mainly 
dendritic labelling in the superficial layers of the dorsal horn (Moussaoui et al., 
1992), whereas others in humans observed numerous cell bodies expressing the 
NK1 receptor (Ding et al., 1999). Cell bodies expressing the NK1 receptor were 
observed in laminae IV, V, X and in the IML, however, no specific cell types have 
been observed to express NK1 receptors in lamina X (Moussaoui et al., 1992; Ding 
et al., 1999). The presence of NK1 receptors and substance P immunoreactive 
terminals in lamina X in the rat (Hokfelt et al., 1975; Gibson et al., 1981) indicates 
that cells within lamina X receive inputs from substance P expressing terminals and 
have the machinery to mediate a response. The relevance of these terminals to the 
function of cells within lamina X is unknown but would depend greatly on whether 
the terminals are from cells located in the periphery, nuclei of the brain or 
intraspinally. 
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1.9.3 Role of substance P receptors in postnatal neurogenesis 
The role of substance P in postnatal neurogenesis is currently poorly understood. 
The number of SVZ-derived neurospheres cultured in-vitro increased in the 
presence of substance P in the rat; this increase was reversed in the presence of 
the NK1 receptor antagonist, L-703,606 (Park et al., 2007). This indicates that 
substance P promoted cell proliferation of neural progenitor cells through NK1 
receptor activation. Infusion of substance P into the lateral ventricles for five days 
whilst giving injections of BrdU resulted in an increase in the number of BrdU- and 
Dcx-expressing cells within both the SVZ and DG (Park et al., 2007). In contrast, a 
decrease in the number of BrdU- and Dcx-expressing cells was observed in both 
the SVZ and DG following the infusion of L-703,606 (Park et al., 2007). These 
experiments suggest that substance P promotes neurogenesis in-vivo in both the 
SVZ and DG. The above experiments were all carried out following the induction of 
transient focal ischaemia, however, using the same experimental paradigm but 
following a traumatic brain injury there was no significant increase in the number of 
BrdU- and Dcx-expressing cells (Carthew et al., 2012). Instead, a large increase in 
BrdU- and IBA1-expressing microglia was observed along with a decrease in 
functional motor recovery that was assessed by the rotarod test (Carthew et al., 
2012). Thus the role of substance P in neurogenesis is obviously a complex one.  
NK1 receptor knock out studies have also been used to investigate the role of 
substance P in neurogenesis. Mice deficient in the NK1 receptor and wild-type 
littermates were both injected with BrdU and terminated at a number of time points. 
An increase in BrdU expressing cells was observed in the DG but not in the SVZ in 
NK1 receptor knockout mice when animals were terminated one day after BrdU 
injection (Morcuende et al., 2003). When animals were terminated 28 days after 
BrdU injection there was no longer an increased number of BrdU expressing cells in 
the NK1 receptor knockout mice (Morcuende et al., 2003). This indicates that NK1 
receptor knockout mice have an elevated amount of neurogenesis but not of 
newborn neuronal survival compared to their wild-type littermates. Although there 
are complicated effects of substance P on neurogenesis, it is clearly influential and 
deserves further investigation. Given the presence of substance P and NK1 
receptors in lamina X and the neurogenic potential of the area surrounding the CC, 
it is possible that substance P could be influencing neurogenesis within this area.  
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1.10 Hypothesis and Aims 
There is currently very little understanding of how cells in the area surrounding the 
CC of the spinal cord are affected by neurotransmitters and neuromodulators and 
how they are integrated into the circuitry of the spinal cord. Sections 1.6-1.9 have 
demonstrated the presence of ACh, GABA, 5HT, substance P and some of their 
respective receptors within this area. It has also provided evidence that each of the 
neurotransmitters/neuromodulators can influence cells within other neurogenic 
niches.   
There are two overarching aims of this study. The first is to determine whether 
ependymal cells and CSFcCs are integrated into the spinal cord and to begin to 
assign a functional role to CSFcCs. The second is to investigate whether any 
parallels can be established between the cells in this area and those of other 
postnatal neurogenic niches. Hypotheses have been developed which relate to 
either the first aim, second aim or both aims; these specific hypotheses and the 
reasoning behind them are as follows: 
1. It is hypothesised that CSFcCs from rats aged P9-P21 have properties 
resembling those observed in rats aged P0-P5 and represent a similar 
heterogenous population. This will aid in determining whether CSFcCs are 
in the process of maturation or have reached their terminal phenotype. 
2. It is hypothesised that CSFcCs in rats and mice aged P9-P21 respond to 
GABA, given the ability of CSFcCs in rats aged P0-P5 to respond to GABA 
and the ability of immature neurones in other postnatal neurogenic niches to 
respond to GABA.  
3. It is hypothesised that CSFcCs are capable of responding to 5HT and 
substance P given the large amount of 5HT- and substance P-
immunoreactive terminals in close proximity to the CC. Although a number 
of neurotransmitters and neuromodulators are found in close proximity to 
the CC, 5HT and substance P will be investigated as they have more 
specific functional roles which, if CSFcCs are responsive, could illuminate a 
functional role for CSFcCs.   
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4. It is hypothesised that ependymal cells in rats and mice aged P9-P21 have 
passive response properties and a high degree of gap junction coupling, as 
observed in rats aged P0-P5 and neural stem/progenitor cells in other 
postnatal neurogenic niches. 
5. It is hypothesised that ependymal cells in rats aged P9-P21 are capable of 
responding to GABA given the ability of neural stem/progenitor cells in other 
postnatal neurogenic niches to respons to GABA.  
6. It is hypothesised that both CSFcCs and ependymal cells in rats aged P9-
P21 are capable of responding to ACh as there is an abundance of 
cholinergic terminals surrounding the CC and ACh is known to influence 
other postnatal neurogenic niches.  
These hypotheses will be tested using a combination of whole cell patch clamp 
electrophysiology, intracellular dye-loading and immunohistochemistry.  
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Chapter 2 - General Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
All experiments were carried out in line with the Animals Scientific Act (1986) and 
the ethical standards set out by the University of Leeds Ethical Review Committee 
by individuals with Home Office approval. Every effort was made to minimise the 
number of animals used and their suffering.  
 
2.1 Animals 
The predominant breed of animal used within this study was the Wistar rat. These 
rats were acquired from the in-house breeding facility at the Central Biomedical 
Services unit here at the University of Leeds. At this facility the rats lived in a 12 
hour light-dark cycle and were provided with water and food ad libitum.  
To show that the results are not solely relevant to this breed, some experiments 
have also been performed using C57bl6 mice. Both wild-type C57bl6 mice and 
GAD67-GFP mice with a C57bl6 background were used. The GAD67-GFP mice 
expressed GFP under the control of the endogenous GAD67 promotor as a result 
of the insertion of GFP cDNA into the GAD67 locus (Tamamaki et al., 2003). These 
mice have been validated since GFP-expressing cells were found in the same 
regions as those in which GAD cells have been reported by both 
immunohistochemistry and in-situ hybridization (Barber et al., 1982; Feldblum et al., 
1995; Tamamaki et al., 2003). Thus GAD67 expressing CSFcCs expressed GFP in 
these mice, aiding the visualisation of these cells when viewed under an 
epifluorescent microscope (Olympus BX50W1; Olympus U-RFL-T). 
 
2.2 Spinal cord slice preparation 
Two different methods of slice preparation were used depending on the age of the 
animal. The first method was used for animals aged 9-20 days old and has been 
used previously in this laboratory (Deuchars et al., 2001). In slices from older 
animals, however, it has proved more difficult to obtain stable neuronal recordings. 
Therefore, the original spinal cord preparation protocol was modified for animals 
aged 21 days or over to maximise the number of healthy cells in such slices (Husch 
et al., 2011).  
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For both types of preparation, Wistar rats (9-21 days old) and C57bl6 mice (9-26 
days old) were anaesthetised by administration of urethane (2 g/kg of body weight) 
or pentabarbitone (60 mg/kg) I.P., respectively.  Animals were deemed sufficiently 
anaesthetised when the pedal withdrawal reflex was abolished in response to a 
noxious pinch.  
2.2.1 Slice preparation for animals aged 9-20 days 
Using blunted scissors an incision was made through the skin from the caudal 
aspect of the sternum to the distal aspect of the clavicle on either side of the animal 
to allow access to the rib cage. The rib cage was then removed to expose the heart, 
clearing away any membranes that may be obstructing access to the heart. A 
transcardiac perfusion was then performed; this involved creating an incision in the 
right atrium, then injecting approximately 10 mls (mouse) or approximately 20 mls 
(rat) of gassed (95 % O2: 5 % CO2), ice cold sucrose artificial cerebrospinal fluid 
(sucrose aCSF; for composition see table 2.1) into the left ventricle using a 
shortened, blunted 19 gauge needle. Animals were considered sufficiently perfused 
when blanching of the liver, tail, paws and nose became apparent. The transcardiac 
perfusion was important as it cooled the spinal cord tissue and reduced the amount 
of Na+ ions present thus reducing the amount of cell death occurring in the spinal 
cord by excitotoxicity. Animals were then killed by decapitation using scissors. A 
dorsal laminectomy was performed which involved using blunted scissors to 
remove the skin above the vertebral column, then using spring scissors to cut 
through the vertebrae surrounding the spinal cord starting at the top as access was 
already available due to the decapitation. The nerve rootlets that are attached to the 
spinal cord were then severed allowing the whole spinal cord to be removed and 
transferred to a petri dish containing ice cold, gassed (95 % O2: 5 % CO2) sucrose 
aCSF. Under a dissecting microscope (SM2 2B, Nikon, Japan), fine forceps were 
used to removed both the dura and pia mater. The lower thoracic or upper lumber 
areas of the spinal cord were chosen to slice; from these areas a section of spinal 
cord roughly 1 cm in length was cut for slicing. 
To improve slicing of the spinal cord it was embedded in a 3 % solution of warm 
agar in sucrose aCSF which was allowed to cool before cutting into a block. The 
block of agar containing the spinal cord was then attached to a larger supporting 
block of 4 % agar (in 0.9 % saline) before gluing onto the cutting platform of a 
vibrating microtome (Leica VT1200s, Leica Microsystems, UK). Submerging the 
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block in ice cold, gassed (95 % O2: 5 % CO2) sucrose aCSF in the cutting chamber 
allowed 300 µm thick transverse slices to be cut using a stainless steel vibratome 
blade with the speed set at 0.3 mm/s and the amplitude at 1.5 mm. Slices were 
transferred to a holding chamber containing gassed (95 % O2: 5 % CO2) aCSF (for 
composition see table 2.1), and left to equilibrate in this solution at room 
temperature for 30-60 minutes. 
 
2.2.2 Slice preparation for animals aged 21 days or above 
Following the initial administration of anaesthetic (see section 2.2 for details), 
animals were maintained at a deep level of anaesthesia by placing on ice and were 
oxygenated to keep tissue alive by placing a small funnel over the nose and mouth 
supplying 95 %O2: 5 % CO2. A dorsal laminectomy was performed, which included 
first removing the skin from the back with blunted scissors, then using spring 
scissors to cut the vertebral column and spinal cord at T1 level, then cutting away 
the vertebrae and nerve rootlets from T1 to the sacral levels. Gassed (95 % O2: 5 % 
CO2), ice cold glycerol aCSF (for composition see table 2.1) was superfused over 
the spinal cord to aid visibility during this procedure. Glycerol aCSF has previously 
been utilised in procedures that have obtained stable recordings from cells within 
spinal cord slices from older animals (Husch et al., 2011) and as such replaced the 
norml use of sucrose aCSF in this method. The spinal cord from T1 to S1 was then 
removed and transferred to a petri dish containing ice cold, gassed (95 % O2: 5 % 
CO2) glycerol aCSF. Under a dissecting microscope, fine forceps were used to 
remove both the dura and pia mater. As before, a section of spinal cord 1 cm long 
was cut from the lower thoracic or upper lumber areas of the spinal cord. 
The spinal cord was embedded in a 3 % solution of warm agar in glycerol aCSF 
and cooled before a block was cut. The block of agar containing the spinal cord was 
attached to a larger supporting block of 4 % agar (in 0.9 % saline) before gluing 
onto the cutting platform of a vibrating microtome. Submerging the block in ice cold, 
gassed (95 % O2: 5 % CO2) glycerol aCSF in the cutting chamber allowed 300 µm 
thick transverse slices to be cut using a stainless steel vibratome blade with the 
speed set at 0.3 mm/s and the amplitude at 1.5 mm. Slices were transferred to a 
holding chamber containing gassed (95 % O2: 5 % CO2) aCSF at 37°C. Once all 
the slices were cut, the solution was allowed to cool to room temperature and the 
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slices were left to equilibrate in this solution for 30-60 minutes before recordings 
were made. 
 
Table 2.1: Compositions of extracellular solutions.  
The components and their final concentration in the solutions are given for the two 
solutions used for spinal cord slice preparation, sucrose aCSF and glycerol aCSF, 
and for the extracellular solution used for recording from cells within the spinal cord 
slices, aCSF. 
Component Final concentration (mM) 
 Slice preparation Recording 
 Sucrose aCSF Glycerol aCSF aCSF 
Sucrose 217   
Glycerol  222  
NaCl   124 
NaHCO3 26 25 26 
KCl 3 3.1 3 
MgSO4.7H2O 2 1.25 2 
NaH2PO4 2.5  2.5 
KH2PO4  1.2  
Glucose 10 11 10 
CaCl2 1 2.5 2 
 
2.3 Electrophysiology 
2.3.1 Whole cell patch electrode preparation 
A Sutter P-97 micropipette puller (Sutter Instruments, USA) was used to pull 
micropipettes (resistance 5-8 MΩ, tip diameter approximately 1-3 µm) from 
borosilicate glass capillary tubing (inside diameter 0.94 mm, outside diameter 1.2 
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mm, Warner Instruments, USA). Micropipettes were filled with intracellular solution 
(mM): K gluconate (110), EGTA (11), MgCl2 (2), CaCl2 (0.1), HEPES (10), Na2ATP 
(2), NaGTP (0.3). Additionally the intracellular solution contained 0.5 % Neurobiotin 
(Vector Laboratories, USA) and 0.02 % dextran tetramethylrodamine (rhodamine; 
Invitrogen, USA) to allow visualisation of the neurone post-recording. 
 
2.3.2 Perforated patch electrode preparation 
A stock solution of 1-2 mg amphotericin B / 50 µl of DMSO was prepared and 
stored in the dark. For recordings, 6 µl of stock was dissolved in 500 µl intracellular 
pipette solution and thoroughly vortexed.  Microelectrodes with a smaller resistance 
(4-6 MΩ) were initially tip dipped in intracellular solution, prior to back filling with the 
amphotericin B-containing intracellular solution.  
 
2.3.3 Experimental set-up 
Spinal cord slices were immersed in a custom made recording chamber and 
secured under tightly stretched crossed threads. From a storage flask, a steady 
flow (~4-6 ml/min) of oxygenated (95 % O2: 5 % CO2) aCSF was gravity fed to flow 
across the recording chamber and was subsequently removed by suction and 
discarded. The solutions were not heated to maximise slice viability and minimise 
electrical noise; therefore the recordings were taken at room temperature. The bath 
application of oxygenated (95 % O2: 5 % CO2) drug solutions was achieved by 
switching a 3-way tap to allow the gravity feed of drug solutions in place of the 
aCSF from the storage chamber. 
A micropipette filled with intracellular solution was placed over a silver chloride wire 
and secured by the electrode holder (QSW A12P, Warner Instruments, USA); it was 
ensured that just enough intracellular solution was present in the micropipette so 
that the wire was in contact with the intracellular solution but that this was as small 
an amount as possible (approximately ¼ of the micropipette was filled with 
intracellular solution). The electrode holder possessed a side arm that allowed the 
application of positive and negative pressure to the electrode tip. A silver chloride 
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pellet was placed in the recording chamber to act as a reference electrode. Both the 
recording electrode and the reference electrode were connected to the CV-4 
1/100U headstage (Axon Instruments, USA) as detailed in figure 2.1; therefore a full 
electrical circuit was achieved when the electrode was lowered into the aCSF within 
the recording chamber. A micromanipulator (PatchStar, Scientifica, UK ) was 
attached to the headstage to allow the course and fine control of the microelectrode 
as it was positioned in the recording chamber. Signals from the recording electrode 
were preamplified by the headstage, filtered by a Bessel low pass filter set at 2-
5kHz, passed through the Axopatch 1D amplifier (Axon Instruments, USA) and 
filtered for mains noise by a HumBug (Quest Scientific via Digitimer, UK). The 
signal was then converted from an analogue signal to a digital signal by the 
Digidata 1322A analogue to digital converter unit (Axon Instruments, USA) before 
being captured by the pClamp 9 software (Axon Instruments, USA) on a PC. The 
acquisition frequencies were 20kHz for the intial recordings to identify cell type (see 
section 2.3.5) and 5kHz for the continuous recordings to identify drug responses. 
A Master-8 stimulator (A.M.P.I., Israel) was used to control the timing and duration 
of current and voltage pulses. Channel 1 of the Master-8 triggered the start of a 
sweep in the pClamp software via the Digidata 1322A, whilst also triggering 
channel 2 of the Master-8. Channel 2 of the Master-8 then initiated a current or 
voltage pulse from the Axopatch 1D amplifier.  
At the opposite side of the recording chamber another micromanipulator (PatchStar, 
Scientifica, UK) held a blunted micropipette (resistance 3-5 MΩ, tip diameter 3-4 
µm) that was filled with drug solutions. The micropipette was connected to a PV800 
pneumatic pico pump (World Precision Instruments Ltd, UK) which was connected 
to a pressurised gas cylinder; this allowed the rapid, focal extrusion of drug 
solutions onto the recorded cell. The PV800 pneumatic pico pump was also 
connected to the Digidata 1322A which was in turn connected to the pClamp 9 
software on the PC; this allowed the visualisation of exactly when the pressure 
ejection of the drug occurred, enabling the time to onset of response to be 
measured.     
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Figure 2.1: Experimental set-up for whole cell patch clamp electrophysiology 
recordings.  
See experimental set-up section for details. 
 
2.3.4 Whole cell and perforated patch clamp recordings 
An upright microscope (Olympus BX50W1) was used to identify the CC at x10 
magnification. Viable CSFcCs, ependymal cells and nearby interneurones were 
viewed at x60 magnification first using the upright microscope then using differential 
interference contrast (DIC) imaging on a computer monitor using QCapture Pro 
software via a camera (QImaging Rolera-XR, Q imaging, Canada) attached to the 
microscope. Ependymal cells were easily identified by their location surrounding the 
CC, their cuboidal shape and their lack of CC-contacting process. CSFcCs were 
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identified by their subependymal location, a more spherical cell body in comparison 
to the ependymal cells and the presence of a CC-contacting process. In GAD67-
GFP mice CSFcCs were visualised using epifluorescence. 
Positive pressure was applied to the electrode before lowering it into the solution. In 
current clamp mode the pipette offset was compensated using the amplifier’s offset 
dial, and the pipette resistance, due to a -250 pA current pulse, was compensated 
using the amplifier’s series resistance dial to give a voltage of 0 mV.  Viewed by the 
x10 objective, the tip of the electrode was positioned above the CC using the 
coarse controls of the micromanipulator. The amplifier was then switched to voltage 
clamp mode and the track function utilised. Changing to the x60 magnification and 
the fine piezoelectric controls of the micromanipulator, the tip of the electrode was 
lowered towards a cell of interest until the positive pressure caused a dimple to 
appear in the cell membrane.  The positive pressure was released and the seal 
formation was observed by monitoring the current response to a voltage pulse of 25 
mV. Sometimes a small amount of gentle suction was required to form a seal of 
sufficient resistance. A seal was considered strong enough when the current 
response equated to a ≥3 GΩ resistance. The amplifier was switched back to 
current clamp, the current pulse reduced to -50 pA and a small negative current 
applied to maintain the cell at -60 mV to -80 mV. To achieve the whole cell patch 
clamp configuration a short, sharp suction was applied. To achieve the perforated 
patch clamp configuration the cell was left following seal formation until the 
resistance began to increase. 
 
2.3.5 Neuronal characterisation 
To characterise voltage responses in current clamp, positive and negative current 
(ranging from -120 pA to +120 pA) was injected into the cells in the form of 1 s 
pulses that were triggered by the Master-8 stimulator, with the amplitude adjusted 
by the amplifier. The injection of positive current brought some cells to the threshold 
for firing an action potential, induced rapid depolarisations in some cells and 
resulted in rectangular depolarisations in other cells. The injection of negative 
current resulted in hyperpolarisations which allowed the input resistance of cells to 
be calculated using Ohm’s law. Together these challenges gave an indication of the 
cell type.  
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2.3.6 Preparation and application of drugs 
To characterise the responses of cells to drug solutions/compounds, 
hyperpolarising pulses of -2 to -50 pA were applied, with the size of current 
dependant on cell type; usually -2 to -10 pA for CSFcCs, -5 to -20 pA for 
interneurones and -10 to -50 pA for ependymal cells. The majority of compounds 
were superfused at a flow rate of ~4-6 mls / min. However to allow direct, fast 
application of ACh and GABA, a blunted micropipette that was attached to the pico 
pump was filled with the drug and lowered close to the recorded cell prior to whole 
cell patch clamp configuration being achieved. Intervals of 5 minutes were allowed 
between pressure applications of ACh and GABA to ensure that receptors would 
not be in a desensitised state. In some cases antagonists or allosteric modulators 
were superfused in conjunction with the pressure ejection of ACh. The compounds 
applied, their known functions and the final concentrations in the recording chamber 
are given (Table 2.2). The reasoning for using the given concentrations is also 
stated and is based on either the EC50 or IC50 values of the compounds or the 
previous effective use of the compound at this concentration. All compounds were 
stored at 103 their working concentrations, with the exceptions of ACh and 5HT, 
that were weighed and dissolved fresh on the day of use, and DHβE and MLA that 
were stored at 104 their working concentration. All drugs were dissolved in water 
with the exceptions of diazepam and 18β-Glycyrrhetinic acid that were dissolved in 
ethanol and PNU-120596 that was dissolved in DMSO.  
 
2.3.7 Analysis 
Data was captured using the Clampex programme and data was analysed in the 
Clampfit programme, both part of the pClamp 9 software. The input resistance of a 
cell was calculated using Ohm’s law (input resistance = voltage response / current 
injected), and was taken using the average voltage response from two separate 
negative current injections. Cell types (i.e. ependymal, CSFcC and interneurone) 
and cell subtypes (i.e. CSFcC subtypes 1-3) were determined based on the voltage 
responses to the injection of positive current with regards to the shape of the 
response and the ability to produce an action potential, and on the size of their input 
resistance, calculated from the injection of negative current pulses. The average 
data for each cell type and subtype is expressed as mean ± S.E.  
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Common drug name Chemical name Known function Final concentration Reasoning for concentration Supplier 
5-Hydroxytryptamine, 5HT, serotonin 3-(2-
Aminoethyl)-1H-indol-5-ol 
5HT receptor agonist 10 µM EC50 9.56 µM (Rick et al., 1995), 10 
µM used previously (Wang and Dun, 
1990; Pickering et al., 1994). 
Sigma  
Substance P RPKPQQFFGLM NK1 receptor agonist 1 µM EC50 can vary from 19 nM to 12 µM 
(Nalivaiko et al., 1997). 
Tocris 
GABA γ-Aminobutyric acid GABA receptor 
agonist 
200 µM (bath), 500 
μM (pipette) 
The GABA concentration applied 
was used to induce maximal 
responses (Uchida et al., 1996). 
Sigma 
Bicuculline [R-(R*,S*)]-5-(6,8-Dihydro-8-
oxofuro[3,4-e]-1,3-benzodioxol-6-yl)-5,6,7,8-
tetrahydro-6,6-dimethyl-1,3-dioxolo[4,5-
g]isoquinolinium  
GABAA receptor 
antagonist, α7*nAChR 
antagonist 
10-100 µM 10 µM used previously (Bradaia & 
Trouslard, 2002; Deuchars et al., 
2005). 100 µM ensures effect at 
extrasynaptic receptors (Wang et 
al., 2008). 
Ascent 
Table 2.2: Drugs used in this study.   
Common and chemical names, known functions, final bath concentrations, the reasoning for these concentrations and the suppliers are given. 
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Common drug name Chemical name Known function Final concentration Reasoning for concentration Supplier 
Gabazine, SR-95531 6-Imino-3-(4-
methoxyphenyl)-1(6H)-pyridazinebutanoic acid  
 
GABAA receptor 
antagonist 
2.5 -50 µM Previously used effectively (Wang et 
al., 2008).  
Sigma 
Baclofen (R)-4-Amino-3-(4-
chlorophenyl)butanoic acid 
 
GABAB receptor 
agonist 
5-10 µM IC50 2.5 µM at rat SPNs (Wu and 
Dun, 1992). 
Tocris 
Acetylcholine, ACh 2-(Acetyloxy)-N,N,N-
trimethylethanaminium  
 
AChR agonist 3-10 mM (pipette) Previously used effectively in rodent 
hippocampus (Henderson et al., 
2005; John, 2010). 
Sigma  
Atropine α-(Hydroxymethyl)benzeneacetic acid 
8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester 
mAChR antagonist 5 µM Previously used effectively 
(Henderson et al., 2005; John, 
2010). 
Sigma 
Mecamylamine, MCA N,2,3,3-
Tetramethylbicyclo[2.2.1]heptan-2-amine 
 
nAChR antagonist 50 µM Previously used effectively at 25 µM 
(Henderson et al., 2005). 
Tocris 
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Common drug name Chemical name Known function Final concentration Reasoning for concentration Supplier 
Dihydro-β-erythroidinne, DHβE (2S,13bS)-2-
Methoxy-2,3,5,6,8,9,10,13-octahydro-1H,12H-
benzo[i]pyrano[3,4-g]indolizin-12-one 
 
Non α7*nAChR 
antagonist 
1 µM 1 µM determined effective but 10 
µM unspecific (Bradaia & Trouslard, 
2002). 
Tocris 
Methyllycaconitine, MLA [1α,4(S),6β,14α,16β]-
20-Ethyl-1,6,14,16-tetramethoxy-4-[[[2-(3-methyl-
2,5-dioxo-1-
pyrrolidinyl)benzoyl]oxy]methyl]aconitane-7,8-diol 
α7*nAChR antagonist 20 nM 20 nM is specific for α7*nAChRs, 
higher concentrations are unspecific 
(Wonnacott, 1993). Previously used 
effectively (Henderson et al., 2005; 
John, 2010). 
Tocris 
PNU-120596 N-(5-Chloro-2,4-dimethoxyphenyl)-
N′-(5-methyl-3-isoxazolyl)-urea 
α7*nAChR positive 
allosteric modulator 
10 µM Previously used effectively 
(Dickinson et al., 2007; John, 2010). 
Ascent 
Tetrodotoxin, TTX Octahydro-12-
(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-
10aH-[1,3]dioxocino[6,5-d]pyrimidine-
4,7,10,11,12-pentol 
 
Voltage-gated Na+ 
channel blocker 
1 µM Commonly used effectively (Bordey 
et al., 1996a; Wang et al., 2008). 
Sigma 
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Common drug name Chemical name Known function Final concentration Reasoning for concentration Supplier 
AP-5 D-(-)-2-Amino-5-phosphonopentanoic acid NMDA receptor 
antagonist 
50 µM Previously used effectively 
(Henderson et al., 2005; John, 
2010). 
Tocris 
NBQX 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide 
AMPAR and kainate 
receptor antagonist 
20 µM Previously used effectively 
(Henderson et al., 2005; John, 
2010). 
Tocris 
18β-Glycyrrhetinic acid 3β-Hydroxy-11-oxo-
18β,20β-olean-12-en-29-oic acid 
Gap junction blocker 100 µM Previously used effectively (Pierce 
et al., 2010). 
Sigma 
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To determine the effects of superfused drugs, the input resistance and membrane 
potential were measured before, during and after the drug application, and for each 
condition, an average was determined from three measurements. Data is 
expressed as mean ± S.E. Current was not injected during the pressure application 
of drugs as this would distort the fast voltage responses observed, therefore, for 
these applications only the change in membrane potential/voltage was used to 
determine the size of the drug effect. The time to onset of response and time to 
peak response were also measured following the pressure application of drugs. The 
data for each cell type in response to the pressure ejection of drugs was expressed 
as mean ± S.E. To determine whether a superfused drug had affected the response 
of the cell to the pressure ejected drug, the size of the voltage change in response 
to the pressure ejected drug was measured before, during and after the superfusion 
of the additional drug.  
 
2.3.8 Statistics 
Data were tested to ensure that they were normally distributed. If data was normally 
distributed a parametric test was used to determine whether there was any 
significant difference between subtypes or following drug applications. If data was 
not normally distributed the equivalent non-parametric test was used to determine 
any significant differences between subtypes or following drug applications. The 
specific tests used to determine significant differences between groups are detailed 
in table 2.3.  
Post-hoc Bonferroni tests were used following one-way ANOVAs, repeated 
measures ANOVAs and two-way ANOVAs to determine the differences between 
specific groups. Where a Kruskall-Wallis H test or a Friedman test were used to 
determine whether there was a significant difference, a Mann-Whitney U test or a 
Wilcoxon Signed Rank test, respectively, were used to determine the differences 
between specific groups. Statistical results were reported with the test statistic, the 
degrees of freedom and the p value. Data was considered significant when p < 0.05 
(denoted by *), however, to highlight results with higher degrees of significance p < 
0.01 (denoted by **) and p < 0.001 (denoted by ***) were used.  
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Table 2.3: Statistical tests used in this study.  
Displayed are the parametric tests and the equivalent non-parametric tests used to 
determine whether there were statistically significant differences between groups of 
data for specific circumstances. 
What difference is being 
tested for? 
Parametric test and 
associated test statistic 
Non-parametric test and 
associated test statistic 
Between subtypes (2 
groups) or species 
Independent samples t-
test (t) 
Mann-Whitney U test (U) 
Between subtypes (3 or 
more groups) 
One-way ANOVA (F) Kruskal-Wallis H test (H) 
Before and during drug 
application 
Paired samples t-test (t) Wilcoxon Signed Rank 
test (Z) 
Before, during and after 
drug application 
Repeated measures 
ANOVA (F) 
Friedman test (X2) 
Between subtypes and 
drug application 
Two-way ANOVA (F) n/a 
Correlation n/a Spearman’s Rank-Order 
Correlation (rs) 
 
2.4 Histological identification of recorded cells 
As detailed in section 2.3.1, the intracellular solution contained Neurobiotin and 
rhodamine which diffused into the cells during recording to allow the morphology of 
the cell to be determined.  
2.4.1 Identification of recorded cells using rhodamine 
The rhodamine could be visualised immediately post-recording whilst the electrode 
was still attached, the rhodamine was visualised when excited by a wavelength of 
550 nm using an epifluorescence microscope (Olympus BX50W1; Olympus U-RFL-
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T). The image of a rhodamine-filled cell was captured using QCapture Pro software 
via a camera (QImaging Rolera-XR, Q imaging, Canada) that is attached to the 
microscope. Following the image capture of rhodamine the recording electrodes 
were carefully removed from cells by applying a small amount of positive pressure.  
 
2.4.2 Identification of recorded cells using Neurobiotin 
Neurobiotin is a gap junction permeable tracer (Kita and Armstrong, 1991; Vaney, 
1991), unlike rhodamine (Heyman and Burt, 2008), therefore it can reveal whether 
the recorded cell was coupled by gap junctions to neighbouring cells; it also 
enables a more detailed cell morphology to be visualised. The visualisation of 
Neurobiotin requires multiple steps. Firstly, the recovered slices were fixed in 0.1 M 
phosphate buffer (PB) containing 4 % paraformaldehyde (PFA) and 0.25 % 
glutaraldehyde for < 24 hours at 4°C. Following 3 x 10 minute washes in 0.1 M PB, 
slices were removed from the agar in which they were originally cut and embedded 
in gelatine (10 % solution in distilled water). The gelatin embedded slices were fixed 
for 1 hour in 0.1 M PB containing 4 % PFA and 0.25 % glutaraldehyde before 
washing for 3 x 10 minutes in 0.1 M PB and cutting serial sections of 50-80 µm 
using a vibrating microtome (VT1000S, Leica Microsystems, UK). Sections were 
collected and washed for 3 x 10 minutes in 0.1 M PBS. At this stage some cells 
were incubated in 0.1 M PBS containing 0.1 % Triton X100 and streptavidin 
conjugated to AlexaFluor 555 (Invitrogen) at a concentration of 1:1000 which 
directly binds to Neurobiotin. Sections were washed 3 x 10 minutes in 0.1 M PBS, 
mounted on glass coverslips and air dried. Sections were then mounted in 
Vectasheild (Vector Laboratories) and covered with a glass coverslip before being 
visualised using a Zeiss LSM510 Meta laser scanning confocal microscope. Using 
the confocal microscope z-stacks were taken of the sections to allow the processes 
to be followed throughout the slice. Projections of the whole cell were created from 
the z-stacks using Carl Zeiss LSM software. Most cells, however, were visualised 
by 3, 3’-diaminobenzidine (DAB). To allow visualisation of cells with DAB, sections 
were incubated in 0.1 M PBS containing 0.1 % Triton X100 and 1 % H2O2, to 
permeabilise the cell membranes and block endogenous peroxidise activity, 
respectively. Sections were then washed for 3 x 10 minutes in 0.1 M PBS and 
incubated in extravidin peroxidise (EAP; Sigma-Aldrich, Poole, 1:250 in 0.1 M PBS) 
for 36-78 hours at 4°C to detect the Neurobiotin. Sections were washed for 3 x 10 
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minutes in 0.1 M PBS, then 10 minutes in tris buffer (pH 7.6) to remove any 
unbound EAP. Sections were incubated in DAB (0.5 mg/ml in tris buffer) for 10 
minutes before adding H2O2 to give a resulting concentration of 0.01 % H2O2. The 
progress of the reaction was then monitored every minute until the cell could be 
visualised. The reaction was stopped by washing in tris, followed by 3 x 10 minute 
washes in 0.1 M PB. Sections were mounted temporarily for imaging and drawing 
using the Nikon Eclipse E600 microscope in 0.1 M PB under glass coverslips. For 
permanent mounting, sections were washed in distilled H20 for 10 minutes before 
dehydrating in increasing concentration of alcohol 30 %, 50 %, 70 % and 95 % for 5 
minutes each and in 100 % for 10 minutes. Sections were incubated in Xylene for 2 
x 5 minutes before mounting on a glass coverslip and leaving to air dry. DPX was 
used to cover the sections, a coverslip added and left to harden overnight before 
further viewing if necessary.  
 
2.5 Immunohistochemistry 
2.5.1 Fixed spinal cord section preparation 
As previously stated, all experiments were carried out in line with the Animals 
Scientific Act (1986) by individuals with Home Office approval. Wistar rats and 
GAD67-GFP mice (9-12 days old or adult) were anaesthetised by administration of 
pentabarbitone (60 mg/kg) I.P.  Animals were deemed sufficiently anaesthetised 
when the pedal withdrawal reflex was abolished in response to a noxious pinch. 
Using blunted scissors an incision was made through the skin from the caudal 
aspect of the sternum to the distal aspect of the clavicle on either side of the animal 
to allow access to the rib cage. The rib cage was then removed to expose the heart, 
clearing away any membranes that may be obstructing access to the heart. A 
transcardiac perfusion was then performed; this involved creating an incision in the 
right atrium, then injecting approximately 10 mls (mouse) or approximately 20 mls 
(rat) of 4 % PFA into the left ventricle using a shortened, blunted 19 gauge needle. 
Using blunted scissors the whole vertebral column was dissected out, from which 
the whole spinal cord was dissected out using spring scissors and post-fixed in 4 % 
PFA overnight. The spinal cord was washed in 0.1 M PB and the dura and pia 
mater were removed. Roughly 3 mm of lower thoracic or upper lumbar spinal cord 
was cut, the same area as that used in the preparation of slices for 
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electrophysiology recordings, and sectioned at 50 µm in 0.1 M PB on a vibrating 
microtome (VT1000S, Leica Microsystems, UK).  
 
2.5.2 Immunohistochemistry on fixed sections 
Sections were collected in 0.1 M PBS and washed for 3 x 10 minutes in 0.1 M PBS. 
Sections were incubated in pepsin (2 mg/ml in 0.2 M hydrochloric acid) for 5 
minutes (Watanabe et al., 1998); pepsin digests both bound and unbound proteins 
enabling the primary antibody to better penetrate the tissue. Sections were washed 
for 3 x 10 minutes in 0.1 M PBS, before incubating in primary antibodies overnight 
in 0.1 M PBS containing 0.3 % Triton X100, 3 % donkey serum, 0.8 % bovine 
serum albumin at the concentrations given in table 2.4. Triton X100 is a detergent 
that permeabilises the cell membranes allowing access to intracellular antigens. 
Donkey serum and bovine serum albumin are used to reduce the amount of 
unspecific binding of the antibodies used to the tissue. An anti-PKD2L1 antibody 
(for details see table 2.4) was used to identify CSFcCs; the antibody used produced 
the same distribution pattern for PKD2L1 as that seen in PKD2L1-GFP recombinant 
mice (Huang et al., 2006). Alternatively, to identify CSFcCs in GAD67-GFP mice, 
an anti-GFP antibody (for details see table 2.4) was used. An anti-calbindin 
antibody (for details see table 2.4) was used to identify ependymal cells, this 
antibody has been demonstrated to reliably identify calbindin as there was no 
labelling in calbindin knock-out mice (Airaksinen et al., 1997). An anti-ChAT 
antibody (for details see table 2.4) was used to identify cholinergic terminals; the 
antibody used has reliably identified ChAT-expression in the rat spinal cord 
previously and produced the same distribution pattern for ChAT as that seen with 
other anti-ChAT antibodies (Barber et al., 1984; Phelps et al., 1984) and that seen 
in mice expressing Cre under control of the ChAT promotor (GENSAT).  An anti-
5HT antibody (for details see table 2.4) was used to identify 5HT-containing 
terminals; the antibody used was specific for 5HT-expressing neurones (Milstein et 
al., 1983) and produced an identical distribution pattern of 5HT-expressing 
terminals to that previously observed (Newton et al., 1986). An anti-substance P 
antibody (for details see table 2.4) was used to identify substance P-containing 
terminals; this antibody has been shown to be specific for substance P (Cuello et 
al., 1979) and  produced an identical distribution pattern of substance P expressing 
terminals to that previously observed (Barber et al., 1979). Sections were washed in 
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0.1 M PBS for 3 x 10 minutes before incubating in the appropriate secondary 
antibodies at 1:1000 (Table 2.5) for 2 hours. Sections were then washed in 0.1 M 
PBS for 3 x 10 minutes before leaving to air dry onto glass slides. Once dry, 
sections were mounted in Vectasheild (Vector Laboratories) and covered with a 
glass coverslip. To eliminate the possibility of unspecific staining occurring with the 
secondary antibodies, sections that had not been incubated in primary antibodies 
were incubated in both secondary antibodies.  
 
2.5.3 Image capture and analysis 
Initial images were taken on the Nikon Eclipse E600 microscope, and then z-stacks 
were taken of the CC area using a scanning confocal microscope. Images were 
viewed using Carl Zeiss LSM software before importing to CorelDRAW X4 software 
where images were adjusted for brightness, contrast and intensity, and to assemble 
the figures. 
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Table 2.4: List of primary antibodies.  
Primary antibodies used, detailing the species the antibody was produced in, the 
concentration at which it was used and where it was sourced from.  
Antibody Species Concentration Source 
Anti-5HT Rat 1:200 AbD Serotec 
Anti-calbindin Mouse 1:500 Swant CB300 
Anti-ChAT Goat 1:500 Millipore 
Anti-GFP Rabbit 1:1000 Invitrogen 
Anti-PKD2L1 Rabbit 1:1000 Abcam 
Anti-substance P Rat 1:1000 Medimabs 
 
 
 
 Table 2.5: List of secondary antibodies.  
Secondary antibodies used, detailing the species the antibody was produced in, the 
concentration at which it was used and where it was sourced from. 
Antibody Species  Concentration Source 
Anti-Goat IgG, Alexa Fluor 488 Donkey  1:1000 Invitrogen 
Anti-Mouse IgG Alexa Fluor 555 Donkey 1:1000 Invitrogen 
Anti-Rabbit IgG, Alexa Fluor 488 Donkey 1:1000 Invitrogen 
Anti-Rabbit IgG, Alexa Fluor 555 Donkey 1:1000 Invitrogen 
Anti-Rat IgG, Alexa Fluor 555 Goat 1:1000 Invitrogen 
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Chapter 3 - Basic characteristics of CSFcCs and their 
responses to neurotransmitters and neuromodulators
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3.1 Introduction 
CSFcCs are a unique cell type found surrounding the CC and are defined by their 
CC-contacting process which ends in a large, bulbous terminal contacting the CSF 
(Vigh et al., 1977). They also possess an axon which extends from the cell body to 
terminate on the ventral and ventrolateral surfaces of the spinal cord, although the 
synaptic terminals on these axons do not contain synaptic machinery (Stoeckel et 
al., 2003). As discussed in the general introduction, the function of CSFcCs is 
currently unknown. The intention of this chapter is to investigate the 
electrophysiological properties of CSFcCs and their ability to respond to 
neurotransmitters and neuromodulators in order to resolve this deficiency. The one 
previous study of mammalian CSFcCs categorised the cells into three subtypes: 
cells that had active response properties but could not spike, single spiking cells 
and repetitive spiking cells (Marichal et al., 2009). These data indicated that 
CSFcCs could be immature neurones in varying states of maturity; however BrdU 
studies suggest that these cells do not appear to be born postnatally. Alternatively, 
the CSFcCs could be mature cells with varying electrophysiological subtypes that 
correspond to their varying functions, for example the role of some CSFcCs may 
not require the ability to produce a spike. Instead they may transmit information 
through Ca2+ signalling or the transport of substances from the CSF to different 
areas of the spinal cord.  
An effective method of determining the function of CSFcCs is to investigate which 
neurotransmitters and neuromodulators CSFcCs respond to. To date, however, 
only the effect of GABA on CSFcCs has been investigated (Marichal et al., 2009). 
GABA was shown to have variable effects on CSFcCs, inducing depolarisations in 
some CSFcCs and hyperpolarisations in others, this was taken to support the 
theory that CSFcCs are at different levels of maturity but could also indicate a 
difference in function of CSFcCs. Although the ability of CSFcCs to respond to 
GABA could draw parallels to the newborn neurones in the SVZ and DG (Bolteus 
and Bordey, 2004; Ge et al., 2006), it does not reveal an immediate function for 
them. This is because there is a widespread distribution of GABAergic neurones 
throughout the spinal cord and they are not generally associated with a specific 
function. To help assign a function to CSFcCs it would be useful to study whether 
neurotransmitters or neuromodulators whose distribution is more specific and 
whose role is better defined are interacting with CSFcCs. Both 5HT-immunoreactive 
and substance P-immunoreactive terminals have been identified in the area 
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surrounding the CC of the spinal cord (Barber et al., 1979; Takeoka et al., 2009). 
Although the effects of 5HT and substance P are many and complex, their 
distributions and functions within the spinal cord are more defined than that of 
GABA. For example, 5HT is known to be involved in autonomic control (Pierce et 
al., 2010) and motor control (Dunbar et al., 2010), where as substance P is widely 
associated with nociception (De Koninck and Henry, 1991). Determining whether 
CSFcCs respond to either of these neurotransmitters/neuromodulators is the first 
step towards establishing a functional role for CSFcCs.  
 
3.1 Hypothesis and aims 
To aid in determining whether CSFcCs are in the process of maturation, the basic 
electrophysiological properties of CSFcCs in spinal cord slices from rats aged P9-
P21 are investigated and compared to previous studies of CSFcCs from rats aged 
P0-P5. It is hypothesised that there are no differences in the basic properties of 
CSFcCs or the heterogenity of the population of CSFcCs in rats aged P9-P21 
compared to those aged P0-P5. It is also hypothesised that CSFcCs in spinal cord 
slices from mice aged P9-P21 have similar properties.  
To investigate how CSFcCs are integrated into the spinal cord circuitry, their 
responses to a number of neurotransmitters and neuromodulators that are 
abundant in lamina X are investigated. The neurotransmitters and neuromodulators 
could also be capable of influencing any maturation and/or plasticity occurring in 
CSFcCs. More specifically, given the ability of CSFcCs from rats aged P0-P5 to 
respond to GABA, it is hypothesised that CSFcCs from rats and mice aged P9-P21 
are capable of responding to GABA. Due to the more specific functional roles of 
5HT and substance P within the spinal cord, it is useful to determine whether 
CSFcCs can respond to these neurotransmitters/neuromodulators. As there is an 
abundance of 5HT- and substance P-immunoreactive terminals surrounding the 
CC, it is hypothesised that CSFcCs are capable of responding to 5HT and subtance 
P.  
These hypotheses will be tested using whole cell patch clamp electrophysiology, 
intracellular dye-loading and immunohistochemistry.   
78 
 
 
3.2 Results 
The majority of data in this chapter is from spinal cord slices prepared from Wistar 
rats, however, there is some data collected in spinal cord slices prepared from 
C57/bl6 mice. Unless otherwise stated data is from Wistar rats. 
 3.2.1 CSFcCs can be categorised into three subtypes 
Electrophysiology revealed that CSFcCs were a varied population of cells. Their 
phenotype ranged from one indistinguishable from that of ependymal cells to a 
phenotype resembling a robust repetitively firing neurone. Due to this varied 
phenotype, the criterion used to define a cell as a CSFcC was the visualisation of a 
CSF-contacting process post-recording using either rhodamine or Neurobiotin. To 
aid analysis, CSFcCs were categorised into three subtypes based on their 
responses to depolarising current pulses, however, the phenotypes of CSFcCs vary 
within the subtypes and some of the subtypes could be joined together and viewed 
as responses ranging along a continuum.  
Subtype 1 CSFcCs had a phenotype that was indistinguishable from ependymal 
cells (see chapter 4.2.1; Figure 3.1A). They had a resting membrane potential of -
74.29 ± 0.82 mV (n = 21; Figure 3,1D), a low input resistance of 71.12 ± 8.40 MΩ (n 
= 21; Figure 3.1E, 3.3C) and a lack of spontaneous or evoked activity such as 
EPSPs. There was a significant moderate, positive correlation between the resting 
membrane potential and the input resistance (rs (19) = 0.440, P = 0.046). This 
indicated that cells with a more negative resting membrane potential generally had 
a smaller input resistance. Within subtype 1 CSFcCs, the cells could be further 
categorised into subtype 1A and 1B by visualisation of Neurobiotin with DAB post-
recording. Neurobiotin can pass through gap junctions (Kita and Armstrong, 1991; 
Vaney, 1991), therefore if cells are coupled to neighbouring cells, these cells may 
be visualised by DAB. Only 12 out of 21 CSFcCs could be categorised into 1A or 
1B as cells were not always successfully visualised by DAB. Subtype 1A CSFcCs 
were defined as cells which were coupled to neighbouring cells, resembling 
ependymal cells (see chapter 4.2.1; Figure 3.1B). 7 out of 12 CSFcCs were subtype 
1A, this group had a resting membrane potential of -75.71 ± 1.27 mV (Figure 3.1D) 
and an input resistance of 41.39 ± 3.53 MΩ (Figure 3.1E). Subtype 1B CSFcCs 
were defined as cells which were visualised alone and not coupled to neighbouring 
cells (Figure 3.1C). 5 out 12 CSFcCs were subtype 1B, this group had a resting 
membrane potential of -73.60 ± 0.93 mV (Figure 3.1D) and an input resistance of 
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106.15 ± 12.88 MΩ (Figure 3.1E). The input resistance of subtype 1A CSFcCs was 
significantly lower than that of subtype 1B CSFcCs (U = 0.00, P = 0.004; Figure 
3.1E), this was determined using a Mann-Whitney U test as the data was not 
normally distributed.  The smaller input resistance of subtype 1A CSFcCs indicates 
that there is very little resistance to the movement of ions in and out of these cells 
through either ion channels or gap junctions. In the case of these cells the small 
input resistance is indicative of a high degree of gap junction coupling which was 
highlighted by the dye-coupling. Despite the resting membrane potential of subtype 
1A CSFcCs being more negative than that of subtype 1B CSFcCs, there was no 
significant difference between the two (t (10) = -1.24, P = 0.243; Figure 3.1D). 
Subtype 2 CSFcCs were defined by the production of a single fast depolarisation in 
response to the injection of positive current. The single fast depolarisation ranged 
on a continuum, from a fast but small depolarisation, then a single spike (Figure 
3.2A) and finally to a single action potential (Figure 3.2B). The term spike is used in 
reference to a fast event that has definable depolarising and repolarising phases 
but could not be considered an action potential as it does not overshoot 0 mV. 
Some subtype 2 CSFcCs had membrane potential oscillations that followed the 
single spike or action potential; these oscillations looked like unsuccessful attempts 
to produce further spikes. Within the total population of subtype 2 CSFcCs (n = 
136), 22 produced a fast depolarisation, 59 generated a spike and 55 generated an 
action potential. Rebound depolarisations were often observed following a negative 
current pulse (Figure 3.2A, B). Subtype 2 CSFcCs frequently exhibited 
spontaneous activity, with EPSPs visible (Figure 3.2A, B). Subtype 2 CSFcCs had a 
large input resistance of 2679.66 ± 127.00 MΩ (n = 136) that was significantly 
larger than that of subtype 1 CSFcCs (U = -7.364, P < 0.001; Figure 3.3C), a Mann-
Whitney U test was used to determine this difference following a Kruskal-Wallis H 
test which revealed there was a significant difference between the 3 CSFcC 
subtypes (H (2) = 56.655, P < 0.001); both tests were used because the data was 
not normally distributed. Rebound depolarisations were observed following the 
injection of negative current (Figure 3.2A, B), suggesting the presence of T-type 
Ca2+ channels. Visualisation of subtype 2 CSFcCs post-recording always revealed 
a single CSFcC indicating that these cells were not coupled to neighbouring cells 
(Figure 3.2Ai, Bi).  
Subtype 3 CSFcCs were defined by their ability to produce multiple spikes or action 
potentials in response to the injection of positive current (Figure 3.2C). The 
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Figure 3.1: CSFcCs with passive response properties. 
A) Example whole cell patch clamp trace in current clamp of a subtype 1 CSFcC 
responding to the injection of positive and negative current pulses. B-C) Excitation 
of rhodamine post-recording revealed cells with CSF-contacting processes. Cell 
bodies are highlighted by unfilled arrowheads, CSF-contacting processes are 
highlighted by filled arrowheads and patch pipettes are highlighted by arrows. Inset 
(C) shows cell body in focus on a different level to the CSF-contacting process. Bi-
Ci) Visualisation of Neurobiotin by DAB in the same cells revealed either a cluster 
of cells in the location of the recorded cell (subtype 1A; Bi) or the same single cell 
(subtype 1B; Ci). All images are orientated so dorsal is at the top. D-E) Comparison 
of the mean resting membrane potential ± S.E (D) and the mean input resistance ± 
S.E (E) for subtype 1 CSFcCs, compared to subtype 1A and subtype 1B CSFcCs. 
** = p < 0.01. 
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phenotypes of cells within this subtype varied on a continuum from those only 
capable of producing two spikes or action potentials, to others that could produce 
three or four spikes or action potentials, whilst a rare few cells were capable of firing 
repetitive action potentials. Subtype 3 CSFcCs exhibited spontaneous activity in the 
form of EPSPs and sometimes spikes or action potentials (Figure 3.2C). In 
response to the injection of negative current some subtype 3 CSFcCs displayed a 
voltage sag which is indicative of an Ih. Subtype 3 CSFcCs had a large input 
resistance 2565.64 ± 175.72 MΩ (n = 59) that was significantly larger than subtype 
1 CSFcCs (U = -6.774, P < 0.001; Figure 3.3C) but was not significantly different 
from subtype 2 CSFcCs (U = -0.225, P = 0.822; Figure 3.3C); as prior a Mann-
Whitney U test was used to determine the differences as the data was not normally 
distributed. Visualisation of subtype 3 CSFcCs post-recording revealed a single 
CSFcC with no coupling to neighbouring cells (Figure 3.2Ci). 
The proportion of CSFcCs in each subtype was not the same. The majority of 
CSFcCs, 63 % (n = 136) were classified as subtype 2 CSFcCs, 27 % (n = 59) were 
classified as subtype 3 CSFcCs and 10% (n = 21) were classified as subtype 1 
CSFcCs (Figure 3.3A). The majority of experiments were performed in slices from 
P11 rats; however, there was an age range from P9-P21. To verify that the 
proportion of CSFcC subtypes did not vary within this age range, the percentage of 
CSFcCs categorised in each subtype was investigated in the P21 rats only. Of the 
13 CSFcCs recorded from P21 rat slices, 15 % were subtype 1, 69 % were subtype 
2 and 15 % were subtype 3 (Figure 3.3B), indicating that there are not more 
multiple firing CSFcCs in older P21 rats compared to the population of CSFcCs in 
P9-P21 rats.  
Interneurones located close to the CC were occasionally recorded from, these were 
initially distinguished by their robust, repetitive firing of action potentials and 
confirmed post-recording by a lack of CSF-contacting process (Figure 3.2D). The 
interneurones had an input resistance of 1339.32 ± 385.13 MΩ (n = 7), which was 
significantly different from the input resistance of CSFcCs (H (3) = 62.599, P < 
0.001); this was determined by a Kruskall-Wallis H test as data was not normally 
distributed. Using a Mann-Whitney U test to investigate differences between groups 
determined that the input resistance of interneurones was significantly larger than 
that of subtype 1 CSFcCs (U = 0.00, P < 0.001) and significantly smaller than that 
of subtype 2 CSFcCs (U = 193.5, P = 0.008) and subtype 3 CSFcCs (U = 87, P = 
0.013).  
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Figure 3.2: CSFcCs with active response properties.  
A-B) Example whole cell patch clamp traces in current clamp of two subtype 2 
CSFcCs, one producing a single spike (A) and one producing a single action 
potential (B) in response to the injection of positive current. Rebound 
depolarisations following the injection of negative current were observed in both 
cells. The visualisation of Neurobiotin by DAB post-recording confirmed the cells as 
CSFcCs (Ai, Bi). C) Example trace of a subtype 3 CSFcC producing multiple action 
potentials in response to the injection of positive current. The excitation of 
rhodamine post-recording confirmed the cell as a CSFcC (i). D) Example trace of 
an interneurone repetitively firing action potentials in response to the injection of 
positive current. The visualisation of Neurobiotin by streptavidin 555 post-recording 
confirmed that the cell was an interneurone (i). All images are orientated so dorsal 
is at the top. Black arrows indicate spontaneous synaptic activity; black arrowheads 
indicate rebound depolarisations; white arrows indicate the patch pipette; white 
arrowheads highlight projections.  
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To determine whether CSFcCs with a similar range of properties are conserved in 
other mammalian species as well as rats, recordings were taken from the CC area 
of the spinal cord of mice aged P8-P19. Functional responses could be observed in 
CSFcCs from the spinal cords of mice, with the type and heterogeneity of 
responses being indistinguishable from those observed in the rat spinal cord (data 
not shown). From the 13 CSFcCs recorded in mice, 15 % were classified as 
subtype 1 CSFcCs, 69% were classified as subtype 2 CSFcCs and 15 % were 
classified as subtype 3 CSFcCs. 
As mentioned, some subtype 2 and 3 CSFcCs displayed spontaneous EPSPs 
(Figure 3.2A-C), suggesting that they receive excitatory synaptic input. Bath 
application of AP5 and NBQX, antagonists of glutamatergic NMDA and AMPA 
receptors, respectively, reduced the number of EPSPs produced by CSFcCs (n = 
10; data not shown). This suggests the presence of glutamatergic synapses onto 
subtype 2 and 3 CSFcCs.  
 
3.2.2 CSFcCs possess ventrally or laterally projecting basal processes 
The visualisation of rhodamine immediately post-recording allowed the observation 
of the CSF-contacting process; however, other processes could sometimes be 
seen. These processes were better identified following the visualisation of 
Neurobiotin with DAB. Not all cells were successfully visualised post-recording and 
some processes were lost in the resectioning procedure, therefore no attempt was 
made to quantify process direction or length, or to correlate it in relation to CSFcC 
subtype. Generally only one other process was observed from the CSFcCs, these 
projected from the cell bodies ventrally towards either the ventral horn or the ventral 
median fissure (Figure 3.4A), or laterally towards the IML and the white matter 
beyond (Figure 3.4B). Processes did not appear to branch at any point (Figure 3.4). 
Some of these processes ended in quite large terminals that could be indicative of 
growth cones or could be the result of the resectioning procedure (Figure 3.4Aii, 
Bii).    
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Figure 3.3: Comparisons of CSFcC subtypes. 
A, B) Number of CSFcCs in each subtype expressed as a percentage of total 
CSFcCs, for CSFcCs recorded from rats aged P9-P21 (A) and CSFcCs recorded 
from rats aged P21 only. C) Comparison of the mean input resistance ± S.E 
depending on CSFcC subtype, *** = p < 0.001.
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Figure 3.4: Basal processes of CSFcCs. 
Visualisation of Neurobiotin with DAB revealed ventrally (A) or laterally (B) 
projecting basal processes of CSFcCs. Cell bodies (i) and process endings (ii) are 
highlighted by arrows and expanded in insets. All images are orientated so dorsal is 
at the top.
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3.2.3 CSFcNs respond to GABA 
CSFcCs with active response properties have been previously reported under the 
name of CSF-contacting neurones (CSFcNs; Marichal et al., (2009)). Therefore for 
the rest of this chapter, the CSFcCs from this study which displayed active 
response properties, subtype 2 and 3 CSFcCs, will be referred to as CSFcNs. 
CSFcNs have been shown previously to respond to GABA, this study bath applied 
GABA (200 μM) to CSFcNs to confirm that they did respond to GABA and thus 
further confirm that this was the same population of cells as examined by Marichal 
et al.,(2009). This study observed that all CSFcNs responded to GABA (n = 13), 
although there was great variation in the responses; 7 out of 13 CSFcNs 
depolarised (Figure 3.5A) and 6 out of 13 CSFcNs hyperpolarised (Figure 3.5B). 
With this variation it is not surprising that a Friedman test revealed that there was 
no significant difference between the membrane potential of CSFcNs before (-43.34 
± 0.61 mV; n = 13), during (-44.95 ± 2.19 mV; n =13) and following (-43.13 ± 0.87; n 
= 13; X2 (2) = 0.154, P = 0.926; Figure 3.5C) the bath application of GABA when 
investigated as a single group. There was, however, a significant difference in the 
mean input resistance of CSFcNs before (2434.68 ± 323.89 MΩ; n = 13), during 
(701.44 ± 106.08 MΩ; n = 13) and following (2353.94 ± 341.85; n = 13; F (2, 24) = 
36.196, P < 0.001; Figure 3.5D) the bath application of GABA. With post-hoc tests 
revealing that the input resistance during the application of GABA was significantly 
smaller than before (P < 0.001) and after (P < 0.001) the GABA application.  
Due to the variation in the responses of CSFcNs to GABA, they were sorted into 
depolarising and hyperpolarising groups. Subsequently, a Friedman test 
determined that there was a significant difference between the membrane potential 
of CSFcNs before (-43.63 ± 0.73 mV; n = 7), during (-38.68 ± 0.82 mV; n = 7) and 
following (-44.30 ± 0.60 mV; n = 7; X2 (2) = 10.571, P = 0.005; Figure 3.5E) the bath 
application of GABA in the depolarising CSFcN group. As expected for the 
depolarising CSFcN group, Wilcoxon Signed Rank tests revealed that the 
membrane potential during the GABA application was significantly less negative 
than before (Z = -2.366, P = 0.018) and following (Z = -2.366, P = 0.018) the GABA 
application. As observed for the whole group data, the input resistance before 
(2171.36 ± 518.37 MΩ; n = 7), during (664.45 ± 174.85 MΩ; n = 7) and following 
(2110.21 ± 534.3 MΩ; n = 7) the application of GABA were significantly different 
from each other in the depolarising CSFcN group (F (2, 12) = 13.990, P = 0.008; 
data not shown). The membrane potential of the hyperpolarising CSFcN group was 
also found to be significantly different before (-43.01 ± 1.07; n = 6), during (-52.26 ±  
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Figure 3.5: CSFcNs respond to GABA with both depolarisations and 
hyperpolarisations. 
A-B) Whole cell patch clamp traces in current clamp of CSFcNs depolarising (A) 
and hyperpolarising (B) to the bath application of GABA (200 μM). The downward 
voltage deflections were in response to the regular injection of -10 pA current 
pulses. C-D) Mean ± S.E membrane potential (C) and input resistance (D) under 
control conditions, during the bath application of GABA and following wash of 
GABA. E-F) Mean ± S.E membrane potential of CSFcNs in the depolarising group 
(E) and in the hyperpolarising group (F) under control conditions, during the bath 
application of GABA and following wash of GABA. * = p < 0.05, ** = p < 0.01, *** = 
p < 0.001. 
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2.01; n = 6) and following (-41.76 ± 1.67; n = 6; F (2, 10) = 11.081, P = 0.003; 
Figure 3.5F) the bath application of GABA. With post-hoc tests confirming that the 
membrane potential during the GABA application was significantly more negative 
than the membrane potential before GABA was applied (P = 0.046). A Friedman 
test determined that the input resistance before (2741.89 ± 366.41 MΩ; n =6), 
during (744.58 ± 122.55 MΩ; n = 6) and following (2638.28 ± 421.87 MΩ; n = 6) the 
application of GABA was also significantly different in the hyperpolarising CSFcN 
group (X2 (2) = 9, P = 0.011; data not shown). The change in input resistance on 
application of GABA was not significantly different between the depolarising 
(1506.90 ± 376.77 MΩ; n = 7) and hyperpolarising (1997.31 ± 378.63 MΩ; n = 6) 
CSFcN groups (t (11) = -0.913, P = 0.381; data not shown). This indicates that the 
difference in the change in membrane potential between the two groups is not a 
result of differences in input resistance. To ensure that the difference was not due 
to a difference in the set membrane potentials of the two groups, they were 
compared. There was no significant difference between the set membrane potential 
of the depolarising CSFcN group and that of the hyperpolarising CSFcN group (t 
(11) = -0.491, P = 0.633; Figure 3.5E, F), indicating that this had no influence over 
the response to GABA. There did not appear to be any association between the 
CSFcN subtype and whether the CSFcN depolarised or hyperpolarised to GABA. 
For example, 57 % of depolarising CSFcNs were subtype 2 CSFcCs compared to 
67 % of hyperpolarising CSFcNs and 43 % of depolarising CSFcNs were subtype 3 
CSFcCs compared to 33 % of hyperpolarising CSFcNs.  
GABA was also bath applied to CSFcNs in mouse spinal cord slices to give an 
indication of whether the ability of CSFcNs to respond to GABA is conserved in 
more than one mammalian species. The changes in membrane potential of 
CSFcNs in mice were also varied, with 2 CSFcNs depolarising and 2 CSFcNs 
hyperpolarising in response to GABA bath application. The mean input resistance 
of these CSFcNs was significantly different before (1391.92 ± 285.74 MΩ; n = 4), 
during (400.83 ± 156.92 MΩ; n = 4) and following (1388.42 ± 335.96 MΩ; n = 4; F 
(2, 6) = 21.723, P = 0.002; data not shown) the bath application of GABA.  
To better understand the response of CSFcNs to GABA, the focal pressure 
application of GABA (500 µM) at different membrane potentials was investigated. At 
more hyperpolarised membrane potentials (-60 and -80 mV), the pressure 
application of GABA could elicit a spike followed by a slower, more sustained 
depolarisation (Figure 3.6A). When the membrane potential of the CSFcNs was 
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adjusted by changing the amount of current applied to CSFcNs, the reversal from a 
hyperpolarising response to a depolarising response to GABA occurred between -
30 mV to -40 mV (n = 3; Figure 3.6). 
To verify the previous report that the GABA response is mediated by GABAA 
receptors (Marichal et al., 2009), GABA was bath applied in the presence of the 
GABAA antagonists, bicuculline or gabazine. Both depolarising (n = 2) and 
hyperpolarising (n = 2) GABA responses could be antagonised by bicuculline (10-
50 μM; n = 3; Figure 3.7A) or gabazine (50 μM; n = 1; Figure 3.7B). Bicuculline 
could also antagonise the GABAergic response in CSFcNs recorded from mouse 
spinal cord slices (n = 2). Neither bicuculline nor gabazine appeared to have an 
effect on the membrane potential, input resistance or spontaneous activity of 
CSFcNs when applied alone. Although, bicuculline (50 μM) and gabazine (50 μM) 
could fully antagonise the GABAergic response, the effect of the GABAB receptor 
agonist, baclofen was still investigated to eliminate any possibility that GABAB 
receptors contribute to the GABAergic response. CSFcNs did not respond to 
baclofen (10 μM) in rats (n = 2) or mice (n = 4; Figure 3.7C). There was no 
significant difference in the input resistance of CSFcNs in mice under control 
conditions (1709.58 ± 387.14 MΩ; n = 4), during the bath application of baclofen 
(1728.17 ± 372.16 MΩ; n = 4) and following the bath application of baclofen 
(1807.33 ± 419.45 MΩ; n = 4; F (2, 6) = 1.561, P = 0.285). Neither was there a 
significant difference in the membrane potential of CSFcNs in mice under control 
conditions (-45.53 ± 1.54 mV; n = 4), during the bath application of baclofen (-45.49 
± 1.68 mV; n = 4) and following the bath application of baclofen (-45.28 ± 1.92 mV; 
n = 4; X2 (2) = 0.500, P = 0.779).
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Figure 3.6: Focal pressure application of GABA indicates the reversal 
potential of GABA in CSFcNs.  
A) Whole cell patch clamp traces in current clamp of a CSFcN responding to the 
focal pressure application of GABA (500 µM) at increasingly negative membrane 
potentials that were set by adjusting the current injected. B) The change in 
membrane potential of three CSFcNs (          ) in response to the focal pressure 
application of GABA at different membrane potentials. 
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Figure 3.7: GABA responses in CSFcNs are mediated by GABAA receptors. 
A) Whole cell patch clamp traces in current clamp of the same CSFcN during the 
application of GABA (200 µM) alone (A) and during the application of GABA in the 
presence of bicuculline (50 µM; Ai). The downward voltage deflections are in 
response to the regular injection of -5 pA current pulses. B) Whole cell patch clamp 
traces in current clamp of the same CSFcN during the application of GABA (200 
µM) alone (B) and during the application of GABA in the presence of gabazine (50 
µM; Bi). The downward voltage deflections are in response to the regular injection 
of -10 pA current pulses. C) Whole cell patch clamp traces in current clamp of a 
CSFcN from a mouse spinal cord slice during the bath application of baclofen (10 
μM). The downward voltage deflections are in response to the regular injection of -5 
pA current pulses.
95 
 
 
 
 
96 
 
 
3.2.4 5HT-immunoreactive terminals are found in close apposition to CSFcNs, 
however, there is no immediate electrophysiological response to 5HT 
As CSFcNs have been shown to respond to GABA, their ability to respond to other 
neurotransmitters was investigated. In particular an interaction between CSFcNs 
and 5HT was examined due to previous reports of 5HT-containing terminals in the 
area surrounding the CC (Takeoka et al., 2009). Immunohistochemistry using a 
specific anti-5HT antibody confirmed the presence of numerous 5HT-
immunoreactive terminals in the area surrounding the CC (Figure 3.8A). When 
spinal cord sections were dual labelled with the anti-5HT antibody and the anti-
PKD2L1 antibody, which selectively labels CSFcNs, 5HT-immunoreactive terminals 
were observed in close apposition to CSFcNs (Figure 3.8B, C; work completed by 
J.Burgess). The amount of CSFcNs with close appositions from 5HT-
immunoreactive terminals was not quantified but it was clear that not every CSFcN 
received a close apposition. To investigate whether CSFcNs could respond to 5HT, 
it was bath applied to spinal cord slices. There was no electrophysiological 
response that could be observed to the bath application of 5HT (10 µM) in rat 
CSFcNs (Figure 3.8D). Specifically, there was no significant difference between the 
membrane potential before the 5HT application (-48.86 ± 3.32 mV; n = 8), during 
the 5HT application (-48.29 ± 3.24 mV; n = 8) and following the 5HT application (-
48.83 ± 3.28 mV; n = 8; F (2, 14) = 3.542, P = 0.057; Figure 3.8E). Neither was 
there a significant difference between the input resistance before the 5HT 
application (2340.73 ± 417.18 MΩ; n = 9), during the 5HT application (2405.36 ± 
454.06 MΩ; n = 9) and following the 5HT application (2403.47 ± 440.02 MΩ; n = 9; 
Χ2 (2) = 2.457 P = 0.293; Figure 3.8F).  
Due to the lack of discernable effect of 5HT (10 µM) on CSFcNs in the rat spinal 
cord, the effect of 5HT was investigated in the mouse spinal cord. Again, however, 
there were no electrophysiological responses to the bath application of 5HT (10 
µM) in mice CSFcNs (n = 4: data not shown). There was no significant difference 
between the membrane potential before the 5HT application (-46.47 ± 1.68 mV; n = 
4), during the 5HT application (-45.55 ± 1.46 mV; n = 4) and following the 5HT 
application (-46.35 ± 1.38 mV; n = 4; F (2, 6) = 4.680, P = 0.06). Neither was there 
a significant difference between the input resistance before the 5HT application 
(1991.83 ± 235.76 MΩ; n = 4), during the 5HT application (2110.00 ± 353.49 MΩ; n 
= 4) and following the 5HT application (2055.50 ± 255.17 MΩ; n = 4; F (2, 6) = 
0.573, P = 0.592). 
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In contrast, there was a significant difference in the membrane potential of nearby 
interneurones within the rat spinal cord before (-57.42 ± 0.48 mV; n = 3), during (-
53.34 ± 1.5 mV; n = 3) and after (-57.06 ± 0.82 mV; n = 3; F (2, 4) = 7.932, P = 
0.041) the bath application of 5HT (10 µM; Figure 3.8G). The depolarisation of 
interneurones to 5HT was accompanied by an increase in firing (Figure 3.8G). In 
two separate interneurones, the pressure application of 5HT (10 mM) resulted in 
either a depolarisation (n = 1; Figure 3.8Gi) or a hyperpolarisation (n = 1; Figure 
3.8Gii). 
As 5HT receptors are G-protein coupled receptors, with the exception of 5HT3, it 
was possible that a response to 5HT was being missed in CSFcNs because some 
of the molecules necessary to mediate the response were being washed out by the 
intracellular solution from the patch pipette. The perforated patch technique was 
therefore employed, using amphotericin B in the intracellular solution. Although 
responses to GABA were sometimes observed, responses to 5HT (10 μM; n = 3) 
were unconvincing and as a result the use of this technique was discontinued. 
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Figure 3.8: Immunohistochemistry and electrophysiology of 5HT in relation to 
CSFcNs. 
A-C) Immunohistochemistry for 5HT (A) and PKD2L1 (B), with close appositions 
between 5HT-immunoreactive terminals and PKD2L1-immunoreactive CSFcNs 
revealed in the merged image (C). Ai-Ci) Insets highlight an example close 
apposition. D) A whole cell patch clamp trace in current clamp from a CSFcC during 
the bath application of 5HT (10 µM). Downward voltage deflections are in response 
to the regular injection of -5 pA current pulses. Grouped data (mean ± S.E) of 
membrane potential (E) and input resistance (F) for CSFcNs in rats under control 
conditions compared to the bath application of 5HT (10 µM) and following the wash 
of 5HT. G) Whole cell patch clamp traces in current clamp from an interneurone 
during the bath application of 5HT (10 µM) and from two different interneurones 
during the focal pressure application of 5HT (10 mM; Gi, Gii).  Downward voltage 
deflections in Gii are in response to the regular injection of -5 pA current pulses. 
Immunohistochemistry in this figure was completed by J.Burgess. 
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3.2.5 Substance P-immunoreactive terminals are found in close apposition to 
CSFcNs, however, there is no immediate electrophysiological response to 
substance P 
As with 5HT, substance P-immunoreactive terminals have been observed in the 
area surrounding the CC (Barber et al., 1979). Substance P-immunoreactive 
terminals have been observed in close apposition to some PKD2L1-
immunoreactive CSFcNs in rats (Unpublished observation Deuchars’s lab) and to 
some GFP-expressing CSFcNs in GAD67-GFP mice (Figure 3.9A-C; work 
completed by I.Edwards). The possible interaction between substance P and 
CSFcNs was therefore investigated using electrophysiology, with a view to 
understanding the function of CSFcNs. In response to the bath application of 
substance P (1 μM), however, there was no electrophysiological response in 
CSFcNs of the rat spinal cord (n = 29; Figure 3.9D). The membrane potential of 
CSFcNs was not significantly different before (-55.12 ± 1.71 mV; n = 29), during (-
54.19 ± 1.66 mV; n = 29) and following the application of substance P (-54.69 ± 
1.62 mV; n = 29; F (2, 56) = 2.927, P = 0.076; Figure 3.9E). Grouped data for the 
input resistance of CSFcNs before, during and following the application of 
substance P was not normally distributed. The Friedman test determined that there 
was no significant difference between the input resistance of CSFcNs before 
(2397.49 ± 209.80 MΩ; n = 29), during (2255.88 ± 180.08 MΩ; n = 29) and 
following the application of substance P (2262.43 ± 202.19 MΩ; n = 29; X2 (2) = 
1.310, P = 0.519; Figure 3.9F). In addition, there appeared to be no difference in 
the spontaneous activity that was recorded from CSFcNs under control conditions 
and in the presence of substance P (data not quantified; Figure 3.9Di, Dii). In 
CSFcNs that were spontaneously firing spikes or action potentials, there was no 
observable change in the shape of the spikes or action potentials. Due to the 
uncertain nature of the success of perforated patch clamp recordings of CSFcNs in 
response to 5HT, perforated patch clamp recordings were not used to investigate 
the effect of substance P on CSFcNs.    
In contrast, there was a significant difference between the membrane potential of 
nearby interneurones before (-59.50 ± 0.39 mV; n = 4), during (-52.37 ± 1.88; n = 4) 
and after (-59.86 ± 0.62 mV; n = 3) the bath application of substance P (1 µM; F (2, 
4) = 14.723, P = 0.014). The depolarisation of interneurones observed in substance 
P was accompanied by an increase in action potential firing (Figure 3.9G). 
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Figure 3.9: Substance P has no effect on the electrophysiology of CSFcNs.  
A-C) Immunohistochemistry for substance P (A) and GFP to highlight GAD67-GFP 
expressing CSFcNs (B). Close appositions between substance P-immunoreactive 
terminals and GAD67-GFP-expressing CSFcNs are revealed in the merged image 
(C). Insets highlight a CSFcN with a number of substance P-immunoreactive close 
appositions. D) Whole cell patch clamp traces in current clamp from a CSFcN 
during the bath application of substance P (1 µM). Downward voltage deflections 
are in response to the regular injection of -10 pA.  Expanded traces before (Di) and 
during (Dii) substance P application allow any changes in spontaneous activity to 
be observed. E-F) Grouped data (mean ± S.E) of membrane potential (E) and input 
resistance (F) of CSFcNs under control conditions compared to the bath application 
of substance P (1 µM) and following the wash of substance P. G) Whole cell patch 
clamp traces in current clamp from an interneurone during the bath application of 
substance P (1 µM). Downward voltage deflections are in response to the regular 
injection of -5 pA.  Expanded traces before (Gi) and during (Gii) substance P 
application allow any changes in spontaneous activity to be observed. 
Immunohistochemsitry in this figure was completed by I.Edwards.
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3.3 Discussion 
This chapter characterises the basic electrophysiological properties of CSFcCs. It 
categorises CSFcCs into three subtypes based on their response to the injection of 
positive current pulses. The first subtype responded passively and is the first report 
of a glial-like CSFcC, the second subtype produced a single fast depolarisation and 
the third subtype produced multiple spikes. Due to the active response properties of 
subtype 2 and 3 they have been subsequently, collectively referred to as CSF-
contacting neurones (CSFcNs). Processes from CSFcCs were observed projecting 
both ventrally and laterally. The study confirmed previous reports that CSFcNs 
could respond to GABA, with strong evidence indicating that the response was 
mediated by GABAA receptors and not GABAB receptors. This study observed 
spontaneous EPSPs in CSFcNs and provided evidence that these EPSPs were 
glutamatergic in nature. This study found that although 5HT-immunoreactive 
terminals were observed in close apposition to CSFcNs, no immediate 
electrophysiological response was observed when 5HT was bath applied to 
CSFcNs. Similarly, although substance P-immunoreactive terminals have 
previously been observed in close apposition to CSFcNs, there was no 
electrophysiological response of CSFcNs to substance P.  
3.3.1 There appear to be CSFcCs with different phenotypes 
Both the electrophysiological data and the post-recording histology demonstrate 
that there are CSFcCs with different phenotypes. The electrophysiology provides 
evidence that they have varied responses to current pulses, however, whether they 
are several populations of cells with varied phenotypes or one population of cells 
that are at different stages of maturation is not clear. Similar phenotypes to that of 
the CSFcCs described in this study were observed in the study by Marichal et al., 
(2009). The exception to this is the subtype 1 CSFcCs; a population of CSFcCs 
with passive response properties has never been reported before. This subtype of 
CSFcCs resembled glial cells due to their more negative resting membrane 
potential, low input resistance and passive responses. These subtype 1 CSFcCs 
could be very immature CSFcCs that have not yet matured into subtype 2 and 3 
CSFcCs. This is quite unlikely, however, as there is such a large disparity between 
the electrophysiological properties of subtype 1 and subtype 2 CSFcCs; if one was 
to become the other, more intermediate phenotypes would be observed, as 
between subtype 2 and 3 CSFcCs. A recent study using electron microscopy to 
104 
 
 
study the cell types surrounding the CC, identified a population of cells called CC-
contacting astrocytes (Accs), that possess CC-contacting processes but express 
GFAP (Alfaro-Cervello et al., 2012). Given the location, morphology and glial-like 
electrophysiological properties of subtype 1 CSFcCs, it appears likely that they are 
in fact these Accs. To confirm this, immunohistochemistry for GFAP could be 
performed on slices from which subtype 1 CSFcCs have been recorded and filled 
with rhodamine. As this study found that there were two populations of subtype 1 
CSFcCs, one where cells had lower input resistances and were dye coupled and 
one with cells with higher input resistances that were not dye coupled, it suggests 
that some Accs could be gap junction coupled. The phenotype of the cells with 
which these subtype 1A CSFcCs are coupled is unknown but from the large 
number of dye filled cells in the ependymal layer it is highly probable that subtype 
1A CSFcCs are coupled to ependymal cells. Whether subtype 1A CSFcCs are gap 
junction coupled to ependymal cells because they are at an earlier stage of 
differentiation than subtype 1B CSFcCs or whether they are simply performing a 
different function is unclear. The number of subtype 1 CSFcCs recorded in this 
study could have been underestimated as a percentage of the entire CSFcC 
population. This is due to an improvement in technology part way through the study 
which enabled the subtype 1A CSFcCs to be more easily distinguished from 
ependymal cells. 
The cells defined in this study as subtype 2 and 3 CSFcCs had active response 
properties and appear to correspond to the three subtypes of CSFcNs described by 
Marichal et al., (2009); therefore it has been proposed that subtype 2 and 3 
CSFcCs from this study can be collectively referred to as CSFcNs. The three 
subtypes of CSFcNs that Marichal et al., (2009) described were depolarising 
CSFcNs whose responses were predominantly mediated by Ca2+ channels rather 
than voltage-gated Na+ channels, single spiking CSFcNs and multiple spiking 
CSFcNs. These same subtypes were observed in this study, however, there 
appeared to be too few of the depolarising cells present to form their own subtype; 
therefore for this study those cells were combined with the single spiking cells to 
form one category, the subtype 2 CSFcCs. Interestingly, if the population of only 
CSFcNs (subtype 2 and 3 CSFcCs) within this study are considered using the same 
defining criteria as Marichal et al., (2009), for example, splitting subtype 2 CSFcCs 
into depolarising and single spiking cells, a very similar proportion of cell types are 
observed. 11 % of depolarising/non-spiking cells in this study compared to 11.5 % 
in Marichal et al., (2009), 59 % of single spiking cells in this study compared to 57 
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% in Marichal et al., (2009) and 30 % of multiple spiking cells compared to 31.5 % 
in Marichal et al., (2009). This remarkable similarity suggests that there was no bias 
in either study as to which cells were targeted. As the study by Marichal et al., 
(2009) was completed in rats P0-P5, the fact that the same proportion of subtypes 
was observed in the present study which was completed predominantly in P11 rats 
suggests that the cells are already in their final phenotype by P0. In addition, the 
fact that there was not a greater proportion of multiple spiking cells in P21 rats in 
this study indicates that CSFcNs are not undergoing the process of maturation from 
one subtype to another over this time period. All of this data supports the evidence 
that CSFcNs are not born in the postnatal spinal cord (Marichal et al., 2009) and 
supports the hypothesis that there is no difference between the properties of 
CSFcNs in rats aged P0-P5 and rats aged P9-P21.   
The histology performed post-recording also revealed differences within the CSFcC 
population regarding where the non CSF-contacting process projected. Although it 
was not confirmed in this study, it is highly likely that these processes are axons 
rather than dendrites, as a previous study identified similar long basal processes 
expressing synaptotagmin and GAP 43, a protein expressed highly during 
axogenesis (Stoeckel et al., 2003). The indirect nature of projections and the fact 
that the final destination of some projections may not be in the slice from which the 
cell was recorded makes it difficult to determine where every projection terminates. 
It is clear, however, that the CSFcCs do not all project to the same spinal cord area 
or group of cells. Some of the CSFcCs projected ventrally, whereas others 
projected laterally towards the IML. It has been proposed that CSFcCs 
communicate information from the internal CSF to the external CSF (Vigh et al., 
2004) and some CSFcC projections were observed close to the ventral median 
fissure, supporting this theory. Some projections, however, seem to terminate within 
the grey matter, ending in quite large terminals. These terminals could be growth 
cones, although no lamellipodia and filopodia which are indicative of growth cones 
could be visualised (see review Landis (1983)), however, this could be due to a lack 
of sensitivity of the DAB. Alternatively, large endings at the end of processes can 
indicate that an axon has been damaged in the cutting procedure. These 
projections could be bound for the external CSF but are in the process of growing. 
Alternatively there could be a subset of CSFcCs that have a different function and 
project to cells within the grey matter of the spinal cord. The ventrally projecting 
CSFcCs could be heading towards motor neurones or neurones involved within the 
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locomotor circuitry, where as the laterally projecting CSFcCs could be coursing 
towards the SPNs in the IML.  
 
3.3.2 Understanding the varied GABA responses within the CSFcN population 
The ability of CSFcNs to respond to GABA is consistent with the only other 
functional study of mammalian CSFcNs (Marichal et al., 2009) and supports the 
hypothesis that CSFcNs from rats aged P9-P21 can respond to GABA as well as 
those from rats aged P0-P5. The large decrease in input resistance on bath 
application of GABA is consistent with an opening of channels within the cell 
membrane. Both depolarising and hyperpolarising responses were observed in 
response to the bath application of GABA. This is unexpected as even if there are 
differences in the physiological concentrations of intracellular Cl-, this should not 
matter as the Cl- concentration of all cells should be set by the intracellular pipette 
solution. The reversal potential of GABA (EGABA) is based predominantly on the Cl- 
reversal potential (ECl), which was -103 mV in this study. It is also affected by the 
HCO3- reversal potential (EHCO3; Bormann et al., (1987)), which was -12 mV in this 
study; this makes EGABA slightly less negative than -103 mV, however, not enough 
to explain the depolarisations observed from ~-45 mV. One possible explanation is 
that the bath application was not in the presence of TTX or low Ca2+ solutions, 
therefore there could be an indirect effect contributing to the depolarisation. For 
example, GABA could be hyperpolarising inhibitory neurones which tonically inhibit 
CSFcNs, thus creating a disinhibition of CSFcNs. This is unlikely, however, as 
bicuculline or GABA did not have any effect on the CSFcNs unless in the presence 
of bath applied GABA, suggesting that there is not tonic GABAergic input to 
CSFcNs. To fully confirm that the GABAergic effects are directly onto CSFcNs, 
GABA should be bath applied in the presence of blockers of synaptic transmission 
such as TTX or low Ca2+ solution.  
Another possible explanation for the depolarising action of GABA has been 
developed and substantiated by Staley et al., (1995) in which they argue that the 
overstimulation of GABAA receptors can lead to a shift in EGABA away from ECl 
towards EHCO3; the theory is as follows. When GABAA receptors are initially 
activated there is a Cl- influx and a HCO3- efflux, resulting in an accumulation of Cl- 
in the intracellular solution and an accumulation of HCO3- in the extracellular 
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solution near the cell membrane. These accumulations shift the electrochemical 
gradients for both ions, reducing their flux.  It is this point at which the HCO3- 
gradient can be more swiftly corrected than the Cl- gradient, leading to a greater 
efflux of HCO3- compared to the influx of Cl-, thus depolarising the cell. The HCO3- 
gradient is better maintained because the decrease in intracellular HCO3- drives the 
diffusion of membrane permeable CO2 into the cell. Here CO2 joins with intracellular 
H2O allowing carbonic anhydrase to catalyse the regeneration of HCO3-, which 
subsequently moves out of the cell (Pasternack et al., 1993). This hypothesis is 
supported by data from Staley et al., (1995) showing that decreasing the 
regeneration of HCO3-  (by either removing extracellular CO2 by buffering aCSF 
with HEPES and 100 % O2,  inhibiting carbonic anhydrase with acetazolamide and 
increasing neuronal H+ using amiloride, an inhibitor of the neuronal Na+-H+ 
exchanger) prevents depolarising responses to GABA. Indirect evidence to support 
this theory is that GABAergic-mediated IPSPs have been observed in neurones that 
depolarise in response to the bath application of GABA (Milligan et al., 2004). 
Unfortunately, as IPSPs have not been observed in CSFcNs this cannot be used as 
a method to demonstrate that the GABA-mediated depolarisation is due to an 
overstimulation. It is also not a fully satisfactory explanation as some of the CSFcNs 
can actually hyperpolarise in response to the bath application of GABA. A possible 
explanation of why some CSFcNs hyperpolarise and some depolarise could be due 
to the expression of GABAA receptors which are composed of different subunits. 
There are a large number of subunits and subsequent combinations of these 
subunits that can form GABAA receptors. Each subunit confers different properties 
to the GABAA receptor, resulting in GABAA receptors with varying biophysical 
properties, including their affinity for GABA, the efficacy of GABA, mean channel 
open time and rate of desensitisation (see review Farrant and Nusser (2005)). 
Given the unknown subunit assembly of the GABAA receptors mediating the 
responses in CSFcNs it is difficult to speculate whether there are GABAA receptors 
composed of different subunits on certain CSFcNs and exactly how the receptor 
compositions would affect transmission if there were different GABAA receptors. It 
could, however, be proposed that those CSFcNs which hyperpolarised in response 
to GABA expressed GABAA receptors at which GABA had a lower affinity and was 
not very efficacious and thus the receptors were not over stimulated and the 
balance of Cl- influx to HCO3- efflux was maintained throughout the GABA 
application. Conversely, CSFcNs which depolarised in response to GABA could 
express GABAA receptors at which GABA had a high affinity and was very 
efficacious and could induce a long mean channel open time, resulting in rapid 
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overstimulation by GABA and a fast imbalance between Cl- influx to HCO3- efflux. 
This is only speculation and further investigation into the composition of the GABAA 
receptors expressed is needed.     
To reduce both the issues of indirect GABAergic responses and of overstimulation 
by the bath application of GABA, GABA was pressure ejected locally onto CSFcNs. 
Using this method EGABA was found to be between -30 mV and -40 mV, which 
implies that the intracellular pipette solution is incapable of setting EGABA to a more 
negative potential. This was not the case in the study by Marichal et al., (2009), 
where EGABA was found to be close to the expected ECl imposed by the intracellular 
pipette solution. Although it is not clear, it is likely that Marichal et al, (2009) used 
TTX to block voltage gated Na+ channels and TEA to block voltage gated K+ 
channels during their investigation of EGABA, thus preventing any secondary 
responses. Given the different responses to the bath application of GABA in this 
study, it would be an interesting future experiment to compare whether the cells that 
depolarised or hyperpolarised in response to the bath application of GABA had 
different reversal potentials when calculated from the pressure application of GABA. 
As the pressure application of GABA can still induce depolarisations in CSFcNs at 
membrane potentials at which a hyperpolarisation should occur, other possible 
explanations for the depolarisation other than overstimulation must be considered. 
One such possible explanation involves the GABA transporter, GAT1. Images from 
both the Allen Brain Atlas and the brain atlas of gene expression, GENSAT, 
suggest that CSFcNs express GAT1. The uptake of GABA from the extracellular 
fluid into cells via GAT1 requires the uptake of two Na+ ions and one Cl- ion, 
indicating that for every GABA molecule taken into a cell, a net positive ion is taken 
up (Mager et al., 1993). Therefore the application of GABA to CSFcNs would result 
in the uptake of GABA into CSFcNs with a net positive charge; although it is 
doubtful that this would be sufficient to result in a depolarisation of CSFcNs. There 
is another possible yet highly unlikely reason for observing depolarisations in some 
CSFcNs and this is that the CSFcNs were unhealthy. For example, Dzhala et al., 
(2012) found that there was an increase in intracellular Cl- within neurones in the 
superficial layers of acute hippocampal brain slices, compared to smaller healthier 
looking cells deeper within the slices. The reason this explanation is unlikely is 
because the characterisation of CSFcNs in this study demonstrated healthy, robust 
cells. 
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Despite the uncertainty with regards to the nature of the GABAergic response, the 
important point is that this study confirms that CSFcNs are capable of responding to 
GABA. It must be noted, however, that although CSFcNs could respond to the bath 
or pressure application of GABA, no evidence of endogenous GABA was found. In 
particular, IPSPs which would indicate the presence of synaptic GABA release onto 
CSFcNs were not observed. Neither was there an effect on the membrane potential 
or input resistance of CSFcNs when bicuculline or gabazine were applied, 
indicating a lack of endogenous GABA. Nevertheless, given the nature of the 
preparation the endogenous supply of GABA may have been disrupted. The 
antagonism of the GABAergic response by the GABAA antagonist, gabazine, is 
consistent with the antagonism observed by Marichal et al.,(2009) and 
substantiates that the GABAergic response of CSFcNs is mediated by GABAA 
receptors. Furthermore, despite previous reports of GABAB receptor expression by 
CSFcNs (Margeta-Mitrovic et al., 1999), the lack of response to the GABAB agonist, 
baclofen, strongly suggests that there is no involvement from GABAB receptors. As 
GABAB receptors are G-protein coupled receptors, there is the possibility that wash 
out of molecules essential to mediate downstream effects occurred. The complete 
antagonism of the GABAergic response in the presence of GABAA antagonists, 
combined with the lack of effect of baclofen, however, suggests that GABAB 
receptors are simply not involved in mediating the CSFcN response to GABA. As 
stated earlier, the subunit compositions of the GABAA receptors are unknown. A 
number of GABAA receptor subunits have been observed in lamina X using 
immunohistochemistry, including high levels of α1, α3, β2/3, γ2 subunits and lower 
levels of α2 and α5 subunits (Bohlhalter et al., 1996). Only α6 and δ subunits have 
been confirmed as absent within lamina X using in-situ hybridisation (Wisden et al., 
1991). Therefore, the only assumption that can currently be made as to the 
composition of the GABAA receptor is that it contains β2/3 and γ2 combined with 
one of the α subunits, α1, α2, α3 or α5. 
An extremely important point to consider regarding the functional importance of 
CSFcNs responding to GABA is the source of the GABA. Whether the source is 
synaptic terminals from other neurones (Mclaughlin et al., 1975), paracrine release 
from nearby cells, autocrine release from CSFcNs or from the CSF has a great 
impact on the role of CSFcNs. This will be discussed further in the general 
discussion as it also applies to other chapters.    
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3.3.3 CSFcNs do not have any immediate changes in membrane potential or 
input resistance to 5HT or substance P 
As 5HT- and substance P-immunoreactive terminals have been previously 
observed close to the CC (Hokfelt et al., 1975; Barber et al., 1979; Takeoka et al., 
2009) it was hypothesised that there could be interactions between 5HT- and 
substance P-expressing cells and CSFcNs. Although, CSFcNs have been shown to 
respond to GABA, GABAergic neurones are located throughout the CNS so this 
does not provide much evidence as to the functional role of CSFcNs with regards to 
their integration into the rest of the spinal cord circuitry. As 5HT- and substance P-
containing neurones have much more restricted distribution patterns and are 
attributed to more specific functional roles, the investigation of the interaction 
between these neurones and CSFcNs was deemed important to understand the 
functional importance of CSFcNs. Unfortunately, despite immunohistochemistry that 
was performed in this study or previously, suggesting that there are 5HT- and 
substance P-containing terminals in close apposition to some CSFcNs, there were 
no identified responses in the electrophysiological parameters measured to 5HT or 
substance P in the spinal cord slice preparation. The ability of nearby interneurones 
within the same spinal cord slices to respond to either 5HT or substance P 
demonstrates the viability of both the spinal cord slices and the compounds applied, 
therefore excluding either of these possibilities as reasons for the discrepancy 
between the immunohistochemistry and the electrophysiology. This lack of 
response of CSFcNs to 5HT or substance P should lead to the rejection of the 
hypothesis that CSFcNs can respond to 5HT and substance P, however, as some 
possible types of cellular effects were not measured, it still leaves this hypothesis 
open for acceptance or rejection. It is possible that 5HT or substance P could affect 
electrophysiological parameters not measured in this study; to investigate the effect 
of 5HT and substance P on a wider range of channels, the responses of cells to the 
injection of positive or negative current injections could have been investigated. 
Other possible reasons for the discrepancy between the immunohistochemistry and 
the electrophysiology include the fact that the close apposition does not actually 
confirm the presence of direct synaptic contacts on to CSFcNs; this would need to 
be confirmed by electron microscopy. Another explanation could be that the 
intracellular contents are being diluted and washed out by the intracellular solution 
from the patch pipette, removing some of the molecules needed to enable G-protein 
coupled responses. Although this is obviously not the case for the interneurones, 
CSFcNs are smaller cells which could make them more susceptible to wash out. 
Steps were made to reduce the likelihood of this occurrence, for example ATP and 
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GTP were added to the intracellular solution. To completely rule out this possibility 
perforated patch clamp recordings were attempted using amphotericin B in the 
intracellular patch pipette solution. Possible depolarisations were observed in 
response to the application of 5HT; however, there were a number of discrepancies 
that questioned the validity of the perforated patch clamp recordings. The final 
possibility to explain the discrepancy between the immunohistochemistry and the 
electrophysiology is that 5HT and substance P are activating receptors on the 
CSFcNs and downstream effects are being initiated but these effects do not result 
in the opening of any ion channels so there is no immediately detectable 
electrophysiological response. The downstream effects could be initiating 
intracellular cascades that are capable of influencing gene expression and cellular 
processes like growth or migration (see general introduction sections 1.8 and 1.9). 
This likelihood is supported for 5HT by the possible expression of 5HT5B and 5HT6 
receptors by CSFcNs (GENSAT); if 5HT receptors are expressed by CSFcNs then 
they must be mediating some response to 5HT. Effects like growth or migration 
which occurs over a longer time period would be better monitored using techniques 
like organotypic slice cultures and time lapse imaging, as will be discussed further 
in the general discussion.  
 
3.3.4 Conclusions 
There appear to be numerous subtypes of CSFcCs including a glial CSFcC, 
subtype 1 and a neuronal CSFcC, subtype 2 and 3. There also appears to be 
subtypes defined by different criteria, such as whether they are gap junction 
coupled or not, where the destination of the non CSF-contacting process is and 
how the cells respond to GABA. These differences highlight the varied nature of the 
CSFcC population and suggest that there are CSFcCs with specific roles 
performing different functions within the spinal cord. The lack of responses to both 
5HT and substance P is intriguing and highlights the importance of investigating 
these cells by a wider range of electrophysiological challenges and by means other 
than electrophysiology. Finally, the presence of EPSPs and the confirmation that 
CSFcNs respond to GABA through GABAA receptors suggests that they could be 
either integrated into the wider spinal cord circuitry or GABA could be used as a 
method of communication between the different cells of the neurogenic niche 
surrounding the CC. 
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Chapter 4 - Basic characteristics of ependymal cells and 
their response to GABA
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4.1 Introduction 
Ependymal cells surrounding the CC of the mammalian spinal cord have received 
very little attention and their functional characteristics are poorly understood. Most 
of the work on ependymal cells within the spinal cord to date has been concerned 
with their ultrastructure. This has led to the discovery that there are subtypes of 
ependymal cells, including the classical cuboidal to columnar shaped cells (Bruni 
and Reddy, 1987) and the more recently defined radial ependymal cells (see 
chapter 1.3.4; Meletis et al., (2008)). More recent work has focussed on the role of 
ependymal cells as neural stem/progenitor cells and their importance in 
neurogenesis following spinal cord injury or the onset of other pathological 
conditions, as discussed in the general introduction (Danilov et al., 2006; Barnabe-
Heider et al., 2010).  
A recent study has provided the first characterisation of the basic 
electrophysiological properties of ependymal cells surrounding the CC of the 
mammalian CC (Marichal et al., 2012). This study defined the cells as having a low 
input resistance (124 ± 24 MΩ), a resting membrane potential of -84 ± 2 mV and 
passive response properties to current pulses (Marichal et al., 2012). Gap junction 
proteins connexin 43 and connexin 45 are present on ependymal cells surrounding 
the CC (Ochalski et al., 1997; Chapman et al., 2012; Marichal et al., 2012) and dye-
coupling has been observed (Marichal et al., 2012), however the significance of gap 
junction coupling between ependymal cells has yet to be considered. This could be 
of importance as gap junction coupling is known to influence proliferation in the 
developing CNS and is also observed between neural progenitor cells in the 
postnatal SVZ (Bittman et al., 1997; Lacar et al., 2011).  
There are currently no studies that have investigated the effect of neurotransmitters 
on ependymal cells surrounding the CC of the mammalian spinal cord. A recent 
study by Reali et al., (2011) explored the effects of GABA on BLBP immunoreactive 
progenitor cells that are found surrounding the CC of turtle spinal cord; these cells 
appear to be similar to the radial ependymal cells or potential radial glia observed 
surrounding the mammalian CC (Meletis et al., 2008; Marichal et al., 2012). GABA 
was capable of depolarising these progenitor cells and inducing increases in 
intracellular Ca2+, suggesting that GABA is capable of stimulating long lasting 
intracellular effects within these cells (Reali et al., 2011). The response to GABA 
could be antagonised by either the GABA transporter-3 (GAT3) blocker, SNAP 
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5114, the GABAA receptor antagonist, gabazine or both SNAP 5114 and gabazine 
combined (Reali et al., 2011), highlighting variation within the population of 
progenitor cells. This variation was even more apparent when GABA was applied in 
the presence of the gap junction blocker, carbenoxelone, which completely 
abolished GABA induced depolarisations in some cells, indicating that the initial 
response originated from a neighbouring, coupled cell. Mammalian ependymal cells 
could be capable of responding to GABA in a similar manner, especially as there 
are two potential sources of GABA around the mammalian CC; GABAergic CSFcCs 
which express VGAT (Conte, 2009) and GABAergic terminals (Mclaughlin et al., 
1975).  
Given the importance of ependymal cells as a neural stem/progenitor population 
and our current poor understanding of the electrophysiological properties of 
ependymal cells, it is pertinent to increase our knowledge about how mammalian 
ependymal cells communicate between themselves and whether they can respond 
to external stimuli, such as GABA. 
 
4.1 Hypothesis and aims 
This chapter aims to ascertain whether ependymal cells in spinal cords from rats 
and mice aged P9-P21 have similar properties to those from rats aged P0-P5 and 
thus determine whether there are any changes in their properties during postnatal 
development. As such it is hypothesised that ependymal cells from the spinal cords 
of rats and mice aged P9-P21 have passive electrophysiological properties as 
observed for ependymal cells from rats aged P0-P5. It is also hypothesised that a 
high degree of gap junction coupling occurs between ependymal cells as observed 
in younger animals. This second hypothesis also relates to the second aim of this 
chapter, which is to determine whether ependymal cells share common properties 
with neural stem and/or progenitor cells from other postnatal neurogenic niches. To 
further meet the second aim, it is hypothesised that ependymal cells are capable of 
responding to GABA, given the many sources of GABA near ependymal cells and 
the effects of GABA on other neural stem/progenitor cells. This third hypothesis 
also relates to the final aim of this chapter which is to investigate whether 
ependymal cells are integrated into the spinal cord circuitry. These hypotheses will 
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be tested using whole cell patch clamp electrophysiology and intracellular dye 
loading. 
 
4.2 Results  
The majority of data in this chapter is from spinal cord slices prepared from Wistar 
rats, however, there are some data collected in spinal cord slices prepared from 
GAD67-GFP mice. Unless otherwise stated, data is from Wistar rats and all figures 
are produced from data collected in Wistar rats. 
 
4.2.1 Basic electrophysiological characteristics of ependymal cells 
Post-recording visualisation of cells using rhodamine allowed confirmation of the 
cell type; cells were considered ependymal if they were within the ependymal layer 
and no CC-contacting process could be observed (Figure 4.1C). The ependymal 
cells recorded in this study had negative resting membrane potentials, small input 
resistances and displayed no spontaneous or evoked activity (Figure 4.1A-C). 
There is a linear relationship between the change in voltage in response to a 
current pulse and the size of the current pulse (Figure 4.1B); this demonstrates that 
ependymal cells have passive responses indicative of a lack of voltage-gated ion 
channels. In Wistar rats, a resting membrane potential of -75.67 ± 0.52 mV (n = 79) 
was observed compared to a resting membrane potential of -73.14 ± 0.88 mV (n = 
6) in GAD67 mice; the two resting membrane potentials from different species were 
not significantly different (t (84) = -1.440, P = 0.154; Figure 4.1D). In rats, the input 
resistance was calculated as 96.35 ± 12.65 MΩ (n = 79) compared to 80.29 ± 12.83 
MΩ (n = 7) in GAD67 mice; again the input resistances from different species were 
not significantly different (t (84) = 0.375, P = 0.709; Figure 4.1E). A Spearman’s 
rank order correlation test found a significant but weak positive correlation between 
the resting membrane potential and the input resistance of ependymal cells in rats 
(rs (79) = 0.337, P = 0.002; Figure 4.1F), demonstrating that ependymal cells with 
more negative resting membranes potentials generally have smaller input 
resistances.
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Figure 4.1: Basic electrophysiological characteristics of ependymal cells.  
A) Example whole cell patch clamp trace recorded in current clamp of an ependymal cell responding to the injection of positive and negative 
current pulses. B) The change in voltage (ΔV) with respect to the current injected for the same ependymal cell. C) The recorded cell was 
confirmed as an ependymal cell post-recording by visualisation of rhodamine, indicated by the arrowhead, the arrow indicates the rhodamine-filled 
patch electrode. D) Mean resting membrane potential ± S.E in rats and GAD67 mice. E) Mean input resistance ± S.E in rats and GAD67 mice. F) 
Relationship between resting membrane potential and input resistance of ependymal cells in rats.
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4.2.2 Dye coupling and gap junction blockers reveal that ependymal cells are 
coupled to each other 
Neurobiotin, one of the tracers included in the intracellular solution, is gap junction 
permeable (Kita and Armstrong, 1991; Vaney, 1991). Therefore, if the recorded 
ependymal cell is coupled to other ependymal cells by gap junctions, the 
Neurobiotin will diffuse through the gap junctions to fill some of the connected 
ependymal cells. In this study, the visualisation of Neurobiotin with DAB revealed 
that the ependymal cells were highly coupled (n = 28 out of 28 recovered; Figure 
4.2). The degree of Neurobiotin labelling demonstrated different levels of coupling 
between ependymal cells, for example a single layer of ependymal cells in one 
region of the CC could be observed as dye-filled (n = 18; Figure 4.2A), or a larger 
group consisting of multiple layers of ependymal cells but still within one region of 
the CC (n = 7; Figure 4.2B), or very rarely the whole ependymal layer surrounding 
the CC were dye-filled (n = 3; Figure 4.2C). Post-recording visualisation of cells with 
rhodamine, which is not gap junction permeable (Heyman and Burt, 2008), showed 
no coupling of cells, indicating that there was no spillage of tracers. 
Visualisation of Neurobiotin and/or rhodamine revealed that some of the ependymal 
cells had processes (n = 24; Figure 4.2D). Only with the visualisation of rhodamine 
could it be guaranteed that the processes originated from the ependymal cells 
recorded; with visualisation of Neurobiotin, the processes could be arising from the 
dye-coupled cells. Based on both the rhodamine and Neurobiotin visualisation, 
many processes were found originating at the dorsal pole of the CC, from which 
they extended dorsally along the midline, often reaching the white matter (n = 12; 
Figure 4.2D). Slightly fewer processes were observed from the ventral pole, 
extending ventrally towards the ventral median fissure (n = 10). Finally, a small 
number of processes were observed from the lateral aspects of the CC (n = 2). Of 
the processes observed there appeared to be no branching.  
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Figure 4.2: Intracellular dye-loading of Neurobiotin revealed coupling between 
ependymal cells. 
Visualisation of Neurobiotin by DAB revealed a single layer of ependymal cells that 
were dye-coupled around a region of the CC (A), multiple layers of ependymal cells 
that were dye-coupled around a region of the CC (B), ependymal cells that are dye-
coupled around the whole of the CC (C) and dorsal processes extending from some 
of the cells within a group of dye-coupled ependymal cells located at the dorsal pole 
of the CC (D). Images are all orientated with dorsal at the top.
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To determine the effect that the gap junction coupling was having on the 
electrophysiological properties of ependymal cells, the non selective gap junction 
blocker 18β-glycyrrhetinic acid (100 µM; Davidson and Baumgarten (1988)) was 
bath applied. On application of 18β-glycyrrhetinic acid, the input resistance of every 
ependymal cell tested increased (n = 6; Figure 4.3A, B, D), with increases ranging 
from 57 MΩ to 1346 MΩ and an average increase of 360 ± 201 MΩ (n = 6), which 
translated to a percentage increase of 592 ± 248 % (n = 6). The input resistance 
was significantly greater following the bath application of 18β-glycyrrhetinic acid (Z 
= -2.201, P = 0.028; Figure 4.3D); this was determined using a Wilcoxon Signed 
Rank Test as the data were not normally distributed. The range of changes in input 
resistance suggest that the ependymal cells are coupled to different degrees, 
supporting the dye-coupled data. 18β-glycyrrhetinic acid also had an effect on the 
membrane potential of 4 out of 6 ependymal cells, causing a depolarisation in these 
4 cells (Figure 4.3B). The average change in the membrane potential from the 
responders group was 26 ± 10 mV (n = 4); this change was not found to be 
significantly different (t (3) = -2.648, P = 0.077; Figure 4.3C) and is likely due to the 
large range of responses (8.5 mV to 51.6 mV). Interestingly, the average change in 
input resistance for the cells that did not depolarise in response to 18β-
glycyrrhetinic acid (63.43 ± 6.35 MΩ; n = 2) was smaller than that of those that did 
depolarise in response to 18β-glycyrrhetinic acid (505.19 ± 280.82 MΩ; n = 4), 
although the number of cells was too low to test for the significance of this 
difference (Figure 4.3E).  Instead, the correlation between the change in input 
resistance and change in membrane potential was examined. A Spearman’s Rank 
Order correlation found a strong, significant correlation between the change in input 
resistance and the change in membrane potential (rs (4) = 1.000, P < 0.01; Figure 
4.3F). This suggests that the depolarisation that occurs in response to the 
application of 18β-glycyrrhetinic acid is related to the blockade of gap junctions and 
is not a non gap junction specific effect of 18β-glycyrrhetinic acid. Finally, as the 
slices were not pre-incubated with 18β-glycyrrhetinic acid prior to recording, the 
effect of 18β-glycyrrhetinic acid on dye coupling could not be investigated.
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Figure 4.3: A gap junction blocker, 18β-glycyrrhetinic acid, can uncouple 
ependymal cells. 
A-B) Example whole cell patch clamp traces recorded in current clamp. The 
downward voltage deflections are in response to the regular injection of a -50 pA 
current pulse. In some ependymal cells, bath application of 18β-glycyrrhetinic acid 
(100 μM) increased the input resistance but did not affect their resting membrane 
potential (A). In other ependymal cells, 18β-glycyrrhetinic acid both increased their 
input resistance and depolarised the cell (B). Grouped data (mean ± S.E) of 
membrane potential (C) and input resistance (D) under control conditions compared 
to the bath application of 18β-glycyrrhetinic acid, * p < 0.05. E) Grouped data (mean 
± SE) of the change in input resistance for the cells classed as non-depolarising 
cells compared to those classed as depolarising cells in response to the bath 
application of 18β-glycyrrhetinic acid. F) Correlation between the change in input 
resistance and the change in membrane potential in response to the bath 
application of 18β-glycyrrhetinic acid, rs = Spearman’s Rank Order Correlation Co-
efficient. 
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4.2.3 Ependymal cells respond to GABA 
Given the effect of GABA on the neighbouring CSFcCs (see chapter 3.2.3 and 
Marichal et al., (2009)) and on radial glia surrounding the CC in the turtle (Reali et 
al., 2011), responses of ependymal cells to GABA were investigated. There was a 
significant difference in the membrane potential before (-76.14 ± 0.91 mV; n = 11), 
during (-72.52 ± 1.12 mV; n = 11) and after (-76.47 ± 0.82 mV; n = 11) the bath 
application of GABA (200 μM; F (2, 20) = 51.914, P < 0.001; Figure 4.4A, B). Post-
hoc testing revealed that the membrane potential of ependymal cells in GABA was 
significantly more depolarised than either before or after the GABA application (P < 
0.001). It also revealed that the effect of GABA was fully reversible as there was no 
significant difference between the membrane potential of the ependymal cells 
before and after the GABA application (P = 0.240). The changes in membrane 
potential in response to GABA ranged from 2.03 mV to 6.46 mV, with an average 
change in membrane potential of 3.62 ± 0.46 mV (n = 11). Despite this 
depolarisation, the bath application of GABA had no significant effect on the input 
resistance of ependymal cells (F (2, 18) = 1.936, P = 0.173; Figure 4.4A, C) when 
comparing input resistance before (71.10 ± 12.17 MΩ; n = 10), during (68.81 ± 
10.75 MΩ; n =10) and after the application of GABA (76.40 ± 13.25 MΩ; n = 10). It 
is unlikely that the depolarisation could be masking any GABA-induced changes in 
input resistance through the opening or closing of voltage gated channels, as 
ependymal cells do not appear to possess voltage-gated channels and the 
depolarisation is relatively small. Nevertheless, to confirm that there is no 
interference, negative current was applied during the bath application of GABA to 
return the cell to the membrane potential that it was resting at prior to the GABA 
application. During this protocol, the input resistance of the cell did not change from 
that observed during the control period or during the application of GABA at the 
depolarised membrane potential (n = 1).    
To better determine the kinetics of the GABA response, GABA (500 µM) was focally 
pressure ejected (10 psi, 500 ms) on to ependymal cells (Figure 4.4D). This 
resulted in a depolarisation with an amplitude of 4.40 ± 2.68 mV (n = 3), the time to 
the onset of the depolarisation was 140.33 ± 27.94 ms (n = 3) and the time to the 
peak of the depolarisation was 848.33 ± 61.97 ms (n = 3). Since the positioning of 
the GABA-filled electrode could affect the time to onset and time to peak 
depolarisation, therefore, these were not extensively examined. 
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Figure 4.4: Ependymal cells are depolarised by GABA.  
A) Whole cell patch clamp trace in current clamp during the bath application of 
GABA (200 μM) to an ependymal cell. The downward voltage deflections are in 
response to the injection of -50 pA pulses. B-C) Group data for membrane potential 
(B) and input resistance (C) during control conditions, the bath application of GABA 
and recovery, ns = not significant, *** = p < 0.001. D) Focal pressure ejection of 
GABA (500 μM; 500 ms; 10 psi) rapidly depolarised ependymal cells.  
 
125 
 
 
 
To determine which receptors were mediating the GABA response in ependymal 
cells, GABA (200 µM) was bath applied in the presence of the GABAA antagonists, 
bicuculline (100 µM) and gabazine (2.5 µM), or the GABAB agonist, baclofen (10 
µM) was applied alone. There was no significant difference in the input resistance 
of the ependymal cells before (78.68 ± 14.08 MΩ; n = 4), during (79.94 ± 14.99 MΩ; 
n = 4) and after (80.38 ± 15.24 MΩ; n = 4) the co-application of bicuculline and 
GABA (F (2, 6) = 0.310, P = 0.745). As would be expected, the lack of significant 
change in input resistance during the co-application of bicuculline and GABA (1.26 
± 1.43 MΩ; n = 4) was not significantly different from that during the application of 
GABA alone (3.27 ± 1.74 MΩ; n = 4; t (3) = 0.871, P = 0.448; Figure 4.5A, C). As 
during the application of GABA alone, there was a significant difference in the 
membrane potential before (76.08 ± 1.41 mV; n = 4), during (-74.70 ± 1.24 mV; n = 
4) and after (-76.18 ± 1.39 mV; n = 4) the application of GABA in the presence of 
bicuculline, with post-hoc tests revealing a significant depolarisation on application 
of GABA (P = 0.029; Figure 4.5A). This depolarisation by GABA in the presence of 
bicuculline (1.38 ± 0.24 mV; n = 4) was significantly smaller than the depolarisation 
observed in GABA alone (3.62 ± 0.46 mV; n = 4; t (3) = 3.685, P = 0.035; Figure 
4.5A, B), with the GABAergic response in bicuculline being 41.18 ± 12.14 % (n = 4) 
of the initial GABA response. The effect of bicuculline on the GABAergic response 
was reversible (Figure 4.5Aii). The bath application of gabazine (2.5 µM) could also 
antagonise the GABA response, with a 37 ± 11 % (n = 2) decrease in the size of 
the depolarisation evoked by GABA (Figure 4.5D). The effect of gabazine on the 
GABAergic response was also reversible (Figure 4.5Dii). In the majority of cases 
bicuculline and gabazine had no effect on the membrane potential or input 
resistance of ependymal cels when applied alone, however, a small depolarisation 
was observed during the bath application of bicuculline on a small number of 
occasions (data not shown). 
As the GABAA antagonists could not entirely antagonise the GABAergic response, 
the effect of baclofen was investigated. There was, however, no significant 
difference in the membrane potential before (-78.38 ± 1.45 mV; n = 3), during (-
78.57 ± 1.59 mV; n = 3) and after (-78.70 ± 1.63 mV; n = 3) the bath application of 
baclofen (F (2, 4) = 2.601, P = 0.189; Figure 4.6A, B). Neither was there a 
significant difference in the input resistance before (68.90 ± 13.38 MΩ; n = 3), 
during (70.55 ± 13.92 MΩ; n = 3) and after (71.98 ± 14.55 MΩ; n = 3) the 
application of baclofen (F (2, 4) = 1.449, P = 0.366; Figure 4.6A, C). 
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Figure 4.5: The GABAergic response in ependymal cells is mediated by 
GABAA receptors. 
Whole cell patch clamp traces in current clamp demonstrate that the depolarisation 
in response to GABA (200 μM; A, D) is partially antagonised by bicuculline (100 
µM; Ai) or gabazine (2.5 μM; Di) in a reversible manner (Aii; Dii). The downward 
voltage deflections are in response to the regular injection of -50 pA current pulses. 
Pooled data of the amplitude of the response (B) and of the change in input 
resistance (C) during the response to the application of GABA compared to the co-
application of GABA and bicuculline, * = p < 0.05.
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Figure 4.6: Baclofen, a GABAB agonist, did not elicit a response in ependymal 
cells. 
A) Baclofen (10 μM) had no effect on the membrane potential or input resistance of 
ependymal cells when bath applied. The downward voltage deflections are in 
response to the regular injection of -50 pA current pulses. B-C) Mean ± S.E of the 
membrane potential (B) and input resistance (C) during control conditions, the bath 
application of baclofen and recovery.
129 
 
 
 
4.3 Discussion 
This chapter provides a detailed characterisation of the electrophysiological 
properties of ependymal cells surrounding the CC and is the first study to 
demonstrate that ependymal cells in this area within the mammalian spinal cord are 
capable of responding to neurotransmitters. 
Ependymal cells display typical characteristics of glial cells, with negative resting 
membrane potentials of -74 mV or -76 mV, low input resistances, no spontaneous 
or electrically evoked activity and passive responses to current pulses which are 
indicative of a lack of voltage-gated channels. The visualisation of Neurobiotin with 
DAB following intracellular loading revealed not only that the ependymal cells were 
coupled but that different degrees of coupling were present.  This coupling could be 
reduced in the presence of the gap junction blocker 18β-glycrrhetinic acid, as 
evidenced by a large increase in input resistance. Ependymal cells consistently 
responded to GABA with a depolarisation that could be antagonised by the GABAA 
receptor antagonists bicuculline and gabazine, but could not be mimicked by the 
GABAB agonist baclofen. 
4.3.1 Basic electrophysiological characteristics are consistent with those 
previously observed 
The resting membrane potential of ependymal cells determined in this study in rats, 
- 76 mV, is relatively similar to those determined previously, -84 mV for ependymal 
cells in the rat spinal cord (Marichal et al., 2012) and -80 mV for ependymal cells of 
the rat third ventricle (Jarvis and Andrew, 1988). The resting membrane potentials 
of ependymal cells in the turtle are higher in both the spinal cord, -87 mV (Russo et 
al., 2008) and the dorsal cortex, -90 mV (Connors and Ransom, 1987). The resting 
membrane potential of ependymal cells is highly dependent on the reversal 
potential of K+ (EK+; Jarvis and Andrew (1988)), which in this study was -91 mV, 
therefore in studies with a more negative EK+, due to a higher extracellular K+ 
concentration or a lower intracellular K+ concentration, more K+ ions will move down 
the electrochemical gradient into the cell resulting in a less negative membrane 
potential. Slight variations in the extracellular K+ concentration within the aCSF or 
intracellular K+ concentration within the intracellular patch pipette solution, 
combined with differences in the region of the ventricle/CC studied and differences 
in the age of animal studied appear enough to explain the small variation between 
studies.  
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The input resistance of ependymal cells determined in this study was 96 MΩ, this is 
slightly lower than that previously determined for ependymal cells in the rat spinal 
cord, 124 MΩ (Marichal et al., 2012) and in the turtle spinal cord, 167 MΩ (Russo et 
al., 2008). The lower input resistance observed in this study compared to others 
suggests that the cells recorded in this study could be more extensively coupled, or 
alternatively they could express more channels that are constitutively open. There 
are two main differences about the ependymal cells in this study compared to that 
of Marichal et al., (2012) that could explain the variation. Firstly, this study recorded 
cells from the lower thoracic and upper lumbar levels of the spinal cord compared to 
the cervical spinal cord; the ependymal population could have slightly different 
functions at different levels, with the function requiring a different degree of 
coupling. Secondly, this study recorded from animals P11-P21 compared to P0-P5; 
the expression of ion channels by other glial cell types within the spinal cord has 
been shown to change during postnatal development from P1-P19 (Chvatal et al., 
1995) and the expression of connexins can vary during development in other 
regions of the CNS (Leung et al., 2002). In the rat midbrain floor, connexin 43 
mRNA expression and protein expression increased steadily from P0 to adulthood 
(Leung et al., 2002). If the same ontogenic expression pattern occurred in 
ependymal cells of the spinal cord this could be observed as a smaller degree of 
coupling and thus an increase in input resistance of ependymal cells at P0 
compared to P21; supporting the lower input resistance observed in this study 
compared to Marichal et al., (2012). Although there are slight differences between 
the properties of ependymal cells in P9-P21 rats compared to those in P0-P5 rats, 
the hypothesis that ependymal cells in spinal cords from P9-P21 rats have passive 
elctrophysiological properties is supported by this data.    
The weak correlation between the resting membrane potential and input resistance 
of ependymal cells in this study suggested that ependymal cells with more negative 
resting membrane potentials have smaller input resistances. This correlation is 
supported when observing the effect of the gap junction blocker, carbenoxelone, on 
the ependymal, progenitor cell population surrounding the CC of the turtle spinal 
cord. The increase in input resistance that was observed by the application of 
carbenoxelone was accompanied by a decrease in the resting membrane potential 
from an average of -88 mV to -78 mV (Russo et al., 2008). Thus together it 
suggests that more highly coupled cells could have more negative resting 
membrane potentials.  
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The lack of spontaneous or evoked activity and the linear voltage-current 
relationship agreed with previous studies of rat and turtle spinal cord ependymal 
cells (Russo et al., 2008; Marichal et al., 2009, 2012). This suggests that 
ependymal cells lack voltage-gated ion channels. When a leak subtraction protocol 
and carbenoxelone were applied to ependymal, progenitor cells surrounding the 
turtle CC a small outward current was revealed in some cells (Russo et al., 2008). 
This current could be reduced by tetraethylammonium (TEA), which suggests the 
presence of delayed rectifier K+ channels. It is possible that such a channel could 
be present in ependymal cells of the rat spinal cord; however, a leak subtraction 
protocol was used by Marichal et al., (2012) when recording from ependymal cells 
in the rat and they did not observe any outward current. Other voltage-gated 
channels such as TTX-sensitive voltage-gated Na+ channels have also been 
identified in other glial cell types (Barres et al., 1989) but not in ependymal cells to 
date. The data in this study suggests that ependymal cells of the postnatal 
mammalian CC do not express voltage-gated Na+ channels. 
 
4.3.2 Ependymal cells are coupled by gap junctions to varying degrees 
This study confirmed previous reports that dye-coupling occurs between ependymal 
cells of the rat spinal cord (Marichal et al., 2012) and demonstrated that the 
coupling occurs in older animals of P9-P21 as well as those aged P0-P5. This data 
supports the hypothesis that a high degree of coupling occurs between ependymal 
cells. Additionally it highlighted the different degrees of coupling that occur, with 
some ependymal cells found in larger groups than others. This variation in the 
degree of coupling has been found in the ependymal, progenitor population of 
turtles, where they referred to different sized clusters of cells ranging from clusters 
covering a whole quadrant to smaller clusters containing a few cells only (Russo et 
al., 2008). The visualisation of more than one dorsally projecting fibre following 
recordings indicates that the radial ependymal cells are also capable of dye-
coupling. 
The increase in input resistance observed in the presence of the gap junction 
blocker, 18β-glycyrrhetinic acid, is consistent with the dye-coupling and the 
hypothesis that gap junctions are present between ependymal cells. 18β-
glycyrrhetinic acid is a non-selective gap junction blocker, therefore the specific 
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identity of the connexin subunits forming the gap junctions were not identified. Both 
connexin 43 (Ochalski et al., 1997; Marichal et al., 2012) and connexin 45 
(Chapman et al., 2012) are expressed by ependymal cells of the mammalian spinal 
cord, and the coupling observed around the turtle CC has been attributed to the 
connexin 43 subunit as immunohistochemistry revealed its presence there  (Russo 
et al., 2008). Therefore the expression data suggests that connexin 43 and 
connexin 45 constitute the gap junctions formed between ependymal cells.  
The application of 18β-glycyrrhetinic acid depolarised 4 out of 6 cells, with the size 
of the depolarisation varying greatly between these 4 cells. As stated earlier, 
depolarisations in cells surrounding the turtle CC have been shown to accompany 
the increase in input resistance (Russo et al., 2008). The strong correlation 
between the change in input resistance and the change in membrane potential in 
response to 18β-glycyrrhetinic acid indicates that the depolarisation is a direct 
effect of gap junction blockade. The depolarisation could be explained by 
considering the comparative influences of the in-vivo ependymal intracellular Cl- 
concentration and the patch pipette intracellular Cl- concentration, in gap junction 
coupled and uncoupled states. Ependymal cells lining the ventricles of the rat brain 
and progenitor cells that surround the CC of the turtle express high levels of 
NKCC1 which transports Cl- ions into the cell and thus maintains a high intracellular 
Cl- concentration (Kanaka et al., 2001; Reali et al., 2011). It is likely that ependymal 
cells of the mammalian CC could express high levels of NKCC1 and thus also have 
high intracellular Cl- concentrations. Under normal circumstances this in-vivo 
expression of Cl- transporters would not be relevant as the intracellular solution 
within the pipette would diffuse into the cell and set a new lower Cl- concentration. 
In these cells, however, the highly coupled nature could make it impossible for the 
intracellular solution within the pipette to set the Cl- concentration, as Cl- could pass 
through the gap junctions connecting the recorded cell to neighbouring cells (Wang 
and Veenstra, 1997), maintaining a high intracellular Cl- concentration. 
Consequently, blocking the gap junctions would prevent any Cl- entering the 
recorded cell from neighbouring cells, which would allow the pipette solution to set 
the Cl- concentration to a lower concentration. As a result the membrane potential 
would be less negative, thus the gap junction blocker caused a depolarisation. The 
variation in the size of the depolarisations could be dependent on how large a 
cluster of cells the recorded cell is part of and therefore how highly coupled the 
recorded cell is.   
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Another factor to consider when using 18β-glycyrrhetinic acid is the non gap 
junction specific effects. For example, a study recording from cells within a 
confluent monolayer culture found that 18β-glycyrrhetinic acid not only uncoupled 
the cells but it also dramatically reduced the Cl- conductance with little affect on the 
Na+  and K+ conductances (Bohmer et al., 2001). This reduction was attributed to a 
block of chloride channels not GABAA receptors, nevertheless, if ependymal cells 
express chloride channels their blockade by 18β-glycyrrhetinic acid could influence 
the intracellular Cl- concentration and the membrane potential of the ependymal 
cells. In dissociated smooth muscles cells, 18β-glycyrrhetinic acid could induce a 
depolarisation of the membrane potential which was associated with a decrease in 
both inward rectifying K+ channel currents and Ca2+-activated K+ channel currents 
(Guan et al., 2007). Although the current-voltage relationship data in this study 
suggests that ependymal cells do not possess these channels, the depolarisation of 
ependymal cells in the presence of 18β-glycyrrhetinic acid could suggest that they 
are in fact present. On the other hand, if these channels are not present in 
ependymal cells then it is less likely that 18β-glycyrrhetinic acid could be having a 
non gap junction specific effect. This likelihood is supported by the correlation 
between the change in input resistance and the change in membrane potential 
which suggests that the depolarisation is a gap junction related effect and could be 
a result of the NKCC1 and Cl- mechanism suggested above. 
 
4.3.3 Understanding the GABAergic response 
A depolarisation of ependymal cells was observed following either the bath or focal 
pressure application of GABA, proving the hypothesis that ependymal cells are 
capable of responding to GABA. Given that GABAA receptors are Cl- channels, and 
the Cl- reversal potential (ECl-) set by the intracellular solution is -103 mV, a 
hyperpolarisation would have been expected as Cl- moved into the cell down the 
electrochemical gradient. Nevertheless, there are a number of possibilities that 
could explain the depolarisation seen in ependymal cells in response to GABA. 
Firstly, ependymal cells express NKCC1; if these channels are expressed in close 
proximity to the GABAA receptors in the cell membrane, there could be a local 
intracellular accumulation of Cl- near the GABAA receptors, despite the Cl- 
concentration in many areas of the cell being lower due to the lower Cl- 
concentration in the intracellular solution from the patch pipette. Thus activation of 
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the GABAA receptors by GABA would result in a depolarisation. Secondly, the high 
degree of gap junction coupling between ependymal cells could result in Cl- moving 
from neighbouring cells, which have a high intracellular Cl- concentration due to the 
NKCC1 expression, into the recorded cell, which has a low intracellular Cl- 
concentration due to the intracellular solution in the patch pipette. The influx of Cl- 
into the recorded cell could increase the intracellular Cl- concentration so that it is 
high enough to cause a depolarisation on the activation of GABAA receptors. 
Despite this suggestion, it is unlikely that there would be a sufficient number of gap 
junctions to overcome the intracellular Cl- concentration set by the intracellular 
solution of the patch pipette. Thirdly, GABA could be hyperpolarising the recorded 
cell but depolarising the neighbouring gap junction coupled cells; in this case the 
greater number of cells depolarising could mask the hyperpolarisation observed in 
the recorded cell. Fourthly, it is possible that the depolarisation could be caused by 
the GABA transporter, GAT3. GAT3 belongs to a family of Na+-Cl- dependent 
GABA transporters; studies on another member of the family, GAT1, have revealed 
that GABA is transported back into the cells with two Na+ ions and one Cl- ion, 
driven by the electrochemical gradient for Na+ (Mager et al., 1993). Thus the 
application of GABA can evoke a depolarisation in cells expressing GABA 
transporters, as an increase in extracellular GABA results in the uptake of GABA 
and a net single positive charge. Evidence supporting the presence of GAT3 is that 
the GABAergic response could not be fully antagonised by GABAA antagonists, 
bicuculline and gabazine, even at a high concentration of 100 μM for bicuculline 
and did not involve GABAB receptors. In addition, GAT3 has been observed to 
contribute to the mediation of the GABA response in progenitor cells surrounding 
the turtle CC (Reali et al., 2011). This was demonstrated by the antagonism of the 
GABA response by the GAT3 antagonist, SNAP5114. The presence of GABA 
transporters in ependymal cells was not investigated in this study; however, it is 
likely that expression of the glial GABA transporter, GAT3 in ependymal cells could 
contribute to the depolarisation in response to GABA. To verify this, an interesting 
future experiment would be to apply GABA in the presence of SNAP5114. Finally, 
as suggested for the GABAergic response in CSFcNs in chapter 3, the GABAA 
receptors could be over stimulated leading to an imbalance of the HCO3- efflux and 
Cl- influx. Again, as for CSFcNs the likelihood of overstimulation could depend on 
the subunit composition of the GABAA receptors (Farrant and Nusser, 2005). It is 
likely that the depolarisation of ependymal cells to GABA is not a result of one of 
these possibilities but a combination of some or all of the suggestions. 
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Ependymal cells in the dorsal cortex of the turtle were previously shown to slowly 
depolarise during repetitive neural stimulation (Connors and Ransom, 1987). 
Repetitive neural stimulation involves neurones depolarising and the subsequent 
opening of voltage-gated K+ channels and Ca2+-activated K+ channels, which allows 
a K+ efflux and thus increases extracellular K+ concentrations. It was demonstrated 
that the increase in local extracellular K+ concentration fully accounted for the slow 
depolarisation (Connors and Ransom, 1987). The depolarisation evoked by GABA 
application could not be mediated by a local increase in extracellular K+ 
concentration for a number of reasons. Firstly, although GABA will be acting on 
neighbouring neurones, for example CSFcNs (see chapter 3), it will mediate an 
opening of GABAA receptors which allows the movement of Cl- ions, thus the 
response predominantly affects extracellular Cl- concentrations, not K+ 
concentrations. Secondly, the focal pressure application of GABA, which will only 
affect a small number of cells, still induced a depolarisation in ependymal cells. 
Finally, the GABAergic response in CSFcNs can be strongly antagonised by 
GABAA antagonists (see chapter 3.2.3; Marichal et al., (2009)) but that of 
ependymal cells can only be partially antagonised by GABAA antagonists, therefore 
if the ependymal cells response was due to the CSFcN response, it would be 
antagonised to the same degree by GABAA antagonists. Whether the response of 
ependymal cells to GABA was direct was not specifically investigated, for example, 
GABA was not applied in the presence of blockade of synaptic transmission, such 
as TTX or low Ca2+ solution. There are, however, synapses between GABAergic 
terminals and ependymal cells in the rat spinal cord (Magoul et al., 1987) which 
provides strong evidence that the effect is direct. In addition, the concentration of 
bicuculline applied would not only fully antagonise the GABAergic response of 
CSFcCs but would likely fully antagonise the GABAergic response of any other 
neurones within the spinal cord, which would support the direct nature of the 
GABAergic response in ependymal cells. 
Despite the consistent depolarisation that occurred in response to the bath 
application of GABA, there was no change in input resistance. A change in input 
resistance would normally be expected to accompany a response to GABA, as 
GABAA receptors would open, allowing the movement of ions and thus decreasing 
the resistance of the membrane. The input resistance was already very low in these 
cells due to the extensive coupling; therefore the relative effect of ion channels 
opening on the size of the input resistance could have been too small to measure. 
To remove the factor of gap junction coupling, it would be interesting to apply GABA 
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in the presence of a gap junction blocker; it is possible that a change in input 
resistance would then be observed. The membrane potential of ependymal cells 
was repolarised to the resting membrane potential during the application of GABA 
to ensure that any voltage-gated channels that opened or closed as a result of the 
depolarisation did not affect the input resistance of the ependymal cell. As there 
was no difference in input resistance at the repolarised membrane potential and at 
the depolarised membrane potential during this protocol, this confirmed that the 
input resistance was not changing during the GABA application and strengthened 
the argument that ependymal cells do not express any voltage-gated channels. 
As the GABAergic response could be antagonised by the GABAA antagonist, 
bicuculline, it indicates that the response to GABA is in part being mediated by 
GABAA receptors. No cell specific expression of GABAA receptor subunits has been 
explored for ependymal cells of the CC, however immunohistochemistry revealed a 
high expression of α1, α3, β2/β3 and γ2 subunits, a lower expression of α2 and α5 
and in-situ hybridisation revealed a lack of expression of mRNA for α6 and δ 
subunits in lamina X (Wisden et al., 1991; Bohlhalter et al., 1996). Therefore, there 
are a number of possible subunit compositions for the GABAA receptor mediating 
the ependymal cell response, with it likely that β2/β3 and γ2 subunits are present 
combined with α1, α2, α3 or α5 subunits. The composition of the GABAA receptors 
could reflect the type of effect that GABA is having on ependymal cells. For 
example, the subunits confer different properties to the receptors which make them 
more suited to respond to lower or higher concentrations of GABA and thus more 
suited to tonic or phasic transmission (Farrant and Nusser, 2005).  
As alluded to previously, bicuculline could not completely antagonise the 
GABAergic response, even at the high concentration of 100 µM. This suggests that 
there was another receptor or transporter contributing to the mediation of the 
GABAergic response. The contribution of the GABAB receptor was investigated 
using the GABAB agonist, baclofen. A lack of response to baclofen suggests that 
ependymal cells do not express GABAB receptors. This agrees with expression 
patterns for GABAB receptors within the spinal cord; with a lack of protein 
expression and mRNA expression for the GABABR1 subunit and a lack of mRNA 
expression for the GABABR2 subunit in ependymal cells (Allen Brain Atlas, 
Margeta-Mitrovic et al., (1999)). The residual GABA response could be a result of 
GAT3 activity; the presence of GAT3 in mammalian ependymal cells has not been 
investigated. To investigate whether GAT3 is contributing to the residual GABA 
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response, the GAT3 blocker SNAP 5114 could be co-applied with bicuculline to see 
if together they can completely antagonise the GABA response. 
The demonstration of ependymal cells responding to GABA is extremely exciting; 
however, its functional relevance is highly dependent on the source of the GABA. 
The source could be solely the GABAergic terminals that synapse with ependymal 
cells (Magoul et al., 1987) or there could also be GABA released in a paracrine 
manner and found within the CSF; this second suggestion is supported by the small 
number of cells in which bicuculline alone was observed to have an effect, providing 
evidence that there could be an endogenous source of tonic GABA.  This, along 
with the possible downstream effects of ependymal cells being excited by GABA 
and the functional importance of gap junction coupling, will be discussed in the 
general discussion. 
 
4.3.4 Conclusion 
This study demonstrates that ependymal cells surrounding the CC of the postnatal 
mammalian spinal cord are functionally coupled via gap junctions and is the first 
study to demonstrate that ependymal cells are capable of responding to the 
neurotransmitter GABA. The different sizes of gap junction coupled groups of 
ependymal cells indicate varied degrees of coupling and suggest that ependymal 
cells function as groups of cells not as lone cells. GABA induces a depolarisation in 
ependymal cells, which is likely to be a combined result of NKCC1 expression, gap 
junction coupling and the possible expression of the GABA transporter, GAT3. The 
GABA response is mediated partially by GABAA receptors but not GABAB receptors 
and could also receive a contribution from GAT3. The ability of ependymal cells to 
respond to GABA demonstrates that they are capable of responding to changes in 
the environment and could suggest that they are more integrated into the spinal 
cord circuitry than previously thought.
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Chapter 5 - Responses of CSFcCs and ependymal cells to 
ACh
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5.1 Introduction 
There are a large number of cholinergic terminals within lamina X of the mammalian 
spinal cord (Barber et al., 1984; Phelps et al., 1984). These terminals are likely to 
originate from the considerable number of cholinergic interneurones that are 
located within lamina X, including the partition neurones and the CC-cluster cells 
(Barber et al., 1984; Phelps et al., 1984). Processes originating from CC-cluster 
cells have been observed to contribute to ChAT-immunopositive processes located 
near the ependymal layer (Barber et al., 1984; Phelps et al., 1984). A number of 
ChAT-immunopositive terminal-like structures of unidentified origin have also been 
identified near ChAT-immunonegative cells in the ependymal layer (Barber et al., 
1984). This suggests that cells within the ependymal layer, either ependymal cells 
and/or CSFcCs could be receiving cholinergic inputs.  
Cholinergic receptors or subunits have also been located in lamina X, including M2 
mAChRs identified by autoradiography (Hoglund and Baghdoyan, 1997) and the 
nAChR subunits, α2, α3, α4, α7 and β2, identified by in-situ hydridisation (Wada et 
al., 1989; Seguela et al., 1993). Pharmacology from electrophysiological studies 
has suggested the presence of both α4β2*nAChRs and α7*nAChRs in lamina X 
(Bordey et al., 1996a; Bradaia and Trouslard, 2002b). Despite this, the expression 
of cholinergic receptors by cells directly surrounding the CC is yet to be investigated 
in either mammals or lower vertebrates.  
ACh has been implicated in postnatal neurogenesis in the SVZ (Cooper-Kuhn et al., 
2004; Kaneko et al., 2006) and in the DG (Harrist et al., 2004; Campbell et al., 
2010). In the DG, there is a decrease in the number of BrdU-expressing newborn 
cells in β2*nAChR knockout mice (Harrist et al., 2004) and there is a decrease in 
the survival, maturation and integration of newborn neurones in α7*nAChR 
knockout mice (Campbell et al., 2010). Given the neural stem cell potential of 
ependymal cells and the possible immature or plastic nature of CSFcCs, it is 
feasible that ACh could be influencing the proliferation, survival and plasticity of 
cells surrounding the CC. Unlike chapter 3, the ability of all CSFcC subtypes to 
respond to ACh will be investigated, as subtype 1 CSFcCs could be an important 
cell type within the neurogenic niche. If either ependymal cells or CSFcCs are 
capable of responding to ACh it is important to distinguish which receptor subtypes 
are mediating the effects as their activation clearly has different consequences.    
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There are numerous cholinergic receptor antagonists and modulators that have 
preferential selectivity for cholinergic receptors containing specific subunits and 
have thus become useful in determining what cholinergic receptors are expressed 
by different cell types. Atropine is a well known selective antagonist of mAChRs, 
whereas MCA is a well known selective antagonist of nAChRs (Rang, 2003). To 
further determine the subunits which constitute nAChRs, DHβE, MLA and PNU-
120596, amongst others, can be utilised. DHβE is a selective non α7*nAChR 
antagonist at a concentration of 1 μM or lower (Alkondon and Albuquerque, 1993; 
Bradaia and Trouslard, 2002b) and is a selective α4β2*nAChR antagonist at a 
concentration of 10 nM or lower (Alkondon and Albuquerque, 1993). MLA is a 
useful compound to study the involvement of α7*nAChRs, as it is considered to be 
a selective α7*nAChR antagonist at concentrations of 20 nM or lower (Wonnacott, 
1993). An alternative to the use of MLA is to use the more recent discovery, PNU-
120596, which is a specific potentiator of α7*nAChR mediated responses (Hurst et 
al., 2005). 
  
5.1 Hypothesis and aims 
Given the close proximity of numerous cholinergic interneurons to the CC and the 
importance of ACh in other postnatal neurogenic niches, the hypothesis of this 
chapter is that ependymal cells and CSFcCs of the mammalian spinal cord are 
capable of responding to ACh. Specifically, this chapter aims to use whole cell 
patch clamp electrophysiology, intracellular dye-loading and immunohistochemistry 
to investigate whether ependymal cells and CSFcCs respond to ACh, what type of 
cholinergic receptors are mediating the response to ACh and whether the receptors 
mediating the ACh response vary between cell types and cell subtypes. 
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5.2 Results 
All data in this chapter are from cells recorded in spinal cord slices obtained from 
Wistar rats, P9-P21. 
5.2.1 All cell types respond to ACh  
All cell types recorded responded to the focal pressure application of ACh (3 mM; 
500 ms) with a depolarisation (Figure 5.1). The amplitudes of these responses 
varied between cell types and cell subtypes (Figure 5.1E, F).  
The cholinergic response of ependymal cells ranged from depolarisations of 0.58 
mV to 8.09 mV, with an average response of 2.96 ± 0.28 mV (n = 36; Figure 5.1A, 
F). The time to onset of the response was 145.67 ± 17.04 ms (n = 18; Figure 5.2A) 
and the time to peak amplitude of the depolarisation was 1463.25 ± 92.00 ms (n = 
36) following the onset of the response (Figure 5.2B). The amplitude of the 
cholinergic response in ependymal cells did not correlate with the input resistance 
of the cell (rs (36) = -0.167, P = 0.330), indicating that the degree to which an 
ependymal cell is coupled does not affect its response to ACh. The cholinergic 
response of CSFcCs ranged from depolarisations of 0.95 mV to 42.33 mV, with an 
average response of 17.14 ± 1.24 mV (n = 82; Figure 5.1F), a time to onset of the 
response of 202.28 ± 24.59 ms (n = 81) and a time from onset to peak amplitude of 
the depolarisation of 793.25 ± 61.90 ms (n = 82). Due to the wide variety in the 
amplitude of the cholinergic CSFcC response, the responses of different CSFcCs 
subtypes (defined in chapter 3.2) to ACh were investigated. Subtype 1 CSFcCs 
responded with depolarisations ranging from 0.95 to 3.63 mV, with an average 
amplitude of 2.19 ± 0.22 mV (n = 17; Figure 5.1B, F), a time to onset of the 
response of 143.71 ± 21.60 ms (n = 17; Figure 5.2A) and a time from onset to peak 
amplitude of the depolarisation of 1620.00 ± 113.15 ms (n = 17; Figure 5.2B). 
Subtype 2 CSFcCs responded with depolarisations ranging from 4.82 mV to 33.14 
mV, with an average response of 18.92 ± 1.21 mV (n = 46; Figure 5.1C, F), a time 
to onset of the response of 246.68 ± 41.76 ms (n = 45; Figure 5.2A) and a time 
from onset to peak amplitude of the depolarisation of 573.86 ± 54.64 ms (n = 46; 
Figure 5.2B). Subtype 3 CSFcCs responded with depolarisations ranging from 7.02 
mV to 42.33 mV, with an average response of 26.19 ± 2.20 mV (n = 19; Figure 
5.1D, F), a time to onset of response of 149.53 ± 20.09 ms (n = 19; Figure 5.2A) 
and a time from onset to peak amplitude of response of 584.68 ± 57.37 ms (n = 19; 
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Figure 5.2B). The depolarisations evoked by ACh in subtype 2 and 3 CSFcCs were 
sometimes accompanied by a spike or multiple spikes (Figure 5.1D).  
A one-way ANOVA revealed that there was a significant difference in the amplitude 
of the cholinergic response of ependymal cells, subtype 1 CSFcCs, subtype 2 
CSFcCs and subtype 3 CSFcCs (F (3, 113) = 80.315, P < 0.001). Post-hoc tests 
revealed there was no significant difference between the amplitude of the 
cholinergic response in ependymal cells and subtype 1 CSFcCs (P = 1), however, 
the amplitudes of these responses were significantly smaller than those of both 
subtype 2 and subtype 3 CSFcCs (P < 0.001; Figure 5.1E, F). The amplitude of the 
cholinergic response of subtype 2 CSFcCs was also found to be significantly 
smaller than that of subtype 3 CSFcCs (P = 0.001; Figure 5.1 E, F). There was no 
significant difference in the time to onset of response between ependymal cells, 
subtype 1 CSFcCs, subtype 2 CSFcCs and subtype 3 CSFcCs (H (3) = 0.659, P = 
0.883; Figure 5.2A); this was determined using a Kruskal-Wallis H test as the data 
was not normally distributed. There was a significant difference in the time from 
onset to peak response between ependymal cells, subtype 1 CSFcCs, subtype 2 
CSFcCs and subtype 3 CSFcCs (H (3) = 66.857, P < 0.001); this was also 
determined using a Kruskal-Wallis H test as the data was not normally distributed. 
To further identify between which groups the time to peak response was 
significantly different, Mann-Whitney U tests were used. These determined that the 
time to peak response was significantly longer in ependymal cells and subtype 1 
CSFcCs than in subtype 2 and 3 CSFcCs (P < 0.001; Figure 5.2B). There was no 
significant difference in the time to peak response between ependymal cells and 
subtype 1 CSFcCs (P = 0.350) or between subtype 2 and 3 CSFcCs (P = 0.502). 
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Figure 5.1: Ependymal cells and CSFcCs respond to ACh. 
Whole cell patch clamp traces in current clamp from an ependymal cell (A), a 
subtype 1 CSFcC (B), a subtype 2 CSFcC (C), a subtype 3 CSFcC (D) and all cell 
types (E) in response to the focal pressure application of ACh (3 mM; 500 ms). F) 
Amplitude ± S.E of the response to ACh, depending on cell type and cell subtype 
(see text section 5.2.1 for significance). 
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Figure 5.2: The kinetics of the cholinergic response vary between ependymal 
cells and some CSFcC subtypes. 
Time to onset of response (ms; A) and time from onset to peak of response (ms; B) 
for ependymal cells, subtype 1 CSFcCs, subtype 2 CSFcCs and subtype 3 
CSFcCs. *** = p < 0.001, ns = not significant.
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5.2.2 The cholinergic response of ependymal cells and CSFcCs is likely due 
to a direct effect  
To give an indication of whether ACh was having a direct effect on ependymal cells 
and CSFcCs, it was applied in the presence of the voltage-gated Na+ channel 
blocker, TTX and in the case of CSFcCs, the glutamate receptor antagonists, AP5 
and NBQX. In ependymal cells, there appeared to be a trend towards a small 
decrease in the amplitude of the response to ACh (3-10 mM; 500 ms; Figure 5.3A), 
however, a repeated measures ANOVA determined that there was no significant 
difference between the amplitude of the response during control conditions (2.41 ± 
0.75 mV; n = 3), during the bath application of TTX (1.90 ± 0.62 mV; n = 3) and 
following the wash out of TTX (2.19 ± 0.56 mV; n = 3; Figure 5.3Ai). In CSFcCs, a 
repeated measures ANOVA determined that there was a significant difference 
between the amplitude of the response to ACh (3 mM; 500 ms) during control 
conditions (21.97 ± 5.93 mV; n = 5), during the bath application of TTX (1 µM), AP5 
(50 µM) and NBQX (20 µM; 23.82 ± 6.43 mV; n = 5) and following the wash out of 
drugs (19.27 ± 5.46 mV; n = 5; F (2) = 6.888, P = 0.018; Figure 5.3B). Post-hoc 
bonferroni tests, however, did not reveal any significant difference between the 
individual groups of control, drug and wash data. These responses were 
independent of CSFcC subtype. There was no significant difference in the time to 
onset of the response from control conditions (183.80 ± 80.64 ms; n = 5), during 
TTX, AP5 and NBQX (219.40 ± 92.62 ms; n = 5) and following the wash out of 
drugs (252.00 ± 100.70; n = 5; X2 (2) = 2.211, P = 0.331) in CSFcCs; this was 
determined using a Friedman test as the data was not normally distributed. There 
was also no significant difference in the time to peak response from control 
conditions (1029.40 ± 157.49 ms; n = 5), during TTX, AP5 and NBQX (1066.80 ± 
243.72 ms; n = 5) and following the wash out of drugs (1373.00 ± 352.63 ms; n = 5; 
X2 (2) = 2.800, P = 0.247) in CSFcCs.  
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Figure 5.3: The cholinergic response of ependymal cells and CSFcCs is still 
present during the application of synaptic blockers.  
A) Whole cell patch clamp trace in current clamp of an ependymal cell in response 
to the focal pressure application of ACh (10 mM; 500 ms) during control conditions 
and during the bath application of TTX (1 µM). Ai) Mean amplitude ± S.E in 
response to ACh in control conditions, during TTX and following wash out of the 
compounds, ns = not significant. B) Whole cell patch clamp trace in current clamp 
of a CSFcC in response to the focal pressure application of ACh (3 mM; 500 ms) 
during control conditions and during the bath application of TTX (1 µM), AP5 (50 
µM) and NBQX (20 µM). Bi) Mean amplitude ± S.E in response to ACh in control 
conditions, during TTX, AP5 and NBQX and following wash out of the compounds, * 
= p < 0.05.
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5.2.3 The cholinergic responses are mediated by nicotinic receptors 
To understand what type of channel was mediating the cholinergic effects the 
injected current was adjusted to modify the membrane potential; ACh was then 
applied at different membrane potentials to determine whether the amplitude of the 
response is dependent on membrane potential and at what membrane potential the 
current reverses. In CSFcCs, the amplitude of the response to ACh (10 mM; 500 
ms) decreased at less negative membrane potentials, with negligible response 
observed at 0 mV (Figure 5.4A); indicative that the cholinergic response is 
mediated by non-selective cation channels such as nicotinic rather than muscarinic 
receptors. In ependymal cells, however, the amplitude of the response to ACh (10 
mM; 500 ms) did not vary at different membrane potentials (Figure 5.4B); this could 
be due to the highly coupled nature observed in chapter 4. 
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Figure 5.4: Cholinergic responses reverse at 0 mV in CSFcCs but not in 
ependymal cells. 
Whole cell patch clamp traces in current clamp (A, B) and scatter plots (Ai, Bi) of 
the response to ACh (10 mM) when different amounts of current were applied to 
adjust the membrane potential for a CSFcC (A) and an ependymal cell (B). 
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To further investigate which receptors are mediating the cholinergic response, 
selective antagonists and modulators were utilised; the amplitude of the response 
to ACh (3 mM; 500 ms) was measured during the bath application of the muscarinic 
selective antagonist, atropine (5 µM) or the nicotinic selective antagonist, MCA (50 
µM). There was no significant difference between the amplitude of the cholinergic 
response in ependymal cells during control conditions (3.56 ± 0.2 mV; n = 3) and 
during the bath application of atropine (3.13 ± 0.33 mV; n = 3; t (2) = 1.867, P = 
0.203; Figure 5.5A). Neither was there a significant difference between the time to 
peak response during control conditions (2161.00 ± 119.92 ms; n =3) and during 
atropine (2251.00 ± 188.86 ms; n = 3; t (2) = -0.632, P = 0.592). There was also no 
significant difference between the amplitude of the cholinergic response in CSFcCs 
during control conditions (29.58 ± 3.66 mV; n = 4) and during the bath application of 
atropine (25.83 ± 3.45 mV; n = 4; t (3) = 2.536, P = 0.085; Figure 5.5B). Again, 
there was no significant difference between the time to peak response during 
control conditions (711.25 ± 149.96 ms; n = 4) and during atropine (527.64 ± 92.62 
ms; n = 4; t (3) = 0.742, P = 0.512). The effect of atropine on CSFcCs did not vary 
with subtype. MCA significantly decreased the amplitude of the response to ACh in 
ependymal cells from 2.87 ± 0.88 mV (n = 6) to 0.24 ± 0.07 mV (n =6; t (5) = 3.186, 
P = 0.024; Figure 5.5C); the ACh response in MCA was only 9 ± 2 % of the initial 
ACh response. MCA also decreased the amplitude of the ACh response in CSFcCs 
from 17.9 ± 2.33 mV (n = 6) to 1.13 ± 0.54 mV (n = 6; t (5) = 7.094, P = 0.001; 
Figure 5.5D); the ACh response in MCA was only 6 ± 4 % of the initial ACh 
response. The extent of MCA antagonism in CSFcCs did not vary with subtype. 
Differences in the time to peak response were not analysed as it could not always 
be measured in the cases of complete antagonism by MCA. There was sometimes 
a partial reversal of the MCA antagonism, however, this was only after 30-60 
minutes and a return to the original amplitude of the ACh response was never 
observed (n = 6, ependymal; n = 6, CSFcC). Neither atropine nor MCA had any 
observable effects on the membrane potential or input resistance of either 
ependymal cells or CSFcCs when applied alone.  
There are many different nAChRs composed of different subunits, therefore to 
further elucidate the receptors that were mediating the ACh response, drugs 
selective for non α7*nAChRs and α7*nAChRs were utilised.
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Figure 5.5: Cholinergic responses are mediated by nicotinic ACh receptors. 
Whole cell patch clamp traces in current clamp and mean ± S.E of the amplitude of 
the response to ACh (3 mM; 500 ms) under control conditions and during the bath 
application of atropine (5 µM) for ependymal cells (A, Ai) and CSFcCs (B, Bi) and 
during the bath application of MCA (50 µM) for ependymal cells (C, Ci) and 
CSFcCs (D, Di). * = p < 0.05, ** = p < 0.01. Note the differences in scale and y-axis 
for cell types. 
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5.2.4 Contribution of non α7*nAChRs to the cholinergic response is 
dependent on cell type and cell subtype 
To determine whether non α7*nAChRs mediate the cholinergic effect in ependymal 
cells and CSFcCs, DHβE, was bath applied during the focal pressure application of 
ACh (3 mM; 500 ms). DHβE is a selective non α7*nAChR antagonist at the 
concentration used in this study (1 μM).  
DHβE significantly decreased the amplitude of the response of ependymal cells to 
ACh from 3.72 ± 0.66 mV (n = 9) to 1.87 ± 0.38 mV (n = 9; t (8) = 5.208, P = 0.001; 
Figure 5.6A). DHβE also significantly decreased the amplitude of the response of 
CSFcCs to ACh from 16.11 ± 1.84 mV (n = 20) to 3.03 ± 0.51 mV (n = 20; t (19) = 
7.947, P < 0.001). Despite the effect on amplitude of the response, there was no 
significant difference between the time to peak response in ependymal cells in 
control (1810.00 ± 181.01 ms; n = 9) and in DHβE (1779.67 ± 179.33; n =9; t (8) = 
0.513, P = 0.622) and in CSFcCs in control (972.61 ± 155.84 ms; n = 18) and in 
DHβE (1290.28 ± 211.90 ms; n = 18; data not normally distributed; Z = -1.546, P = 
0.122). The decrease in amplitude of the cholinergic response in the presence of 
DHβE was expressed as a percentage of the initial ACh response to allow 
comparison of the effect of DHβE on the two cell types. The antagonism of the ACh 
response by DHβE was significantly greater in CSFcCs than in ependymal cells (t 
(27) = 4.608, P < 0.001; Figure 5.6E), with a cholinergic response of 23 ± 4 % that 
of the initial ACh response (n = 20) in CSFcCs and 52 ± 4 % in ependymal cells (n 
= 9). This suggests a greater contribution of non α7*nAChRs to the cholinergic 
response in CSFcCs. 
Separating the CSFcCs into the defined subtypes revealed that there was a 
differential effect of DHβE on the specific subtypes. DHβE significantly decreased 
the amplitude of the ACh response of subtype 1 CSFcCs from 2.82 ± 0.44 mV (n = 
3) to 1.48 ± 0.31 mV (n = 3; t (2) = 8.916, P = 0.012; Figure 5.6B), subtype 2 
CSFcCs from 16.84 ± 1.42 mV (n = 11) to 3.86 ± 0.68 mV (n = 11; t (10) = 11.506; 
P < 0.001; Figure 5.6C) and subtype 3 CSFcCs from 21.42 ± 2.29 mV  (n = 6) to 
2.29 ± 1.01 mV (n = 6; t (5) = 6.551, P = 0.001; Figure 5.6D). To allow the 
comparison of the degree of antagonism of DHβE between the different CSFcC 
subtypes, the decrease in amplitude of the cholinergic response during the bath 
application of DHβE was expressed as a percentage of the initial ACh response. In 
the presence of DHβE the ACh response was 52 ± 4 % (n = 3) of the initial 
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response in subtype 1 CSFcCs, 22 ± 3 % (n = 11) in subtype 2 CSFcCs and 9 ± 4 
% (n = 6) in subtype 3 CSFcCs. A two-way ANOVA determined that there was a 
significant interaction between the effects of DHβE and CSFcC subtype on the 
amplitude of the ACh response (F (2, 34) = 16.997, P < 0.001). Post-hoc bonferroni 
tests revealed that the antagonism by DHβE was significantly greater in subtype 2 
and subtype 3 CSFcCs compared to subtype 1 CSFcCs (P < 0.001) and in subtype 
3 CSFcCs compared to subtype 2 CSFcCs (P = 0.049; Figure 5.6E). This suggests 
that the contribution of non α7*nAChRs to the cholinergic response is greatest in 
subtype 3 CSFcCs, followed by subtype 2 CSFcCs and finally, the contribution is 
least in subtype 1 CSFcCs.   
Although the effect of DHβE on the cholinergic responses was significantly different 
in ependymal cells compared to CSFcCs as a whole group, when the CSFcCs 
became divided into subtypes the effect of DHβE on the cholinergic responses of 
subtype 1 CSFcCs was not significantly different from that of ependymal cells (t 
(10) = -0.013, P = 0.990).  
Despite the effects of DhβE on the ACh-induced response, there was no 
observable effect of DhβE alone on the membrane potential or input resistance of 
either ependymal cells or CSFcCs.  
 
5.2.5 α7*nAChRs contribute to the cholinergic response  
Although non α7*nAChRs clearly mediate a component of the cholinergic response 
in all cell types studied, DHβE, did not completely antagonise the cholinergic 
response. Therefore, the contribution of α7*nAChRs was investigated using MLA, 
which is a selective α7*nAChR antagonist at the concentration used in this study 
(20 nM; Wonnacott et al., (1993)). 
Bath application of MLA significantly decreased the amplitude of the cholinergic 
response in ependymal cells from 4.05 ± 0.84 mV (n = 6) to 3.47 ± 0.8 mV (n = 6; t 
(5) = 4.420, P = 0.007; Figure 5.7A). The amplitude of the cholinergic response in 
CSFcCs was also significantly decreased in MLA from 24.23 ± 3.55 mV (n = 8) to 
19.65 ± 3.39 mV (n = 8; t (7) = 3.877, P = 0.006; Figure 5.7B). There was no 
significant difference between the time to peak response during control (1952.33 ±  
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Figure 5.6: Non α7*nAChRs contribute to the cholinergic responses of 
ependymal cells and CSFcCs. 
Whole cell patch clamp traces in current clamp (A-D) and mean amplitude ± S.E of 
the response (Ai-Di) to ACh (3 mM; 500 ms) under control conditions and during the 
bath application of DHβE (1 µM) in ependymal cells (A), subtype 1 CSFcCs (B), 
subtype 2 CSFcCs (C) and subtype 3 CSFcCs (D). E) Mean amplitude ± S.E of the 
response to ACh during the bath application of DHβE expressed as a percentage of 
the initial response to ACh, for ependymal cells, CSFcCs and CSFcC subtypes. ns 
= not significant, * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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Figure 5.7: Antagonism by MLA demonstrates that α7*nAChRs contribute to 
the cholinergic response in both ependymal cells and CSFcCs. 
Whole cell patch clamp traces in current clamp (A, B) and mean ± S.E of the 
amplitude of the response to ACh (3 mM; 500 ms; Ai, Bi) under control conditions 
and during the bath application of MLA (20 nM) for ependymal cells (A, Ai) and 
CSFcCs (B, Bi). ** = p < 0.01.
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96.79 ms; n = 6) and during MLA (2046.83 ± 149.68 ms; n =6) for ependymal cells 
(t (5) = -1.297, P = 0.251) and during control (600.00 ± 71.96 ms; n = 8) and during 
MLA (621.50 ± 76.63 ms; n = 8) for CSFcCs (data not normally distributed; Z = 
0.000, P = 1). As for the DHβE results, the decrease in amplitude of the cholinergic 
response in the presence of MLA was expressed as a percentage of the initial ACh 
response to allow comparison of the effect of MLA on the two cell types. In 
ependymal cells, the ACh response in MLA was 84 ± 4 % of the initial ACh 
response (n = 6) and in CSFcCs it was 80 ± 5 % (n = 8); the effect in MLA was not 
significantly different in the two cell types (t (12) = 0.494, P = 0.630). The effect of 
MLA on different CSFcC subtypes was not investigated. Despite the effect of MLA 
on the ACh-induced response, there was no observable effect of MLA on the 
membrane potential or input resistance of either ependymal cells or CSFcCs when 
applied alone.  
The selective α7*nAChR potentiator, PNU-120596, was employed to further 
investigate the contribution of the α7*nAChRs to the cholinergic responses. Bath 
application of PNU-120596 (10 µM) potentiated the cholinergic responses in both 
ependymal cells and CSFcCs (Figure 5.8). In ependymal cells there was a 
significant increase in the amplitude of the cholinergic response from 1.19 ± 0.17 
mV (n = 6) during control to 3.88 ± 1.02 mV (n = 6) during PNU-120596 (t (5) = -
2.879, P = 0.035; Figure 5.8Ai) and in the time to peak response from 954.67 ± 
135.15 ms (n = 6) during control to 1847.33 ± 327.92 ms (n = 6) during PNU-
120596 (t (5) = -4.221, P = 0.008; Figure 5.8Aii). In CSFcCs there was a significant 
increase in the amplitude of the cholinergic response from 10.48 ± 2.23 mV (n = 9) 
during control to 27.84 ± 6.82 mV (n = 9) during PNU-120596 (t (8) = -3.095, P = 
0.015; Figure 5.8Bi) and in the time to peak amplitude from 776.33 ± 140.37 ms (n 
= 9) during control to 3551.78 ± 1399.18 (n = 9) during PNU-120596 (data not 
normally distributed; Z = -2.666, P = 0.008; Figure 5.8Bii). When expressed as 
percentages of the initial ACh response, the percentage increase in the amplitude 
of the response in PNU-120596 of ependymal cells, 323 ± 78 %, was not 
significantly different from that of CSFcCs, 284 ± 45 % (t (13) = 0.469, P = 0.647; 
data not shown). Despite the significant effects of PNU-120596 on the ACh-induced 
response, it did not have any effects on the membrane potential or input resistance 
of either ependymal cells or CSFcCs when applied alone. 
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Figure 5.8: Potentiation by PNU-120596 demonstrates that α7*nAChRs 
contribute to the cholinergic response in both ependymal cells and CSFcCs. 
Whole cell patch clamp traces in current clamp (A, B), mean ± S.E of the amplitude 
of the response to ACh (3 mM; 500 ms; Ai, Bi) and mean ± S.E of the time to peak 
response (Aii, Bii) during control conditions and during the bath application of PNU-
120596 (10 µM) for ependymal cells (A) and CSFcCs (B). * = p < 0.05, ** = p < 
0.01.
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The percentage increases observed in the presence of PNU-120596 could be 
distorted by the different contribution of the non α7*nAChRs in the two cell types. 
This distortion also makes it difficult to study the effect of PNU-120596 on the 
different CSFcC subtypes. To remove this distorting factor, the effect of PNU-
120596 on the cholinergic response was investigated in the presence of the non 
α7*nAChR antagonist, DHβE; therefore only the residual α7*nAChR mediated ACh 
response was potentiated. In ependymal cells there was a significant increase in 
the amplitude of the cholinergic response from 1.51 ± 0.23 mV (n = 4) during DHβE 
only to 7.30 ± 1.85 mV (n =4) during DHβE plus PNU-120596 (t (3) = -3.247, P = 
0.048; Figure 5.9A) and in the time to peak response from 1546.50 ± 185.69 ms (n 
= 4) during DHβE only to 3376.00 ± 173.27 ms (n = 4) during DHβE plus PNU-
120596 (t (3) = -16.105, P = 0.001). In CSFcCs, there was also a significant 
increase in the amplitude of the cholinergic response from 3.64 ± 0.69 mV (n = 10) 
during DHβE only to 27.64 ± 4.03 mV (n = 10) during DHβE plus PNU-120596 (t (9) 
= -6.201, P < 0.001; Figure 5.9B), however, there was no significant difference in 
the time to peak response from 1368.50 ± 240.75 ms (n = 10) during DHβE only to 
2185.30 ± 597.91 ms (n = 10) during DHβE plus PNU-120596 (t (9) = -1.525, P = 
0.162). When expressed as percentages of the initial ACh response, the 
percentage increase in the amplitude of the response in DHβE plus PNU-120596 of 
ependymal cells, 496 ± 150 %, was still not significantly different from that of 
CSFcCs, 948 ± 195 % (t (12) = -1.377, P = 0.194; Figure 5.9C). When divided into 
subtypes, the percentage increase in the amplitude of the response in DHβE plus 
PNU-120596 was 496 ± 167 % (n = 2) for subtype 1 CSFcCs, 1010 ± 306 % (n = 5) 
for subtype 2 CSFcCs and 1147 ± 396 % (n = 3) for subtype 3 CSFcCs (Figure 
5.9C). A two-way ANOVA determined that there was no significant interaction 
between the effects of DHβE plus PNU-120596 and CSFcC subtype (F (2, 14) = 
0.664, P = 0.530). To confirm the selectivity of PNU-120596 for α7*nAChRs, PNU-
120596 was applied in the presence of MLA in addition to DHβE. In CSFcCs, the 
potentiation of the cholinergic response by PNU-120596 could be completely 
antagonised by MLA (20 nM; n = 4; Figure 5.9D). A paired t-test found that there 
was no significant difference between the amplitude of the cholinergic response in 
DHβE alone and in DHβE, PNU-120596 and MLA (t (3) = 1.002, P = 0.39; Figure 
5.9E), with an amplitude of the response in DHβE, PNU-120596 and MLA of 82 ± 
20 % (n = 4) that of those in DHβE alone.
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Figure 5.9: Potentiation by PNU-120596 in the presence of DHβE allows the 
α7*nAChR-mediated component of the cholinergic response in both 
ependymal cells and CSFcCs to be observed. 
Whole cell patch clamp trace in current clamp (A, B) and mean ± S.E of the 
amplitude of the response to ACh (3 mM; 500 ms; Ai, Bi) during the bath application 
of DHβE (1 µM) and DHβE plus PNU-120596 (10 µM) for ependymal cells (A, Ai) 
and CSFcCs (B, Bi). C) Mean amplitude ± S.E of the response in DHβE plus PNU-
120596 expressed as a percentage of the initial response to ACh in DHβE, for 
ependymal cells, CSFcCs and CSFcC subtypes. D) Whole cell patch clamp trace in 
current clamp to ACh in DHβE only and in DHβE plus PNU-120596 plus MLA. E) 
Mean amplitude ± S.E in DHβE only, DHβE plus PNU-120596 and DHβE plus 
PNU-120596 plus MLA. * = p < 0.05, *** = p < 0.001. 
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5.2.6 Cholinergic terminals could be the source of the ACh  
Given the robust responses of all cell types investigated to ACh, it supports the 
theory that ACh could be influencing these cells. To aid in understanding the 
function of ACh on these cell types it is important to determine the source of the 
ACh. The first step towards this is to determine whether cholinergic terminals are 
found in close apposition to CSFcCs and ependymal cells. The presence of 
cholinergic structures in the vicinity of CSFcCs and ependymal cells was 
demonstrated using immunohistochemistry with an antibody raised against ChAT 
(Figure 5.10B, E). An antibody raised against PKD2L1 was used to selectively label 
CSFcCs (Figure 5.10A) and an antibody raised against calbindin was used to 
identify ependymal cells (Figure 5.10D). ChAT immunopositive structures formed 
close appositions to some CSFcCs (n = 3 rats; Figure 5.10C) and some ependymal 
cells (n = 1 rat; Figure 5.10F; immunohistochemistry for calbindin and ChAT was 
performed by Mukti Singh). The number of ChAT immunopositive structures in 
close apposition to CSFcCs and ependymal cells was not quantified; however, it 
was clear that not all of the cells received close appositions. 
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Figure 5.10: Cholinergic structures are found in close apposition to CSFcCs 
and ependymal cells. 
A-C) PKD2L1 immunopositive cell bodies and CC-contacting processes of CSFcCs 
(A) and ChAT immunopositive structures (B) were observed around the CC of the 
thoracic spinal cord in P11 rats. Arrows highlight ChAT immunopositive structures 
that are in close apposition to PKD2L1 immunopositive CSFcCs (C). D-F) ChAT 
immunopositive structures (E) were also observed in close apposition to calbindin 
immunopositive ependymal cells (highlighted by arrows; D, F). The scale is the 
same for images A-C and D-F. Immunohistochemistry for calbindin and ChAT was 
performed by Mukti Singh.
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5.3 Discussion 
This chapter provides the first report that both ependymal cells and CSFcCs of the 
mammalian spinal cord can respond to ACh, thus proving the hypothesis set out at 
the beginning of this chapter. Moreover, the CSFcC subtypes defined in chapter 3 
have responses to ACh of significantly different amplitudes. Evidence supports the 
idea that the responses are likely to be due to a direct effect of ACh on both the 
ependymal cells and CSFcCs, given the presence of cholinergic structures in close 
apposition to these cells and the continued occurrence of a response to ACh in the 
presence of TTX, NBQX and AP5. Pharmacology indicates that the responses are 
mediated by nAChRs, predominantly non α7*nAChRs but also by a smaller 
proportion of α7*nAChRs. The data also suggests that the contribution of non 
α7*nAChRs to the cholinergic response varies between ependymal cells and 
CSFcCs, as well as between CSFcC subtypes. 
5.3.1 Cholinergic responses of ependymal cells and CSFcCs  
The combination of the immunohistochemistry demonstrating the presence of 
cholinergic structures in close apposition to the CSFcCs and ependymal cells and 
the electrophysiology demonstrating the continued existence of the ACh response 
in the presence of TTX, suggests that the ACh responses are direct effects of ACh 
on receptors expressed by CSFcCs and ependymal cells. The lack of change in 
time to onset of the response in the presence of TTX also supports the theory that 
the effect is direct. Nevertheless, although the use of TTX ensures that action 
potential propagation along the axon cannot occur it does not necessarily prevent 
synaptic transmission. It is possible that ACh could be activating nAChRs located 
on a pre-synaptic terminal resulting in the direct influx of Na+ and importantly Ca2+ 
which is capable of triggering synaptic vesicle release independent of an action 
potential. To prevent this possibility an extracellular solution with low Ca2+ would 
need to be used; however, this would also reduce the response of post-synaptic 
nAChRs, therefore low Ca2+ solutions were not used in this study. 
Immunohistochemistry demonstrating the presence of cholinergic structures in 
close apposition to CSFcCs and ependymal cells supports the idea that the 
cholinergic effect is direct, however, electron microscopy will need to be performed 
to confirm the presence of cholinergic synapses onto CSFcCs and ependymal cells. 
Also, it must be noted that not all CSFcCs and ependymal cells received close 
appositions from cholinergic structures. This could be the result of using an anti-
ChAT antibody to identify cholinergic terminals. ChAT is the enzyme that catalyses 
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the synthesis of ACh, therefore it is not necessarily always present in cholinergic 
terminals, as ACh could be synthesised in the cell body and transported to the 
terminal. An alternative to anti-ChAT would be to use an anti-VAChT antibody. 
VAChT is the vesicular ACh transporter which must be present in all terminals to 
transport ACh into the synaptic vesicles; therefore it would identify all cholinergic 
terminals. This would also ensure that the ChAT immunopositive structures seen in 
close apposition to ependymal cells and CSFcCs are in fact terminals and not 
dendrites. It must also be noted that PKD2L1 has been shown to be a specific 
marker for CSF-contacting neurones (CSFcNs), with all recordings from PKD2L1-
expressing cells showing a neuronal phenotype (Huang et al., 2006). It appears 
likely, therefore, that subtype 1 CSFcCs, which could be CC-contacting astrocytes 
(Accs; see chapter 3.3.1), do not express PKD2L1. To determine whether subtype 
1 CSFcCs have cholinergic terminals in close apposition, it is possible that they 
could be identified by the expression of GFAP and the presence of a CC-contacting 
process; the criteria used by Alfaro-Cervello et al., (2012). Alternatively, 
immunohistochemistry for VAChT could be performed on recovered slices which 
have rhodamine-containing subtype 1 CSFcCs, although this method can be 
temperamental and has a low success rate (Deuchars et al., 2001). Finally, even if 
cholinergic synapses with ependymal cells or CSFcCs could not be demonstrated it 
would not necessarily mean that ACh is not acting directly on nAChRs expressed 
by the cells. There is now some evidence demonstrating that cholinergic 
transmission within the CNS does not always occur at synapses (see review 
Lendvai and Vizi (2008)). It has been discovered that in many areas of the CNS, 
cholinergic terminals do not form synapses; this was first demonstrated in the 
somatosensory cortex of the adult rat, where the synaptic incidence was only 14 % 
(Umbriaco et al., 1994). In addition, acetylcholinesterase, the enzyme responsible 
for the breakdown of ACh, has been localised in many areas that are distinct from 
cholinergic terminals or nAChRs, suggesting that it is monitoring the ambient levels 
of ACh that are present within the extracellular solution (Descarries et al., 1997). 
This ambient ACh would be capable of tonically activating nAChRs, which are most 
commonly found at peri- or extra-synaptic locations (Dani and Bertrand, 2007)). In 
fact, a constant nicotine exposure has been demonstrated to stabilise 
α4β2*nAChRs in a high affinity state that is more sensitive to ACh (Vallejo et al., 
2005), suggesting that some nAChRs can adapt to respond robustly to low levels of 
ambient ACh. It is therefore possible that in-vivo ependymal cells and CSFcCs are 
influenced by ambient ACh acting on extrasynaptic nAChRs, either instead of or in 
addition to synaptic cholinergic transmission.    
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The variation in the amplitude of the ACh response in ependymal cells and different 
CSFcC subtypes is unlikely to be due to an inconsistency in the access of the drug 
to the slice as the different cell types and subtypes were all recorded from similar 
depths within the slices. They also had a similar time to onset of the response, 
suggesting that the time it took for the ACh to reach the cells was the same. Of note 
here is that a high concentration of 3 mM ACh was used for these experiments to 
ensure that on pressure application into the bathing aCSF solution the 
concentration would still be high enough to elicit a response; lower concentrations 
could have been diluted to such a low concentration that responses would not have 
been observed. The disadvantage of this is that the exact concentration reaching 
each cell could vary and that concentration is not known. Nevertheless there was 
an obvious variation in the cholinergic response of subtype 1 CSFcCs compared to 
that of subtype 2 and 3 CSFcCs which supports the conclusion from chapter 3.3 
that subtype 1 CSFcCs are glial cells, likely the Accs described by Alfaro-Cervello 
et al., (2012). This is reinforced by the similarities observed between the subtype 1 
CSFcC cholinergic responses and those of ependymal cells. There was also a 
more subtle difference in the cholinergic responses of subtype 2 and subtype 3 
CSFcCs. This difference is more likely to be due to a different density of receptor 
expression or a difference in the proportions of receptors mediating the response.  
The difference in the time to peak response between ependymal cells and subtype 
1 CSFcCs compared to subtype 2 and 3 CSFcCs again suggests variation between 
the cell types. This corresponds with variations seen between glial cells and 
neurones within the hippocampus, for example, α7*nAChR-mediated currents in 
astrocytes have a much longer rise time than those of interneurones (Shen and 
Yakel, 2012). This difference could be brought about by varying intracellular ion 
concentrations between the glial and neuronal cells which result in differences in 
the speed of ion exchange. More likely, it is due to different secondary effects that 
occur following the initial nAChR activation. For example, in cultured hippocampal 
neurones, activation of nAChRs results in the activation of voltage-gated Ca2+ 
channels (Barrantes et al., 1995), whereas in cultured hippocampal astrocytes 
activation of nAChRs does not cause an activation of voltage-gated Ca2+ channels 
but can result in Ca2+ induced Ca2+ release from intracellular store (Sharma and 
Vijayaraghavan, 2001). This could be similar for the cells in this study, with subtype 
2 and 3 CSFcCs expressing voltage-gated Ca2+ channels, while these channels are 
absent in ependymal cells and subtype 1 CSFcCs where a Ca2+ induced Ca2+ 
release mechanism is responsible for effects seen. 
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5.3.2 Evidence suggests that cholinergic responses are mediated by nAChRs 
The variation in the amplitude of the cholinergic response at different membrane 
potentials and the reversal potential at roughly 0 mV in subtype 2 and 3 CSFcCs 
strongly suggests that non-selective cation channels are mediating the effect. The 
non-selective cation channels could be confirmed as nAChRs by the complete 
antagonism of the cholinergic response in CSFcCs by MCA, a selective nAChR 
antagonist. MCA also completely antagonised the cholinergic response in 
ependymal cells, strongly suggesting that this cholinergic response is also mediated 
by nAChRs. This was not verified by the investigation of the reversal potential. The 
amplitude of the response to ACh did not vary when the membrane potential of the 
ependymal cells were set between -40 mV and -90 mV. This is likely due to the 
large degree of coupling observed amongst ependymal cells (see figures 4.2 and 
4.3), which makes it very difficult to control the set potential of an ependymal cell. 
The reversal potential could be investigated in the presence of a gap junction 
blocker, for example 18β-glycrrhetinic acid, to enable the membrane potential to be 
more easily controlled; however, the antagonism by MCA seems sufficient to 
identify the nAChR as that responsible for mediating the cholinergic response in 
ependymal cells. 
 
5.3.3 Pharmacological profiles suggest both non α7*nAChRs and α7*nAChRs 
contribute to the cholinergic responses 
The significant degree of antagonism of the ACh response observed in the 
presence of DHβE suggests that the cholinergic response is mediated in part by 
non α7*nAChRs in both ependymal cells and CSFcCs. In-situ hybridisation studies 
have revealed the expression of α2, α3, α4 and β2 nAChR subunits within lamina X 
of the spinal cord (Wada et al., 1989). As DHβE is a preferential antagonist at 
α4*nAChRs and β2*nAChRs (Harvey and Luetje, 1996; Harvey et al., 1996), and 
they are present within lamina X it is likely that α4β2*nAChRs are mediating this 
cholinergic effect on ependymal cells and CSFcCs, however, this needs further 
confirmation using DHβE at 10 nM which selectively antagonises α4β2*nAChRs 
(Alkondon and Albuquerque, 1993). The different degrees of antagonism of the 
cholinergic response by DHβE suggests that the non α7*nAChRs contribute to 
varying degrees within the cell types investigated. As with the size of the cholinergic 
response, the degree of antagonism by DHβE observed in subtype 1 CSFcCs was 
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similar to that of ependymal cells. The antagonism of the cholinergic response by 
DHβE was greatest in subtype 3 CSFcCs, suggesting that this subtype express the 
greatest proportion of non α7*nAChRs. Since DHβE is most effective at 
α4β2*nAChRs, a greater antagonism of the cholinergic response by DHβE could 
also suggest a greater proportion of α4β2*nAChRs compared to α3*- or β4*-
nAChRs within the non α7*nAChRs. 
Given that DHβE did not completely antagonise the cholinergic response, combined 
with the fact that an α7 nAChR subunit reporter mouse made by the GENSAT 
project showed some GFP expressing CSFcCs, the contribution of α7*nAChRs was 
examined. This was investigated using MLA which is an α7*nAChR selective 
antagonist at concentrations of 20 nM or lower (Wonnacott, 1993). The low 
concentration needed to be selective provides a potential problem when 
investigating its antagonism of the focal pressure application of a high concentration 
(3 mM) of ACh. Thus although a small, significant antagonism of the cholinergic 
response was observed in both ependymal cells and CSFcCs with MLA, it is 
possible that the proportion of α7*nAChRs mediating the cholinergic effect was 
being underestimated. In argument against this, the potentiation by PNU-120596 
could be completely antagonised with MLA, suggesting that in fact MLA at 20 nM 
was sufficient to antagonise any α7*nAChR-mediated responses. If the MLA 
antagonism was entire, it suggests that although there is a difference in the amount 
of non α7*nAChRs in the cell types, there does not appear to be a difference in the 
proportion of α7*nAChRs.    
The presence of α7*nAChRs was confirmed by the potentiation of the cholinergic 
response by PNU-120596. PNU-120596 is a type II positive allosteric modulator 
which increases the peak of the agonist evoked current, prolongs the agonist 
evoked response in the continued presence of the agonist and increases the mean 
channel open time of α7*nAChRs (Hurst et al., 2005). In addition, PNU-120596 is 
capable of reactivating desensitised α7*nAChRs (Gronlien et al., 2007). Importantly 
for this study, PNU-120596 has no detectable effect on currents mediated by 
α4β2*-, α3β4*- and α9α10*-nAChRs (Hurst et al., 2005), therefore, the potentiation 
that was seen in the presence of PNU-120596 is due to the presence of 
α7*nAChRs in the cells recorded. The type of effects that PNU-120596 is reported 
to have on α7*nAChR-mediated currents matched up well to the quantified 
increases in both amplitude and the time it took to reach the peak amplitude and 
the observation that it increased the duration of the cholinergic response in cells of 
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this study. Although the average percentage increase in the amplitude of the 
cholinergic response in ependymal cells was much smaller than that in CSFcCs, 
the large degree in variation within the cell types meant that there was a lack of 
significant difference between the two cell types. As the potentiation by PNU-
120596 does not reach a maximum until 30-60 minutes of incubation in PNU-
120596 (Shen and Yakel, 2012), the potentiation of the cholinergic response could 
vary depending on how long PNU-120596 has been applied before ACh was 
applied. In this case, however, ACh was always applied after a given time of 
incubation in PNU-120596; therefore this should not be contributing to the variation. 
The different contribution of non α7*nAChRs could also be complicating the degree 
of potentiation observed by PNU-120596, which was why it was co-applied with 
DHβE following a pre-incubation in DHβE. There was still a large amount of 
variation in the degree of potentiation within the cell types. This is likely due to the 
inclusion of subtype 1 CSFcCs within the CSFcC cell type; other than their 
morphology these subtype 1 CSFcCs have characteristics that are indistinguishable 
from ependymal cells. The problem with variation could perhaps be overcome with 
an increase in replicates, however, with four different cell types, three of which 
cannot be morphologically distinguished; obtaining enough recordings to reduce the 
variation could be a lengthy procedure.  
Despite the lack of significant difference between the CSFcC subtypes and 
ependymal cells with regards to their potentiation by PNU-120596, it looks like there 
is a trend towards a larger potentiation in subtype 2 and 3 CSFcCs compared to 
subtype 1 CSFcCs and ependymal cells. Initially this could be thought to suggest 
that the proportion of α7*nAChRs contributing to the cholinergic response is greater 
in subtype 2 and 3 CSFcCs than in subtype 1 CSFcCs and ependymal cells, which 
would contradict the DHβE data. However, it is more likely that there are simply 
numerically more α7*nAChRs on subtype 2 and 3 CSFcCs than on subtype 1 
CSFcCs and ependymal cells, thus PNU-120596 has a greater number of receptors 
that it can affect on subtype 2 and 3 CSFcCs. Despite this larger number, the 
amount of α7*nAChRs could still form a relatively low proportion of the nAChRs 
expressed by subtype 2 and 3 CSFcCs. Conversely, despite the potentiation of the 
cholinergic response appearing smaller in ependymal cells and subtype 1 CSFcCs, 
presumably due to a lower number of α7*nAChRs; the proportion of α7*nAChRs to 
non α7*nAChRs is likely to be higher due to the DHβE data. 
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5.3.4 Conclusions 
This chapter has demonstrated that both ependymal cells and CSFcCs of the 
mammalian spinal cord are capable of responding to ACh. The responses observed 
appear to be due to direct effects of ACh on somatodendritic nAChRs. Both non 
α7*nAChRs and α7*nAChRs appear to contribute to the cholinergic response and 
the proportions of this contribution appear to differ between cell types. These varied 
contributions highlight functional differences between the cell types. The 
demonstration in this study that ependymal cells and CSFcCs can respond to ACh 
is the first step towards determining whether ACh is affecting these cell types in a 
physiological system. There is currently no evidence of either cell type responding 
to endogenous ACh, for example no cholinergic EPSPs were observed nor were 
there any lone effects of cholinergic antagonists or modulators. Nevertheless, the 
nature of the preparation could have disrupted the normal source of ACh and the 
work strongly suggests that both cell types will be influenced by ACh under 
physiological conditions and thus suggests that they form an integrated part of the 
spinal cord circuitry.
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Chapter 6 - General Discussion 
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This study has used whole cell patch clamp electrophysiology in an in-vitro spinal 
cord slice preparation, complimented by intracellular dye-loading and 
immunohistochemistry, to characterise the cells surrounding the CC of the postnatal 
mammalian spinal cord. This is an area that has received very little attention with 
regards to its integration into the spinal cord circuitry and the ability of the cells to 
respond to neurotransmitters and neuromodulators. This study has verified that 
there are CSFcCs with varying phenotypes, describing for the first time the 
electrophysiological responses of a glial class of CSFcC. It has demonstrated the 
large degree of coupling that occurs between ependymal cells and how radial 
ependymal cells are also part of this coupling. The findings have confirmed reports 
that CSF-contacting neurones (CSFcNs) respond to GABA and shown that 
ependymal cells can also respond to GABA. Finally, it has been demonstrated that 
both CSFcCs and ependymal cells respond to ACh and that this is likely to be a 
direct effect mediated by differing contributions of non α7*nAChRs and α7*nAChRs. 
The aims of this study were to investigate whether ependymal cells and CSFcCs 
are integrated into the spinal circuitry and establish parallels between this area and 
other postnatal neurogenic niches; the results summarised here provide evidence 
supporting the integration of these cells into spinal cord circuitry and that there are 
parallels to other neurogenic niches. Here, the functional implications of the gap 
junction coupling of ependymal cells and the ability of both ependymal cells and 
CSFcCs to respond to GABA and ACh will be discussed. Finally, technical 
considerations and limitations will be discussed before suggesting what future work 
could be undertaken to further our understanding of this area.       
 
6.1 Functional implications 
6.1.1 Are CSFcCs one cell type on a continuum of maturation or a number of 
cell types whose phenotypes are suited to specific functional roles?  
One of the most intriguing debates concerning CSFcCs is whether they belong to 
one phenotype of cell but cells within that phenotype are at different stages of their 
functional maturation, or whether in fact CSFcCs have all reached their final 
phenotype and they are a varied population whose phenotype is most relevant to 
their function. It appears from this study that subtype 1 CSFcCs are a different 
phenotype to subtype 2 and 3 CSFcCs. The main evidence for this is that subtype 2 
and 3 CSFcCs contain a range of characteristics on which a continuum can be 
established. From subtype 1 to 2 CSFcCs, however, there is a rather large leap 
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from completely passive responses and a very low input resistance in subtype 1 
CSFcCs, to quite obvious active response properties and a much higher input 
resistance in subtype 2 CSFcCs. The electrophysiological profile of subtype 1 
CSFcCs is consistent with that of a mature glial cell and the morphology 
corresponds well to the Accs identified by Alfaro-Cervello et al., (2012), although it 
has not been confirmed by ultrastructural or immunohistochemical studies whether 
the two cell types are indeed the same. If it is assumed that subtype 1 CSFcCs are 
Accs, it is interesting to note that Accs possess a primary cilium which contacted 
the CSF (Alfaro-Cervello et al., 2012); this is similar to the activated SVZ 
astrocytes, which are proposed to be the neural stem cells of the SVZ (Doetsch et 
al., 2002). Unfortunately, neither BrdU and [3H]thymidine identified Accs as 
proliferating cells (Alfaro-Cervello et al., 2012), however, it cannot be ruled out that 
Accs are a quiescent cell population that could become activated following injury or 
a spinal cord pathology. 
Determining the phenotype of subtype 2 and 3 CSFcCs, which can be collectively 
referred to as CSFcNs, appears much more complicated. The wide range of 
electrophysiological responses to the injection of positive current and the fact that 
they seem to range along a continuum rather than represent distinct subtypes, 
suggests one phenotype which contains cells that are at different stages of 
maturation. This is consistent with immunohistochemistry that has demonstrated 
the expression of numerous markers of immature neurones, such as Dcx, PSA-
NCAM and HuC/D (Stoeckel et al., 2003; Hamilton et al., 2009; Marichal et al., 
2009). Of note here is that these markers can also be observed in fully mature 
neurones that are consistently undergoing plastic changes, for example PSA-
NCAM is expressed by neurones of the hypothalamo-neurohypophysial system 
which undergo dendritic remodelling (Theodosis et al., 1994). Therefore, the 
expression of these markers is not unequivocal evidence that they are immature 
neurones; they could be fully mature neurones which undergo numerous plastic 
changes. In support of this, CSFcNs do not express BrdU when injected 
postnatally; they only express it when it is injected during the embryonic period 
(Marichal et al., 2009), indicating that CSFcNs are not born postnatally. This is also 
corroborated by comparing the data in this study which was collected from P11-P21 
rats to that of Marichal et al., (2009) which was collected in P0-P5 rats; together the 
data demonstrates that there is no change in the number of CSFcNs with certain 
firing patterns from P0 to P21. It was suggested by Marichal et al.,(2009) that the 
neurones could be in some kind of standby mode, waiting for a cue to continue 
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maturation. Preliminary evidence supports this suggestion, as CSFcNs appear to 
migrate following a peripheral nerve insult (Conte, 2009), however, this needs to be 
further investigated. The basal processes of CSFcNs that have been demonstrated 
to extend towards the ventral median fissure and ventral horn or laterally, possibly 
towards the IML, suggest that at least some of the CSFcNs are quite well 
developed and are not simple immature neurones. The variation in destination of 
the processes suggests that CSFcNs have different functions. It is possible that the 
processes are all coursing towards the external CSF; however, this work has 
demonstrated that they do seem to terminate within the grey matter. The CSFcNs 
are well placed in a central location of the spinal cord to integrate inputs from the 
dorsal horn and descending tracts from the brainstem and to subsequently 
communicate outputs to the lateral and ventral horns. It is possible that some 
CSFcNs communicate information to the SPNs in the IML that control autonomic 
output, whilst others communicate information to the motor neurones or premotor 
interneurones in the ventral horn that influence motor output. Their possible plastic 
nature could make them amenable to changes induced by sensory input from the 
periphery, dorsal horn or CSF; for example disruption to peripheral input caused by 
a peripheral nerve injury induced the migration of CSFcNs (Conte, 2009). Sensory 
input induced plastic changes in CSFcNs could be translated into a varied output to 
regions involved in autonomic and motor output. It is unclear to date whether it 
would be important for CSFcNs to respond to sensory input in physiological 
situations or whether it is only important during pathological situations. Further 
investigations need to be made considering the nature of CSFcNs to determine 
whether they are immature or plastic neurones and whether they are capable of 
responding to insult or sensory inputs. The future work sections will look at some of 
the ways in which they can be investigated.  
 
6.1.2 Relevance of gap junction coupling within the CC region 
Gap junctions are widely present in neurones to allow the rhythmic firing of groups 
of neurones (see review Connor & Long (2004)). Ependymal cells and subtype 1A 
CSFcCs, the gap junction coupled cells observed in this study, only generate 
passive responses, necessitating the question, what is the function of gap junctions 
in these cells? It has been proposed that ependymal cells could act as regulators of 
extracellular K+, with K+ moving into the cells at the basal surface from the 
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extracellular solution of the grey matter and exiting at the apical surface into the 
CSF, as observed in retinal mϋller cells (Newman, 1986; Jarvis and Andrew, 1988). 
The coupling of the ependymal cells could make this process more efficient, as K+ 
could be shunted via ependymal cells in areas of high extracellular K+ to ependymal 
cells in areas of lower extracellular K+, as observed in glial syncytiums (see review 
Kofuji and Newman (2004)). Another possible reason for ependymal cells and 
subtype 1A CSFcCs to form gap junctions is to allow the control of cellular 
proliferation. Gap junction coupling occurs in ventricular regions of the embryonic 
neocortex and in the adult SVZ (Bittman et al., 1997; Liu et al., 2006a). During 
development, the coupling occurs only between radial glia and neural precursor 
cells, and is cell cycle phase dependent; uncoupling the cells decreases the 
number of cells that enter the S (DNA replication phase) of the cell cycle (Bittman et 
al., 1997). It appears that it is the propagation of Ca2+ waves through gap junctions 
that influences this proliferation; this was demonstrated in the embryonic ventricular 
zone, as reducing the Ca2+ waves between neighbouring radial glia reduces the 
ventricular zone proliferation (Weissman et al., 2004). More recently, it has been 
demonstrated that gap junction coupling between neural progenitor cells and 
another population of astrocyte-like cells within the mouse postnatal SVZ allows the 
propagation of intercellular Ca2+ waves (Lacar et al., 2011). This suggests that the 
propagation of Ca2+ waves through gap junctions is a common mechanism to 
influence proliferation in both the embryonic and postnatal brain. It is tempting to 
suggest that this common mechanism could be extended to the postnatal spinal 
cord, with the propagation of Ca2+ waves between ependymal cells and subtype 1 
CSFcCs controlling the constant proliferation of ependymal cells that occurs to 
maintain the ependymal cell population (Johansson et al., 1999). 
 
6.1.3 GABAergic responses in cells surrounding the CC suggest that they are 
integrated into the spinal cord circuitry and has implications for the 
neurogenic capacity of the area 
There are two possible endogenous sources of GABA that could be influencing 
ependymal cells and CSFcCs (Figure 6.1). The first source is GABAergic terminals 
that are known to be present in the area surrounding the CC (Mclaughlin et al., 
1975).  GABAergic terminals form synapses with ependymal cells (Magoul et al., 
1987) and have been observed in close apposition to CSFcNs (Mclaughlin et al., 
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1975). Axonal bundles co-expressing GAD, P2X2, PSA-NCAM, GAP 43 and 
synaptotagmin have been identified both intra- and sub-ependymally (Stoeckel et 
al., 2003). The co-expression of GAD, P2X2 and PSA-NCAM suggests that these 
axons originate from CSFcNs, indicating that CSFcNs could be influencing 
ependymal cells, subtype 1 CSFcCs and possibly other CSFcNs. Alternative 
sources of GABAergic terminals are the local GABAergic interneurones within 
lamina X or the dorsal horn (Barber et al., 1982). The functional implication of 
ependymal cells and CSFcCs receiving GABAergic inputs would be highly 
dependent on the precise nature of the GABAergic neurones from which the 
terminals originate. For example, if the terminals originate from GABAergic 
neurones in the dorsal horn it could further support the possibility that cells 
surrounding the CC are influenced by sensory inputs.  
The second possible source of GABA is from the large terminals that are found at 
the end of the CSF-contacting processes of CSFcNs. These terminals are 
immunoreactive for VGAT as well as SV2 and synaptophysin (Conte, 2009), 
suggesting that they could be capable of releasing GABA into the CSF, onto the 
apical surfaces of ependymal cells and onto other CSF-contacting processes. If this 
is the case, excitation of CSFcNs could elicit the release of GABA which 
subsequently excites ependymal cells and either further excites or inhibits other 
CSFcNs. Even if CSFcNs are incapable of releasing GABA from their terminals 
using synaptic machinery, they could be releasing GABA in a non-synaptic, 
paracrine manner. This has been observed for newborn neurones in the SVZ, 
where they release GABA in a Ca2+ dependent but SNARE independent manner 
(i.e. non-synaptic) which tonically activates GABAA receptors on the SVZ astrocytes 
(Liu et al., 2005). If a similar mechanism is occurring here, GABA released from 
CSFcNs could be tonically activating GABAA receptors on ependymal cells, causing 
an excitation. The release of GABA into the CSF could also cause wider reaching 
effects than synaptic release from terminals directly onto a postsynaptic site, as 
GABA could diffuse through the CSF to influence cells within different segments of 
the spinal cord. This is, however, only a theory as the ability of CSFcCs to release 
GABA is yet to be tested; the method which could be used to investigate this 
possibility will be discussed in section 6.3.   
The functional consequence of GABA exciting ependymal cells and CSFcCs can 
only be speculative at present. Firstly, considering ependymal cells, their excitation 
by GABA could have secondary effects on K+ currents. In numerous astrocytes, 
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including in the adult hippocampus, activation of GABAA receptors inhibits outward 
K+ currents (Bekar et al., 1999). A similar inhibition could be occurring in ependymal 
cells; however, the passive nature of the cells recorded in this study suggests that 
this is not the case (see section 6.2 for further discussion about the possible 
presence of K+ currents).  A second, greater functional consequence is to consider 
whether GABA is influencing the proliferative nature of ependymal cells, given that 
they are the potential neural stem cells of the CC neurogenic niche (Johansson et 
al., 1999; Barnabe-Heider et al., 2010). In particular, it is helpful to view how GABA 
influences cells within other neurogenic niches and then translate this to ependymal 
cells of the CC. GABA excites a number of progenitor cells, including those in the 
ventricular zone of the developing rat brain (LoTurco et al., 1995), the mammalian 
postnatal SVZ (Liu et al., 2005), the mammalian postnatal DG (Tozuka et al., 2005) 
and most recently, the turtle postnatal spinal cord (Reali et al., 2011). The GABAA 
mediated excitation can induce increases in intracellular Ca2+ (Tozuka et al., 2005; 
Reali et al., 2011) and influence proliferation and differentiation. In particular, GABA 
appears to reduce proliferation of neural stem/progenitor cells and induce 
differentiation to produce more newborn neurones (Liu et al., 2005; Tozuka et al., 
2005). Unlike the postnatal neurogenic niches of the mammalian brain and lower 
vertebrate spinal cord, ependymal cells undergo only symmetrical division to 
maintain the ependymal cell population under physiological conditions (Johansson 
et al., 1999). If cells within the CC area respond to GABA in a similar way to the 
SVZ and DG, the proliferation of ependymal cells rather than differentiation 
suggests a lack of endogenous GABA under physiological conditions. It is possible 
that following an injury or the onset of a pathological condition, GABA could be 
released around this area, limiting proliferation and promoting differentiation. As 
CSFcNs have been shown to depolarise in response to both a decrease in pH and 
an increase in ATP (Huang et al., 2006; Marichal et al., 2009), both of which occur 
during injury, it could be hypothesised that CSFcNs are depolarised following injury 
eliciting the release of GABA which subsequently excites ependymal cells and 
promotes their differentiation into astrocytes and oligodendrocytes (Barnabe-Heider 
et al., 2010). Unfortunately within this study, the effect of GABA on subtype 1 
CSFcCs was not investigated; however, if subtype 1 CSFcCs are the equivalent of 
SVZ astrocytes it is clear that their ability to respond to GABA must also be 
investigated.  
Examining the potential consequences of GABA influencing CSFcNs is difficult 
given that some CSFcNs appear to depolarise in response to GABA and others 
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hyperpolarise. Although electrophysiology concerning GABA can be difficult, it can 
be assumed that the differences in response are not an experimental artefact, given 
that another study using gramicidin perforated patch recordings, in which the 
intracellular Cl- is not affected, also saw both depolarising and hyperpolarising 
responses to GABA (Marichal et al., 2009). The depolarisation of CSFcNs by GABA 
could be a trigger to release GABA themselves, whether this is by their CSF-
contacting terminal or other processes. Alternatively or perhaps additionally, 
newborn neurones produced within the SVZ are known to depolarise in response to 
GABA acting via GABAA receptors which reduces their speed of migration (Bolteus 
and Bordey, 2004); it is possible that GABA depolarising CSFcNs could inhibit their 
migration away from the CC region. It is more difficult to determine a functional 
outcome of CSFcNs responding to GABA with a hyperpolarisation. Firstly, it is 
possible that CSFcNs could be tonically releasing GABA into the CSF or onto 
ependymal cells and that a hyperpolarisation by GABA would reduce this tonic 
release. This is possible as the GABAA antagonist, bicuculline, applied alone had 
an effect on a small number of ependymal cells; however, the lack of effect of 
bicuculline on ependymal cells and the symmetrical proliferation previously 
discussed argues against the presence of tonic GABA. CSFcNs do also have the 
basal processes that project laterally and ventrally from which they could be 
releasing some substance such as GABA; a hyperpolarisation could be affecting 
this release. A second possibility is concerning migration; a hyperpolarisation of 
CSFcNs by GABA could allow migration if a stimulus encouraged them. Both of 
these outcomes are conjecture and the ability of CSFcNs to release GABA and/or 
migrate must be investigated.  
Overall, although little evidence of endogenous GABAergic signalling was observed 
in these cells, the ability of ependymal cells and CSFcNs to respond to exogenous 
GABA provides strong evidence that these cells respond to GABA in-vivo and 
suggests that these cells could be integrated into the spinal cord circuitry. It is 
possible that GABA could enable communication between these different cell types 
and that these cells could use GABA to translate changes in the spinal cord 
environment into influencing the neurogenic capacity of this area. 
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6.1.4 Cholinergic responses of cells surrounding the CC suggest that they are 
integrated into the spinal cord circuitry and has implications for 
neurogenesis and plasticity within the area 
Ependymal cells and CSFcCs also responded robustly to ACh. This strengthens the 
argument that both cell types are integrated into the spinal circuitry. The possible 
source of the ACh has not been identified (Figure 6.1) but it appears to be from 
cholinergic terminals (Barber et al., 1984). In addition, both ACh and its breakdown 
product choline are found in the CSF, although only in low concentrations (Tohgi et 
al., 1994). As choline is a selective agonist at the α7*nAChRs (Papke et al., 1996), 
its presence within the CSF could result in the activation of α7*nAChRs. The 
activation of receptors by ACh/choline within the CSF is likely to be in addition to 
the activation of receptors by ACh released from the cholinergic terminals. The 
cholinergic neurones from which the cholinergic terminals originate is currently 
unknown, although it could be reasoned that they are from either the partition cells 
or the CC-cluster cells which are both cholinergic interneurones located in lamina X, 
or from the less frequently observed cholinergic interneurones in the dorsal horn 
(Barber et al., 1984). If the inputs are from cholinergic interneurones within the 
dorsal horn it could be speculated that ependymal cells and CSFcCs are influenced 
by sensory information. It is more likely, however, that the cholinergic inputs are 
originating from the partition neurones or the CC-cluster cells which have been 
proposed to coordinate the activity of numerous spinal cord segments (Sherriff and 
Henderson, 1994). Increasing evidence suggests that partition neurones are part of 
the circuitry controlling locomotion (Huang et al., 2000; Miles et al., 2007), therefore 
if the cholinergic inputs to ependymal cells or CSFcCs are from partition neurones it 
is possible that their activation could be coordinated with locomotor events. The 
purpose of CSFcNs being coordinated with such events could be to induce a global 
release of GABA into the CSF which could enable communication between different 
spinal cord segments. Alternatively, the activation of CSFcNs by partition neurones 
could result in those CSFcNs with laterally projecting processes communicating 
with neurones involved in autonomic output, thus facilitating the synchronisation of 
motor and autonomic output.  
The function of ACh depolarising ependymal cells and subtype 1 CSFcCs is 
unknown, however, the expression of nAChRs on these cell types should come as 
no surprise given the number of other non-neuronal cells with functional nAChRs 
(see review Sharma and Vijaraghavan (2002)). Both non α7*nAChRs and 
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α7*nAChRs have been identified in non-neuronal cells. For example, in cultured 
oligodendrocyte precursor cells from the postnatal corpus callosum, nicotine could 
induce increases in intracellular Ca2+ that were inhibited by DHβE (10 nM) but not 
by MLA, indicating the presence of α4β2*nAChRs (Rogers et al., 2001). In addition, 
ACh-induced currents within NG2 expressing oligodendrocyte precursor cells of the 
postnatal hippocampus could be antagonised by MLA and potentiated by PNU-
120596, indicating the presence of α7*nAChRs (Velez-Fort et al., 2009). 
Interestingly, in both cases the activation of nAChRs resulted in an increase in 
intracellular Ca2+, suggesting that this is functionally important to non-neuronal 
cholinergic responses (Velez-Fort et al., 2009). Whether the cholinergic responses 
induced in ependymal cells and subtype 1 CSFcCs result in an increase in 
intracellular Ca2+ was not investigated in this study but it is undoubtedly an 
important future experiment. It is possible that the activation of nAChRs on these 
cell types could induce increases in intracellular Ca2+ which could initiate numerous 
effects, including modulating gene expression and influencing plasticity; although 
these downstream effects have been predominantly investigated in neurones (see 
review Dajas-Baildor and Wonnacott (2004)), they could also occur in non-neuronal 
cells. In addition, it could initiate the propagation of Ca2+ waves through gap 
junctions, as seen in radial glial cells during embryonic neurogenesis and neural 
progenitor cells in the postnatal SVZ (Weissman et al., 2004; Lacar et al., 2011) 
which could influence ependymal cell and possibly subtype 1 CSFcC proliferation. 
In the postnatal DG of the hippocampus, a decrease in the number of BrdU 
expressing newborn cells indicated that there was a decrease in the rate of 
proliferation in β2*nAChR knockout mice (Harrist et al., 2004). This suggests that 
neural progenitor cells of the DG express β2*nAChRs and that their activation 
influences the rate of proliferation. The data in this study suggest the presence of 
β2*nAChRs in two possible neural stem/progenitor cell populations, ependymal 
cells and subtype 1 CSFcCs, indicating that ACh could influence proliferation in the 
area surrounding the CC by  activating β2*nAChRs. Alternatively or indeed 
additionally, proliferation could also be influenced by α7*nAChRs.  
A number of functions of ACh depolarising CSFcNs could be speculated. If CSFcNs 
are considered to be immature neurones, ACh could be influencing their survival 
and/or maturation as observed in the DG (Campbell et al., 2010). Newborn dentate 
granule cells express functional α7*nAChRs but as they mature and integrate into 
the hippocampal circuitry, that expression is lost (John, 2010). Even though the 
majority of the cholinergic response of CSFcNs is mediated by non α7*nAChRs in 
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this study, there is still a part of the response that is mediated by α7*nAChRs. As 
discussed in chapter 5.3, the greater antagonism of the ACh response by DHβE in 
subtype 3 CSFcCs compared to subtype 2 CSFcCs, suggests that the proportion of 
non α7*nAChRs is greater in subtype 3 CSFcCs. Although the evidence is indirect 
this could indicate that subtype 3 CSFcCs have a smaller proportion of α7*nAChRs 
than subtype 2 CSFcCs. As subtype 3 CSFcCs could be a more mature phenotype 
than subtype 2 CSFcCs, the smaller proportion of α7*nAChRs in subtype 3 
CSFcCs, is consistent with the reduction in α7*nAChR expression as neurones 
mature in the DG. It could suggest that as CSFcNs mature, they need fewer 
α7*nAChR-mediated cholinergic responses to function correctly. Again in the DG, 
α7*nAChRs have been demonstrated to be essential for the survival and proper 
integration of adult-born neurones into the existing hippocampal circuitry (Campbell 
et al., 2010). It is possible that as with the newborn neurones in the DG, cholinergic 
responses mediated by α7*nAChRs could be important for the survival of CSFcNs. 
If CSFcNs are immature neurones or mature neurones that are involved in 
plasticity, their ability to respond to ACh could also be important for neurite growth 
and path-finding. Experiments have demonstrated that chronic in-vivo nicotine 
exposure increases dendritic length (Brown and Kolb, 2001), however, focal 
pressure application of nicotine induces neurite retraction of cultured chick ciliary 
ganglion neurones in an α-BgT and thus α7*nAChR sensitive manner (Pugh and 
Berg, 1994). In addition, ACh has been shown to induce the turning of nerve growth 
cones through the activation nAChRs during development (Zheng et al., 1994). The 
previous data demonstrate how ACh is capable of influencing neurite growth and 
path-finding, however, it also highlights that the exact role is unclear which makes it 
difficult to determine how it could be affecting such processes in CSFcNs. The 
ability of ACh to influence all of these cellular processes is a result of the Ca2+ 
permeable nature of nAChRs which results in an increase in intracellular Ca2+ (see 
review Fucile (2004)). In particular, the high Ca2+ permeability of α7*nAChRs results 
in the initiation of a number of intracellular effects (Dajas-Bailador and Wonnacott, 
2004). In view of this, an important next step would be to measure the changes in 
intracellular Ca2+ in CSFcNs.  
On the whole, although no evidence of endogenous cholinergic signalling was 
observed, the ability of ependymal cells and CSFcCs to respond to exogenous ACh 
is the first indication that these cells are integrated into the spinal cord circuitry 
through cholinergic signalling. It also suggests that ACh is capable of influencing 
the proliferative capacity of this area and the survival and integration of CSFcNs 
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and finally, indicates that the varying proportions of nAChRs expressed could result 
in differential responses. 
 
Figure 6.1: Possible sources of GABA and ACh. GABA could be released from 
the terminals of GABAergic interneurones, CSFcNs or found within the CSF. ACh 
could be released from cholinergic interneurones or ACh or its breakdown product, 
choline, could be found within the CSF.
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6.2 Technical considerations and limitations 
Although the upmost care was taken to ensure that the most appropriate 
techniques were utilised to examine the cells in this study, all experimental 
techniques have their pros and cons and these must be addressed. Firstly, the use 
of the spinal cord slice preparation will be considered. The prime advantage of this 
preparation is that many of the neuronal circuits are maintained, unlike in cell 
cultures, however, the cells of interest are still highly accessible, unlike during in-
vivo experiments. The disadvantages are that some axons are severed which 
causes the affected cells to become unhealthy and die and it can also result in a 
loss of synaptic inputs onto the cells of interest. Given the complete lack of 
spontaneous activity observed in the ependymal cells, it appears likely that the loss 
of synaptic inputs will have a less significant impact on the phenotype of the 
ependymal cells compared to the impact on other cell types. Nevertheless, inputs 
releasing neurotransmitters in a non-synaptic manner could normally be present 
resulting in different levels of tonic neurotransmitters around ependymal cells and 
the slicing could disrupt some of the gap junction coupled clusters. As CSFcCs 
have fewer processes than many neurones or astrocytes it is likely that they would 
survive the slicing procedure better than many cell types, however, the synaptic 
inputs that they receive could still be interrupted. Even if the cells of interest are not 
damaged, local changes in the environment could induce changes within the cells. 
These changes could occur within minutes, thus affecting the recordings, or they 
could take hours, having a minimal impact on recordings. For example the number 
of receptors present at the cell membrane could be changed within minutes, where 
as changes involving gene transcription would take much longer and are less likely 
to affect the results obtained. A number of modifications have been utilised during 
the spinal cord slice preparation to reduce damage, the spread of cell death and 
thus changes in the environment. For example, the preparation is performed in a 
chilled sucrose based, Na+ free aCSF to reduce cell death by excitotoxicity. Another 
disadvantage of the spinal cord slice preparation is that it restricts the age of the 
animals that can be investigated, as it becomes more difficult to obtain stable 
recordings in slices from older animals. The spinal cord slices used in this study 
were obtained from juvenile animals, P9-P21; therefore they are not fully equivalent 
to an adult spinal cord. The lack of difference in the percentage of CSFcCs in each 
subtype in P21 animals compared to the data from younger animals suggests that 
the study can be tentatively extrapolated to the adult spinal cord. It could be 
suggested that the spinal cord slice procedure results in slices that are more 
representative of a pathological state as opposed to a physiological state. Although 
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this is not intentional, the ultimate interest in this area is to investigate how the cells 
respond to pathological states and how they could be manipulated to promote injury 
during these pathological states. In this light, perhaps the damage created during 
slicing should not be considered as a disadvantage. 
A possible consideration of this study is that the cells were investigated in current 
clamp; this choice was made as the study was primarily interested in the functional 
voltage responses that could be elicited by the cells. For the most part, working in 
current clamp was sufficient to obtain reliable and interesting results. There are 
certain specific questions, however, that could perhaps be more clearly examined 
using voltage clamp. One example is when exploring the passive responses of both 
ependymal cells and subtype 1 CSFcCs. Working in voltage clamp, a study of 
astrocytes throughout the CNS demonstrated that no astrocytes had passive 
responses (Bordey and Sontheimer, 2000). A few astrocytes that initially appeared 
to have a linear current-voltage relationship were shown to possess voltage 
activated currents upon application of a leak subtraction protocol. It is therefore 
possible that the existence of voltage activated currents in ependymal cells and 
subtype 1 CSFcCs could have been overlooked. Other studies have observed 
astrocytes with linear profiles (D'Ambrosio et al., 1998) and the recent study of CC 
ependymal cells observed linear profiles even when using a leak subtraction 
protocol. The rates of onset and desensitisation vary between different nAChRs 
(see review Giniatullin et al., (2005)) and investigating these parameters could have 
been used to reinforce the pharmacological data. Although these parameters could 
be investigated in current clamp they have been more extensively characterised in 
voltage clamp and it could have been an advantage to use this mode.  
The pressure application of ACh was used in this study as it allows immediate rapid 
responses to be observed and reduces the probablility of ACh being broken down. 
It does, however, have the disadvantage that the exact agonist concentration at the 
level of the cell is unknown, as it will become diluted as it interacts with the 
recording aCSF. This is not generally a problem for observing which cells respond 
to ACh but can create difficulties when examining the relative effects of different 
antagonists. As some antagonists will be effective against higher agonist 
concentrations than others, not knowing the agonist concentration could lead to an 
underestimation of the contribution of some receptor subtypes. Despite this, the 
ability of DhβE to almost fully antagonise the cholinergic response in subtype 3 
CSFcCs demonstrates that the concentration of DhβE used can effectively 
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antagonise the cholinergic response, and should be capable of antagonising the 
cholinergic response to similar levels in all cells if the same receptors are present. 
In addition, the ability of MLA to antagonise the PNU-120596 potentiated 
cholinergic response suggests that this concentration of MLA is highly effective 
even at high agonist concentrations. Nevertheless the interpretation of the data 
regarding the contribution of certain nicotinic subtypes to the cholinergic responses 
in different cell subtypes should be viewed solely as interpretations and needs 
further defining, as will be discussed in the future works section.  
The majority of the work concerning cells found within the area surrounding the CC 
has been using turtles and other non-mammalian species (Dervan and Roberts, 
2003; Reali et al., 2011). As mammals, the use of rats and mice within this study 
means that the data can be more confidently related to humans which is the 
ultimate aim of this research and is therefore a great positive of this study. On the 
whole, the most appropriate techniques have been used to study the ependymal 
cells and CSFcCs and they have generated results which provide a solid platform 
from which future studies can be performed. 
 
6.3 Future work 
There are a wide range of future experiments that could be performed, with some of 
the most pertinent already being remarked upon throughout discussion of this work. 
These future experiments could be divided into three main areas: firstly, a direct 
continuation of this work further defining the receptors involved in the cholinergic 
responses, secondly, using culturing techniques or in-vivo protocols to monitor how 
both GABA and ACh influence cell proliferation, differentiation, growth and 
migration and whether 5HT and substance P can affect these processes and 
thirdly, investigating the relationships between the cells within the CC region using 
dual patch clamp electrophysiology. The ultimate aim of all of these future works 
would be to understand the functional importance of this area under physiological 
conditions and to understand how this area could be manipulated following spinal 
cord pathologies to replace damaged cells and enhance functional recovery.  
To further the understanding of the receptors involved in the cholinergic responses 
a combination of performing experiments in gap junction blockers, completing 
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voltage clamp experiments and using genetically modified mice could be employed. 
The gap junction coupled nature of ependymal cells and some subtype 1 CSFcCs 
could be affecting their cholinergic responses, therefore, the experiments could be 
performed in the presence of a gap junction blocker such as 18β-glycyrrhetinic acid. 
This would enable the reversal potential of the cholinergic response to be better 
investigated and would highlight whether all of the cells respond to ACh or whether 
some responses are due to neighbouring cells responding to ACh. Voltage clamp 
experiments would allow the type of current evoked by ACh application to be better 
understood. Both α7*nAChR and β2*nAChR knockout mice are available (as 
demonstrated by Harrist et al., (2004) and Campbell et al.,(2010)); comparison of 
the amplitude and kinetics between wild-type and knockout mice would strengthen 
the evidence of which receptor subunits are involved in the cholinergic responses 
and could give a more reliable estimation of their contribution to the response. To 
further the understanding of the influence of receptor activation on the cells, Ca2+ 
imaging in combination with voltage-gated Ca2+ channel blockers and blockers of 
Ca2+ induced Ca2+ release could be used. Ca2+ imaging would establish whether 
intracellular Ca2+ concentrations are significantly elevated following nAChR 
activation and whether this varies between cell types, with the different blockers 
establishing the source of the Ca2+.    
The influence of GABA and ACh on proliferation of cells within the spinal cord could 
be investigated by using organotypic spinal cord slice cultures. In particular the use 
of PNU-120596 on spinal cord cultures would be informative as this would enhance 
endogenous ACh rather than adding exogenous ACh. PNU-120596 could be 
applied in the presence of MLA as a control, and effects on cell proliferation could 
be monitored by the application of EdU. The effect on specific cell types could be 
evaluated by performing immunohistochemistry with ependymal cell, CSFcC 
subtype 1 and CSFcN specific markers. Given the large proportion of the 
cholinergic response mediated by non α7*nAChR, another experiment in the 
cultures would be to apply DHβE and monitor the effects on proliferation and 
CSFcN numbers. This work could then be translated in-vivo, with injections of PNU-
120596 and EdU given I.P to mice for a week alongside control mice which just 
receive EdU injections. The mice could then be fixed and the spinal cords 
processed to look at the number of EdU-expressing newborn cells and the number 
of PKD2L1-immunoreactive CSFcNs. An alternative to I.P would be to implant 
osmotic minipumps subcutaneously to deliver PNU-120596 over a longer time 
period, at a more consistent level. The effects of GABA and associated antagonists 
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on cell proliferation and numbers of CSFcNs could also be investigated using the 
organotypic spinal cord slice culture. In particular the use of specific GABA 
modulators, such as diazepam, within the cultures would be interesting. Given the 
lack of immediate effects of 5HT and substance P observed in this study, the 
organotypic slice preparation would be a very useful technique to use to investigate 
whether 5HT and substance P are having any long term effects on CSFcNs, such 
as effects on their growth or migration; although further more extensive 
electrophysiological experiments measuring more parameters such as capacitance 
could also be undertaken for 5HT and substance P. A final experiment to be 
considered using the organotypic spinal cord slice culture would be to injure an 
area of the cord and investigate whether this causes changes in proliferation or 
whether it induces migration of CSFcNs. If this does induce changes, the effect of 
GABAergic and cholinergic modulators on the changes could be investigated. 
The relationships between the cells in the area surrounding the CC would be very 
interesting to examine. Dual patch clamp electrophysiology could be used to 
investigate the relationship between ependymal cells and CSFcNs, ependymal cells 
and subtype 1 CSFcCs, subtype 1 CSFcCs and CSFcNs, two ependymal cells or 
two CSFcNs. It would be interesting to stimulate a CSFcN and record from any 
other cell in order to determine whether CSFcNs are capable of releasing GABA 
into the CSF. If a response was observed in the other cell, for example an 
ependymal cell, different GABAA receptor antagonists or modulators could be 
applied to see whether the response could be antagonised or enhanced. An 
alternative way to investigate the relationship between CSFcNs and ependymal 
cells would be to specifically knock-out the CSFcNs and then study the subsequent 
effect on ependymal cell survival and proliferation. The most thorough method of 
specifically removing CSFcNs would be to selectively express diphtheria toxin in 
CSFcNs; this could be achieved by targeting diphtheria toxin to PKD2L1 expressing 
cells, as CSFcNs are the only cells within the spinal cord to express PKD2L1. Such 
mice have been used previously to study the effect of removing PKD2L1 expressing 
taste cells in the tongue (Huang et al., 2006). To investigate the lineage of cells 
surrounding the CC and determine whether any CSFcCs originate from ependymal 
cells the FoxJ1-CreER-RFP mouse could be used; similar mice have been used to 
great effect before by Meletis et al., (2008) and Barnabe-Heider et al., (2010). 
FoxJ1 is expressed solely in cells with motile cilia, therefore in the spinal cord, only 
ependymal cells express FoxJ1. The Cre reporter background of the FoxJ1-CreER 
mice means that the administration of tamoxifen allows inducible, permanent and 
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heritable genetic labelling by the expression of red fluorescent protein (RFP). As a 
result, long term studies of the progeny of ependymal cells can be conducted, with 
the identity of the progeny being distinguished by dual labelling for specific markers 
such as PKD2L1.  
Given the relatively few studies that have been undertaken regarding this area of 
the CC, it is not surprising that the list of future experiments could be far more 
extensive. The experiments suggested are those that are considered to be the most 
relevant to this current study, the most pertinent to discover functional importance 
of ependymal cells and CSFcNs and finally, the most realistic and viable.  
 
6.4 The functional relevance of studying the area surrounding the CC   
There are many situations in which the spinal cord can no longer function to its full 
capacity. These include following a spinal cord injury, during a degenerative illness 
such as multiple sclerosis or simply during ageing. The decline in function can often 
be attributed to a loss of cells, whether it is a dramatic loss of numerous cell types 
including neurones following a spinal cord injury, a slower decline in cell numbers 
with age (Terao et al., 1996) or the specific loss of oligodendrocytes during multiple 
sclerosis. Some of these pathological states are being treated by the use of stem 
cell grafts; however, there is still debate about the practicality of this treatment 
method and there are of course ethical debates over the use of certain types of 
stem cells (Karussis and Kassis, 2008; Thomas and Moon, 2011). In addition, the 
slow loss of cell numbers with age would not be suited to treatment by a stem cell 
graft but would be better suited by a therapy which increases the survival of cells or 
produces new cells at a slower, steady rate. The presence of a population of 
endogenous neural stem cells within the spinal cord is therefore of great 
importance. Following a complete spinal cord transection in lower vertebrates, the 
ependymal cells proliferate and the area surrounding the CC bridges the 
transection, enabling the rest of the spinal cord to reform (Dervan and Roberts, 
2003). The spinal cord of mammals have not retained this regenerative capability, 
however, ependymal cells have still retained the characteristics of neural stem cells 
(Weiss et al., 1996). Under physiological conditions, ependymal cell proliferation is 
symmetrical and appears to simply maintain the ependymal cell population 
(Johansson et al., 1999). Following a spinal cord injury, however, ependymal cells 
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can produce astrocytes and oligodendrocytes (Barnabe-Heider et al., 2010) and in 
a model of multiple sclerosis ependymal cells have been observed to produce new 
neurones (Danilov et al., 2006). The environmental changes that occur in these 
pathological situations must be inducing the transformation from self-renewal to 
differentiation, although what these environmental changes are is not known. It is 
therefore important to determine what stimuli ependymal cells and their 
neighbouring cells respond to and how changes in these stimuli alter the behaviour 
of ependymal cells, as well as determining what stimuli are important for the 
survival of these cells. If this can be understood it could be possible to manipulate 
the proliferation and differentiation of ependymal cells to replace the specific cell 
type that has been affected by a particular pathology.   
 
6.5 Conclusions 
This study has provided an in-depth functional characterisation of the phenotypes of 
cells surrounding the CC of the postnatal mammalian spinal cord and their ability to 
respond to neurotransmitters. The variation of phenotypes demonstrates the 
complexity of the area and the need for further investigation. The ability of 
ependymal cells and CSFcCs to respond to both GABA and ACh suggests that this 
potential neurogenic niche could be influenced by these two neurotransmitters, 
drawing parallels to other postnatal neurogenic niches. It is possible that the 
manipulation of one or both of these neurotransmitter systems could allow a greater 
control over the proliferation and differentiation of cells within this area, with 
beneficial implications for the treatment of spinal cord injury or spinal cord 
pathologies, such as multiple sclerosis. The fundamental physiological responses 
revealed in this study are essential to provide a solid platform on which to build 
towards future clinically relevant studies.  
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